RENAL DOSING BASED ON CREATININE CLEARANCE
abacavir - lamivudine - zidovudine (TRIZIVIR) 300-150-300 mg tablet Yes Renal Dosing:
CrCl<50ml/min: avoid – use separate products
Abacavir component - no adjustment needed
Lamivudine component
CrCl 30-49ml/min: 150mg daily
CrCl 15-29ml/min: 150mg x1, then 100mg daily
Cr Oral
abacavir - lamivudine (EPZICOM) 600-300 mg tablet Yes Renal Dosing:
CrCl<50ml/min: avoid – use separate products
Abacavir component - no adjustment needed
Lamivudine component
CrCl 30-49ml/min: 150mg daily
CrCl 15-29ml/min: 150mg x1, then 100mg daily
CrCl 5-14ml/ Oral
acamprosate (CAMPRAL) 333 mg tablet Yes Renal Dosing:
CrCl 30-50ml/min: initial dose 333mg po tid
CrCl<30ml/min: avoid Oral
acarbose (PRECOSE) 100 mg tablet No Dispense 2 x 50mg
Renal Dosing:
CrCl < 50ml/min: Avoid Oral
acarbose (PRECOSE) 25 mg tablet No Dispense 1/2 of 50mg Oral
acarbose (PRECOSE) 50mg tablet Yes Oral
acebutolol (SECTRAL) 200 mg capsule Yes Renal Dosing:
CrCl 25-50ml/min: decrease usual dose 50%
CrCl<25ml/min: decrease usual dose by 75% Oral
acebutolol (SECTRAL) 400 mg capsule No Dispense 2 x 200mg
Renal Dosing:
CrCl 25-50ml/min: decrease usual dose 50%
CrCl<25ml/min: decrease usual dose by 75% Oral
acetaminophen - asprin - caffeine (EXCEDRIN ES, EXCEDRIN MIGRAINE) 250-250-65 mg tablet Yes Oral
acetaminophen - butalbital - caffeine - codeine (FIORICET with CODEINE #3) 325-50-40-30 mg capsule Yes Renal Dosing:
Codeine
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
acetaminophen - codeine (COCET) 650-30 mg tablet No Renal Dosing:
Codeine
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
acetaminophen - codeine (TYLENOL #2) 300-15 mg tablet Yes Renal Dosing:
Codeine
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
acetaminophen - codeine (TYLENOL #3) 300-30 mg tablet Yes Renal Dosing:
Codeine
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
acetaminophen - codeine (TYLENOL #4) 300-60 mg tablet Yes Renal Dosing:
Codeine
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
acetaminophen - codeine (TYLENOL WITH CODEINE) 120-12 mg/5 ml oral liquid Yes Renal Dosing:
Codeine
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
acetaminophen - codeine (VOPAC) 650-30 mg tablet No Renal Dosing:
Codeine
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
acetaZOLAMIDE (DIAMOX) 125 mg tablet No Dispense 1/2 of 250mg
Renal Dosing:
CrCl >50ml/min: q6h
CrCl 10-50ml/min: q12h
CrCl <10ml/min: Avoid Oral
acetaZOLAMIDE (DIAMOX) 250 mg tablet Yes Renal Dosing:
CrCl >50ml/min: q6h
CrCl 10-50ml/min: q12h
CrCl <10ml/min: Avoid Oral
acetaZOLAMIDE (DIAMOX) 500 mg injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl >50ml/min: q6h
CrCl 10-50ml/min: q12h
CrCl <10ml/min: Avoid Injection
acetaZOLAMIDE ER (DIAMOX SEQUELS) 500 mg capsule Yes Renal Dosing:
CrCl >50ml/min: q6h
CrCl 10-50ml/min: q12h
CrCl <10ml/min: Avoid Oral
acyclovir (ZOVIRAX) 200 mg capsule Yes Renal Dosing:
Normal dose CrCl Adjusted dose
200mg q4h >10ml/min 200mg q4h, 5xdaily
0-10ml/min 200mg q12
400mg q12h >10ml/min 400mg q12h
0-10ml/min 200mg q12h
800m Oral
acyclovir (ZOVIRAX) 200 mg/5 ml oral liquid No Renal Dosing:
Normal dose CrCl Adjusted dose
200mg q4h >10ml/min 200mg q4h, 5xdaily
0-10ml/min 200mg q12
400mg q12h >10ml/min 400mg q12h
0-10ml/min 200mg q12h
800m Oral
acyclovir (ZOVIRAX) 400 mg tablet No Dispense 2 x 200mg capsule
Renal Dosing:
Normal dose CrCl Adjusted dose
200mg q4h >10ml/min 200mg q4h, 5xdaily
0-10ml/min 200mg q12
400mg q12h >10ml/min 400mg q12h
0-10m Oral
acyclovir (ZOVIRAX) 5% topical cream No Topical
acyclovir (ZOVIRAX) 5% topical ointment Yes Topical
acyclovir (ZOVIRAX) 800 mg tablet Yes Renal Dosing:
Normal dose CrCl Adjusted dose
200mg q4h >10ml/min 200mg q4h, 5xdaily
0-10ml/min 200mg q12
400mg q12h >10ml/min 400mg q12h
0-10ml/min 200mg q12h
800m Oral
acyclovir (ZOVIRAX) injection Yes Dosing should be based on IBW in obese patients
Renal Dosing:
CrCl % of Usual Dose Dosing Interval
>50ml/min 100 q8h
25-50ml/min 100 q12h
10-25ml/min 100 IVPB
adalimumab (HUMIRA) 40mg injection Yes Subcutaneous
adapalene (DIFFERIN) 0.1% topical cream No Not routinely stocked - Order PRN Topical
adapalene (DIFFERIN) 0.1% topical gel No Not routinely stocked - Order PRN Topical
adapalene (DIFFERIN) 0.1% topical solution No Not routinely stocked - Order PRN Topical
adapalene (DIFFERIN) 0.3% topical gel No Not routinely stocked - Order PRN Topical
adefovir (HEPSERA) 10 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: 10mg q24h
CrCl 20-49ml/min: 10mg q48h
CrCl 10-19ml/min: 10mg q72h
CrCl<10ml/min: 10mg q week Oral
alendronate - cholecalciferol (FOSAMAX PLUS D) 70mg-2800 unit tablet No Renal Dosing:
CrCl < 35ml/min: Avoid Oral
alendronate (FOSAMAX ) 35 mg weekly tablet Yes Renal Dosing:
CrCl < 35ml/min: Avoid Oral
alendronate (FOSAMAX ) 70 mg weekly tablet Yes Renal Dosing:
CrCl < 35ml/min: Avoid Oral
alendronate (FOSAMAX) 10 mg tablet Yes Renal Dosing:
CrCl < 35ml/min: Avoid Oral
alendronate (FOSAMAX) 40 mg tablet No Dispense 4 x 10mg
Renal Dosing:
CrCl < 35ml/min: Avoid Oral
alendronate (FOSAMAX) 5 mg tablet Yes Renal Dosing:
CrCl < 35ml/min: Avoid Oral
alendronate (FOSAMAX) 70 mg/75 ml oral liquid No Renal Dosing:
CrCl < 35ml/min: Avoid Oral
allopurinol (ALOPRIM) IVPB Yes Renal Dosing:
CrCl >20ml/min: 300mg daily
CrCl 10-20ml/min: 200mg daily
CrCl <10ml/min: 100mg daily IVPB
allopurinol (ZYLOPRIM) 100 mg tablet Yes Renal Dosing:
CrCl >20ml/min: 300mg daily
CrCl 10-20ml/min: 200mg daily
CrCl <10ml/min: 100mg daily Oral
allopurinol (ZYLOPRIM) 300 mg tablet Yes Renal Dosing:
CrCl >20ml/min: 300mg daily
CrCl 10-20ml/min: 200mg daily
CrCl <10ml/min: 100mg daily Oral
almotriptan (AXERT) 12.5 mg tablet No Renal Dosing:
CrCl<10ml/min: initial dose 6.26mg, may repeat in 2 hours.
Maximum 24 hour dose 12.5mg Oral
almotriptan (AXERT) 6.25 mg tablet No Renal Dosing:
CrCl<10ml/min: initial dose 6.26mg, may repeat in 2 hours.
Maximum 24 hour dose 12.5mg Oral
amantadine (SYMMETREL) 50 mg/5ml oral liquid Yes Renal Dosing:
CrCl 30-50ml/min: 100mg daily
CrCl 15-29ml/min: 100mg qod
CrCl<15ml/min: 200mg qwk Oral
amantadine (SYMMETREL) 100 mg capsule Yes Renal Dosing:
CrCl 30-50ml/min: 100mg daily
CrCl 15-29ml/min: 100mg qod
CrCl<15ml/min: 200mg qwk Oral
amantadine (SYMMETREL) 100 mg tablet No Renal Dosing:
CrCl 30-50ml/min: 100mg daily
CrCl 15-29ml/min: 100mg qod
CrCl<15ml/min: 200mg qwk Oral
amikacin (AMIKIN) injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment IVPB
amikacin (AMIKIN) intravitreal injection Yes Injection
amiloride - hydrochlorothiazide (MODURETIC) 5-50 mg tablet No Dispense individual ingredients
Renal Dosing:
Amiloride
CrCl 10-50ml/min: reduce dose by 50%
CrCl <10ml/min: avoid
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
amiloride (MIDAMOR) 5 mg tablet Yes Renal Dosing:
Amiloride
CrCl 10-50ml/min: reduce dose by 50%
CrCl <10ml/min: avoid Oral
aminocaproic acid (AMICAR) 250mg/ml oral liquid No Renal Dosing:
Reduce dose by 15-25% in patients with renal disease Oral
aminocaproic acid (AMICAR) 5 g (Loading dose) Yes Renal Dosing:
Reduce dose by 15-25% in patients with renal disease IVPB
aminocaproic acid (AMICAR) 500 mg tablet Patients with renal impairment and HIV: Renal Dosing:
Reduce dose by 15-25% in patients with renal disease Oral
aminocaproic acid (AMICAR) drip Yes Renal Dosing:
Reduce dose by 15-25% in patients with renal disease Drips
aminocaproic acid (AMICAR) syringe drip (conc: 250 mg/ml) Yes Renal Dosing:
Reduce dose by 15-25% in patients with renal disease Drips
amoxicillin - clarithromycin - lansoprazole (PREVPAC) 500-500-30 mg pack No Renal Dosing:
Amoxicillin
CrCl 10-30ml/min: 250-500mg q12h
CrCl<10ml/min: 250-500mg q24h
Clarithromycin
CrCl <30ml/min: Halve the normal dose or double
the dosing interval. Oral
amoxicillin - clavulanate (AUGMENTIN ES) 600-42.9 mg/5 ml oral liquid No Renal Dosing:
CrCl 10-30ml/min: 250-500mg q12h
CrCl<10ml/min: 250-500mg q24h Oral
amoxicillin - clavulanate (AUGMENTIN) 250-125 mg tablet Yes Renal Dosing:
CrCl 10-30ml/min: 250-500mg q12h
CrCl<10ml/min: 250-500mg q24h Oral
amoxicillin - clavulanate (AUGMENTIN) 250-62.5 mg/5 ml oral liquid Yes Renal Dosing:
CrCl 10-30ml/min: 250-500mg q12h
CrCl<10ml/min: 250-500mg q24h Oral
amoxicillin - clavulanate (AUGMENTIN) 400-57 mg/5 ml oral liquid Yes Renal Dosing:
CrCl 10-30ml/min: 250-500mg q12h
CrCl<10ml/min: 250-500mg q24h Oral
amoxicillin - clavulanate (AUGMENTIN) 500-125 mg tablet Yes Renal Dosing:
CrCl 10-30ml/min: 250-500mg q12h
CrCl<10ml/min: 250-500mg q24h Oral
amoxicillin - clavulanate (AUGMENTIN) 875-125 mg tablet Yes Renal Dosing:
CrCl 10-30ml/min: 250-500mg q12h
CrCl<10ml/min: 250-500mg q24h Oral
amoxicillin - clavulanate ER (AUGMENTIN XR) 1000-62.5 mg tablet Yes Renal Dosing:
Do not use the extended release products in patients with CrCl < 30ml/min Oral
amoxicillin (AMOXIL, TRIMOX) 250 mg capsule Yes Renal Dosing:
CrCl 10-30ml/min: 250-500mg q12h
CrCl<10ml/min: 250-500mg q24h Oral
amoxicillin (AMOXIL, TRIMOX) 400 mg/5 ml oral liquid Yes Renal Dosing:
CrCl 10-30ml/min: 250-500mg q12h
CrCl<10ml/min: 250-500mg q24h Oral
amoxicillin (AMOXIL, TRIMOX) 500 mg capsule Yes Renal Dosing:
CrCl 10-30ml/min: 250-500mg q12h
CrCl<10ml/min: 250-500mg q24h Oral
amoxicillin (AMOXIL, TRIMOX) 875 mg tablet No Renal Dosing:
Do not use the 875 mg tablet in patients with CrCl < 30ml/min Oral
amphotericin B (FUNGIZONE) IVPB Yes Renal Dosing:
CrCl <10ml/min, extend dosing interval to q36h IVPB
amphotericin B cholesteryl sulfate complex (AMPHOTEC) injection No Renal Dosing:
Consider reducing dose if creatinine increases to 2.5-3.0mg/dl during therapy. If the creatinine increases beyond 3.0mg/dl, therapy may need to be interrupted until the creatinine decreases to <2.5.mg/dl. IVPB
amphotericin B lipid complex (ABELCET) injection No Renal Dosing:
Consider reducing dose if creatinine increases to 2.5-3.0mg/dl during therapy. If the creatinine increases beyond 3.0mg/dl, therapy may need to be interrupted until the creatinine decreases to <2.5.mg/dl. IVPB
amphotericin B liposomal (AMBISOME) injection Yes Renal Dosing:
Consider reducing dose if creatinine increases to 2.5-3.0mg/dl during therapy. If the creatinine increases beyond 3.0mg/dl, therapy may need to be interrupted until the creatinine decreases to <2.5.mg/dl. IVPB
ampicillin - sulbactam (UNASYN) 1.5 g injection Yes Renal Dosing:
CrCl >29ml/min: 1.5-3gm q6-8h
CrCl 15-29ml/min: 1.5-3gm q12h
CrCl 5-14ml/min: 1.5-3gm q24h Intravenous
ampicillin - sulbactam (UNASYN) 3 g injection Yes Renal Dosing:
CrCl >29ml/min: 1.5-3gm q6-8h
CrCl 15-29ml/min: 1.5-3gm q12h
CrCl 5-14ml/min: 1.5-3gm q24h Injection
ampicillin (POLYCILLIN, OMNIPEN) 1 g injection Yes Renal Dosing:
CrCl>50ml/min: dose ampicillin q6h
CrCl 10-50ml/min: dose ampicillin q6-12h
CrCl<10ml/min: dose ampicillin q12-16h Intravenous
ampicillin (POLYCILLIN, OMNIPEN) 2 g injection Yes Renal Dosing:
CrCl>50ml/min: dose ampicillin q6h
CrCl 10-50ml/min: dose ampicillin q6-12h
CrCl<10ml/min: dose ampicillin q12-16h Injection
ampicillin (POLYCILLIN, OMNIPEN) 250 mg capsule Yes Renal Dosing:
CrCl>50ml/min: dose ampicillin q6h
CrCl 10-50ml/min: dose ampicillin q6-12h
CrCl<10ml/min: dose ampicillin q12-16h Oral
ampicillin (POLYCILLIN, OMNIPEN) 250 mg/5 ml oral liquid Yes Renal Dosing:
CrCl>50ml/min: dose ampicillin q6h
CrCl 10-50ml/min: dose ampicillin q6-12h
CrCl<10ml/min: dose ampicillin q12-16h Oral
ampicillin (POLYCILLIN, OMNIPEN) 500 mg capsule Yes Renal Dosing:
CrCl>50ml/min: dose ampicillin q6h
CrCl 10-50ml/min: dose ampicillin q6-12h
CrCl<10ml/min: dose ampicillin q12-16h Oral
ampicillin (POLYCILLIN, OMNIPEN) 500 mg injection Yes Renal Dosing:
CrCl>50ml/min: dose ampicillin q6h
CrCl 10-50ml/min: dose ampicillin q6-12h
CrCl<10ml/min: dose ampicillin q12-16h Intravenous
amprenavir (AGENERASE) 15 mg/ml oral solution No Withdranw from the Market (December 2007)
Renal Dosing:
Contraindicated in patients with renal failure due to accumulation of propylene glycol in the vehicle. Oral
apomorphine (APOKYN) 10 mg/ml injection No Renal Dosing:
The test dose and the initial dose should be decreased to 1mg in patients with mild to moderate renal impairment. Subcutaneous
aspirin - caffeine - butalbital - codeine (FIORINAL - CODEINE #3) 325-40-50-30 mg capsule No Renal Dosing:
Aspirin
Reduce dose in impaired renal function.
Avoid in patients with end stage renal disease
Codeine
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
aspirin (ALKA-SELTZER) EFFERVESCENT 325 mg tablet No Renal Dosing:
Reduce dose in impaired renal function. Avoid in patients with end stage renal disease. Oral
aspirin (BAYER CHILDRENS ASPIRIN) 81 mg chewable tablet Yes Renal Dosing:
Reduce dose in impaired renal function. Avoid in patients with end stage renal disease. Oral
aspirin 325 mg tablet Yes Renal Dosing:
Reduce dose in impaired renal function. Avoid in patients with end stage renal disease. Oral
aspirin desentization solution Yes Oral
aspirin desentization tablet Yes Oral
aspirin EC (ECOTRIN) 325 mg tablet Yes Renal Dosing:
Reduce dose in impaired renal function. Avoid in patients with end stage renal disease. Oral
aspirin EC (ECOTRIN, HALFPRIN) 162 mg tablet Yes Renal Dosing:
Reduce dose in impaired renal function. Avoid in patients with end stage renal disease. Oral
aspirin EC (ECOTRIN, HALFPRIN) 81 mg tablet Yes Renal Dosing:
Reduce dose in impaired renal function. Avoid in patients with end stage renal disease. Oral
aspirin(ASA) 300mg rectal suppository Yes Renal Dosing:
Reduce dose in impaired renal function. Avoid in patients with end stage renal disease. Rectal
aspirin(ASA) 600mg rectal suppository Yes Renal Dosing:
Reduce dose in impaired renal function. Avoid in patients with end stage renal disease. Rectal
aspirin, buffered (BUFFERIN) 325 mg tablet No Renal Dosing:
Reduce dose in impaired renal function. Avoid in patients with end stage renal disease. Oral
aspirin-codeine (EMPIRIN W/CODEINE #3) 325-30 mg tablet No Renal Dosing:
Aspirin
Reduce dose in impaired renal function.
Avoid in patients with end stage renal disease.
Codeine
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
aspirin-codeine (EMPIRIN W/CODEINE #4) 325-60 mg tablet No Renal Dosing:
Aspirin
Reduce dose in impaired renal function.
Avoid in patients with end stage renal disease.
Codeine
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
aspirin-hydrocodone (DAMASON-P) 500-5 mg tablet No Renal Dosing:
Aspirin
Reduce dose in impaired renal function.
Avoid in patients with end stage renal disease. Oral
asprin - caffeine - butalbital (FIORINAL) 325-50-40 mg capsule No Renal Dosing:
Aspirin
Reduce dose in impaired renal function.
Avoid in patients with end stage renal disease. Oral
atazanavir (REYATAZ) 200 mg capsule Yes Oral
atazanavir (REYATAZ) 300 mg capsule Yes Oral
atenolol - chlorthalidone (TENORETIC) 100-25 mg tablet No Dispense individual ingredients
Renal Dosing:
Avoid in patients with renal failure Oral
atenolol - chlorthalidone (TENORETIC) 50-25 mg tablet No Dispense individual ingredients
Renal Dosing:
Avoid in patients with renal failure Oral
atenolol (TENORMIN) 100 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: give 50% of usual dose
CrCl<10ml/min: give 25% of usual dose
CrCl 15-35ml/min: max dose 50mg/day
CrCl<15ml/min: max dose 25mg/day Oral
atenolol (TENORMIN) 25 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: give 50% of usual dose
CrCl<10ml/min: give 25% of usual dose
CrCl 15-35ml/min: max dose 50mg/day
CrCl<15ml/min: max dose 25mg/day Oral
atenolol (TENORMIN) 50 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: give 50% of usual dose
CrCl<10ml/min: give 25% of usual dose
CrCl 15-35ml/min: max dose 50mg/day
CrCl<15ml/min: max dose 25mg/day Oral
atovaquone - proguanil (MALARONE) 250-100 mg tablet Yes Renal Dosing:
CrCl < 30ml/min: Avoid Oral
azathioprine (IMURAN) injection Yes Renal Dosing:
CrCl 10-50ml/min: give 75% of usual dose
CrCl<10ml/min: give 50% of usual dose IVPB
azathioprine (IMURAN, AZASAN) 100 mg tablet No Dispense 2 x 50mg
Renal Dosing:
CrCl 10-50ml/min: give 75% of usual dose
CrCl<10ml/min: give 50% of usual dose" Oral
azathioprine (IMURAN, AZASAN) 50 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: give 75% of usual dose
CrCl<10ml/min: give 50% of usual dose Oral
azathioprine (IMURAN, AZASAN) 75 mg tablet No Dispense 1.5 of 50mg
Renal Dosing:
CrCl 10-50ml/min: give 75% of usual dose
CrCl<10ml/min: give 50% of usual dose" Oral
aztreonam (AZACTAM) 1 g injection Yes Renal Dosing:
CrCl 10-50ml/min: 1-2gm q8-12h
CrCl<10ml/min: 1gm q12-24h Injection
aztreonam (AZACTAM) 2 g injection Yes Renal Dosing:
CrCl 10-50ml/min: 1-2gm q8-12h
CrCl<10ml/min: 1gm q12-24h Injection
benazapril-hydrochlorothiazide (LOTENSIN HCT) 10-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Benazepril
CrCl 10-50ml/min: give 50-75% of usual dose
CrCl<10ml/min: give 25-50% of usual dose
Maximum daily dose is 40mg/day
Hydrochlorothiazide
Usually ineffective in patien Oral
benazapril-hydrochlorothiazide (LOTENSIN HCT) 20-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Benazepril
CrCl 10-50ml/min: give 50-75% of usual dose
CrCl<10ml/min: give 25-50% of usual dose
Maximum daily dose is 40mg/day
Hydrochlorothiazide
Usually ineffective in patien Oral
benazapril-hydrochlorothiazide (LOTENSIN HCT) 20-25 mg tablet No Dispense individual ingredients
Renal Dosing:
Benazepril
CrCl 10-50ml/min: give 50-75% of usual dose
CrCl<10ml/min: give 25-50% of usual dose
Maximum daily dose is 40mg/day
Hydrochlorothiazide
Usually ineffective in patien Oral
benazapril-hydrochlorothiazide (LOTENSIN HCT) 5-6.25 mg tablet Yes Renal Dosing:
Benazepril
CrCl 10-50ml/min: give 50-75% of usual dose
CrCl<10ml/min: give 25-50% of usual dose
Maximum daily dose is 40mg/day
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
benazepril (LOTENSIN) 10 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: give 50-75% of usual dose
CrCl<10ml/min: give 25-50% of usual dose
Maximum daily dose is 40mg/day Oral
benazepril (LOTENSIN) 20 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: give 50-75% of usual dose
CrCl<10ml/min: give 25-50% of usual dose
Maximum daily dose is 40mg/day Oral
benazepril (LOTENSIN) 40 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: give 50-75% of usual dose
CrCl<10ml/min: give 25-50% of usual dose
Maximum daily dose is 40mg/day Oral
benazepril (LOTENSIN) 5 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: give 50-75% of usual dose
CrCl<10ml/min: give 25-50% of usual dose
Maximum daily dose is 40mg/day Oral
betaxolol (KERLONE) 10 mg tablet Yes Renal Dosing:
CrCl<10ml/min: maximum daily dose 20mg Oral
bismuth subsalicylate (KAOPECTATE ES, PEPTO-BISMOL MS) 525mg/15 ml oral liquid No Renal Dosing:
CrCl 10-50ml/min: short course (less than 4 weeks)
CrCl<10ml/min: Avoid Oral
bismuth subsalicylate (KAOPECTATE, PEPTO-BISMOL) 262 mg/15 ml oral liquid No Renal Dosing:
CrCl 10-50ml/min: short course (less than 4 weeks)
CrCl<10ml/min: Avoid Oral
bismuth subsalicylate (PEPTO-BISMOL) 262 mg chewable tablet Yes Renal Dosing:
CrCl 10-50ml/min: short course (less than 4 weeks)
CrCl<10ml/min: Avoid Oral
bisoprolol - hydrochlorothiazide (ZIAC) 10-6.25 mg tablet Yes Renal Dosing:
Bisoprolol
CrCl<10ml/min: maximum daily dose 10mg
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
bisoprolol - hydrochlorothiazide (ZIAC) 2.5-6.25 mg tablet Yes Renal Dosing:
Bisoprolol
CrCl<10ml/min: maximum daily dose 10mg
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
bisoprolol - hydrochlorothiazide (ZIAC) 5-6.25 mg tablet Yes Renal Dosing:
Bisoprolol
CrCl<10ml/min: maximum daily dose 10mg
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
bisoprolol (ZEBETA ) 10 mg tablet No Dispense 2 x 5mg
Renal Dosing:
CrCl<10ml/min: maximum daily dose 10mg Oral
bisoprolol (ZEBETA ) 5 mg tablet Yes Renal Dosing:
CrCl<10ml/min: maximum daily dose 10mg Oral
bitolterol (TORNALATE) 0.2% nebulizer solution No Withdrawn from the Market (December 2008) Inhalation
bivalirudin (ANGIOMAX) 250 mg/5 ml injection (loading dose) Yes May be administered in: Cath Lab Only Intravenous
bivalirudin (ANGIOMAX) drip Yes May be administered in: Cath Lab Only Drips
bleomycin (BLENOXANE) 15 unit chemo injection Yes Renal Dosing:
CrCl 10-50ml/min: give 75% of usual dose
CrCl<10ml/min: give 50% of usual dose Injection
bleomycin (BLENOXANE) chemo infusion Yes Renal Dosing:
CrCl 10-50ml/min: give 75% of usual dose
CrCl<10ml/min: give 50% of usual dose Chemo
busPIRone (BUSPAR) 10 mg tablet Yes Renal Dosing:
CrCl<10ml/min: reduce dose 25-50% Oral
busPIRone (BUSPAR) 15 mg tablet No Dispense 1 x 10mg + 1 x 5mg
Renal Dosing:
CrCl<10ml/min: reduce dose 25-50% Oral
busPIRone (BUSPAR) 30 mg tablet No Dispense 3 x 10mg
Renal Dosing:
CrCl<10ml/min: reduce dose 25-50% Oral
busPIRone (BUSPAR) 5 mg tablet Yes Renal Dosing:
CrCl<10ml/min: reduce dose 25-50% Oral
busPIRone (BUSPAR) 7.5 mgtablet No Dispense 1.5 x 5mg
Renal Dosing:
CrCl<10ml/min: reduce dose 25-50% Oral
butorphanol (STADOL NS) 10 mg/ml nasal spray No Renal Dosing:
CrCl 10-50ml/min: give 75% of usual dose
CrCl<10ml/min: give 50% of usual dose
Use same dosing intervals. Nasal
butorphanol (STADOL) 1 mg/ml injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl 10-50ml/min: give 75% of usual dose
CrCl<10ml/min: give 50% of usual dose
Use same dosing intervals Injection
butorphanol (STADOL) 2 mg/ml injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl 10-50ml/min: give 75% of usual dose
CrCl<10ml/min: give 50% of usual dose
Use same dosing intervals Injection
candesartan - hydrochlorothiazide (ATACAND HCT) 16-12.5 mg tablet No Dispense individual ingredients
Renal Dosing
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
candesartan - hydrochlorothiazide (ATACAND HCT) 32-12.5 mg tablet No Dispense individual ingredients
Renal Dosing
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
candesartan - hydrochlorothiazide (ATACAND HCT) 32-25 mg tablet No Dispense individual ingredients
Renal Dosing
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
candesartan (ATACAND) 16 mg tablet Yes Oral
candesartan (ATACAND) 32 mg tablet No Dispense 2 x 16mg Oral
candesartan (ATACAND) 4 mg tablet No Dispense 1/2 x 8mg Oral
candesartan (ATACAND) 8 mg tablet Yes Oral
candida albicans (CANDIDA SKIN TEST) injection Yes Intradermal
capecitabine (XELODA) 150 mg tablet Yes Renal Dosing:
CrCl 30-50ml/min: give 75% of usual dose
CrCl<30ml/min: avoid Oral
capecitabine (XELODA) 500 mg tablet Yes Renal Dosing:
CrCl 30-50ml/min: give 75% of usual dose
CrCl<30ml/min: avoid Oral
captopril - hydrochlorothiazide (CAPTOZIDE) 25 - 25 mg tablet No Dispense individual ingredients
Renal Dosing:
Captopril
CrCl 10-50ml/min: 75% of usual dose q8-12h
CrCl<10ml/min: 50% of usual dose q24h
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
captopril - hydrochlorothiazide (CAPTOZIDE) 50- 25 mg tablet No Dispense individual ingredients
Renal Dosing:
Captopril
CrCl 10-50ml/min: 75% of usual dose q8-12h
CrCl<10ml/min: 50% of usual dose q24h
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
CAPTOpril (capOTEN) 100 mg tablet No Dispense 2 x 50mg
Renal Dosing:
CrCl 10-50ml/min: 75% of usual dose q8-12h
CrCl<10ml/min: 50% of usual dose q24h Oral
CAPTOpril (capOTEN) 12.5 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: 75% of usual dose q8-12h
CrCl<10ml/min: 50% of usual dose q24h Oral
CAPTOpril (capOTEN) 25 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: 75% of usual dose q8-12h
CrCl<10ml/min: 50% of usual dose q24h Oral
CAPTOpril (capOTEN) 50 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: 75% of usual dose q8-12h
CrCl<10ml/min: 50% of usual dose q24h Oral
CAPTOpril (capOTEN) 6.25 mg tablet No Dispense 0.5 x 12.5mg
Renal Dosing:
CrCl 10-50ml/min: 75% of usual dose q8-12h
CrCl<10ml/min: 50% of usual dose q24h Oral
CAPTOpril-hydrochlorothiazide (CAPTOZIDE 25/15) 25-15 mg tablet No Renal Dosing:
Captopril
CrCl 10-50ml/min: 75% of usual dose q8-12h
CrCl<10ml/min: 50% of usual dose q24h
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
CAPTOpril-hydrochlorothiazide (CAPTOZIDE 50/15) 50-15 mg tablet No Renal Dosing:
Captopril
CrCl 10-50ml/min: 75% of usual dose q8-12h
CrCl<10ml/min: 50% of usual dose q24h
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
carisoprodil - aspirin (SOMA COMPOUND) 200-325 mg tablet No Renal Dosing:
Aspirin
Reduce dose in impaired renal function.
Avoid in patients with end stage renal disease. Oral
carisoprodil - asprin - codine (SOMA COMPOUND WITH CODEINE) 200-325-16 mg tablet No Renal Dosing:
Aspirin
Reduce dose in impaired renal function.
Avoid in patients with end stage renal disease
Codeine
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
carteolol (CARTROL) 2.5 mg tablet Yes Renal Dosing:
CrCl 20-60ml/min: usual dose q48h
CrCl<20ml/min: usual dose q72h Oral
carteolol (CARTROL) 5 mg tablet No Dispense 2 x 2.5mg
Renal Dosing:
CrCl 20-60ml/min: usual dose q48h
CrCl<20ml/min: usual dose q72h Oral
cefaCLOR (CECLOR) 250 mg capsule No Renal Dosing:
CrCl 10-50ml/min: give 50-100% of usual dose
CrCl<10ml/min: give 50% of usual dose
Use same dosing intervals Oral
cefaCLOR (CECLOR) 250 mg/5 ml oral liquid No Renal Dosing:
CrCl 10-50ml/min: give 50-100% of usual dose
CrCl<10ml/min: give 50% of usual dose
Use same dosing intervals Oral
cefaCLOR (CECLOR) 500 mg capsule No Renal Dosing:
CrCl 10-50ml/min: give 50-100% of usual dose
CrCl<10ml/min: give 50% of usual dose
Use same dosing intervals Oral
cefADROxil (DURICEF) 500 mg capsule No Renal Dosing:
CrCl 10-50ml/min: 500mg q12-24h
CrCl<10ml/min: 500mg q36h Oral
cefazolin (ANCEF) 2gm/1000ml NS irrigation solution Yes Topical Irrigation
cefaZOLIN (ANCEF) 5% (50 mg /ml) ophthalmic solution Yes Ophthalmic
cefaZOLIN (ANCEF, KEFZOL) 1 g/10 ml syringe Yes Renal Dosing:
CrCl 50-80ml/min: 0.5-2gm q8h
CrCl 10-50ml/min: 0.5-1gm q8-12h
CrCl<10ml/min: 1gm q24h Intravenous
cefDINir (OMNICEF) 250 mg/5 ml oral liquid No Renal Dosing:
CrCl<30ml/min: 300mg q24h Oral
cefDINir (OMNICEF) 300 mg capsule No Renal Dosing:
CrCl<30ml/min: 300mg q24h Oral
cefDITOREN (SPECTRACEF) 200 mg tablet No Renal Dosing:
CrCl 30-49ml/min: 200mg bid
CrCl<30ml/min: 200mg daily Oral
cefePIME (MAXIPIME) 500 mg injection Yes Renal Dosing:
Creatinine Clearance:
>60 ml/min 30-60 ml/min 11-29 ml/min < 10 ml/min
500 mg q12h 500 mg q24h 500 mg q24h 250 mg q24h
1 g q12h 1 g q24h 500 mg q24h 250 mg q24h
2 g q12h Injection
cefePIME (MAXIPINE) 1 g injection Yes Renal Dosing:
Creatinine Clearance:
>60 ml/min 30-60 ml/min 11-29 ml/min < 10 ml/min
500 mg q12h 500 mg q24h 500 mg q24h 250 mg q24h
1 g q12h 1 g q24h 500 mg q24h 250 mg q24h
2 g q12h Injection
cefePIME (MAXIPINE) 2 g injection Yes Renal Dosing:
Creatinine Clearance:
>60 ml/min 30-60 ml/min 11-29 ml/min < 10 ml/min
500 mg q12h 500 mg q24h 500 mg q24h 250 mg q24h
1 g q12h 1 g q24h 500 mg q24h 250 mg q24h
2 g q12h Injection
ceFIXime (SUPRAX) 100 mg/5 ml oral liquid Yes Renal Dosing:
CrCl 50-80ml/min: 200mg q12h or 400mg q24h
CrCl 10-50ml/min: 400mg q24h
CrCl <10ml/min: 200mg q24h Oral
ceFIXime (SUPRAX) 400 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: 200mg q12h or 400mg q24h
CrCl 10-50ml/min: 400mg q24h
CrCl <10ml/min: 200mg q24h Oral
cefoTAXime (CLAFORAN) 1 g injection No Renal Dosing:
CrCl 50-80ml/min: 1-2gm q4-6h
CrCl 10-50ml/min: 1-2gm q8-12h
CrCl<10ml/min: 1-2gm q12h Injection
cefoTAXime (CLAFORAN) 2 g injection No Renal Dosing:
CrCl 50-80ml/min: 1-2gm q4-6h
CrCl 10-50ml/min: 1-2gm q8-12h
CrCl<10ml/min: 1-2gm q12h Intravenous
cefoTAXime (CLAFORAN) 500 mg injection No Renal Dosing:
CrCl 50-80ml/min: 1-2gm q4-6h
CrCl 10-50ml/min: 1-2gm q8-12h
CrCl<10ml/min: 1-2gm q12h Injection
cefoteTAN (CEFOTAN) 1 g injection Yes Renal Dosing:
CrCl 10-30ml/min: usual dose q24h
CrCl<10ml/min: usual dose q48h Injection
cefoteTAN (CEFOTAN) 2 g injection Yes Renal Dosing:
CrCl 10-30ml/min: usual dose q24h
CrCl<10ml/min: usual dose q48h Injection
ceFOXitin (MEFOXIN) 1 g injection No Renal Dosing:
CrCl 50-80ml/min: 1-2gm q8h
CrCl 10-50ml/min: 1-2gm q12h
CrCl<10ml/min: 0.5-1gm q12-48h Intravenous
ceFOXitin (MEFOXIN) 2 g injection No Renal Dosing:
CrCl 50-80ml/min: 1-2gm q8h
CrCl 10-50ml/min: 1-2gm q12h
CrCl<10ml/min: 0.5-1gm q12-48h Intravenous
cefPODOxime (VANTIN) 100 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: 200-400mg q12h
CrCl 10-50ml/min: 200-400mg q24h
CrCl<10ml/min: 200mg q24h Oral
cefPODOxime (VANTIN) 100 mg/5 ml oral liquid No Renal Dosing:
CrCl 50-80ml/min: 200-400mg q12h
CrCl 10-50ml/min: 200-400mg q24h
CrCl<10ml/min: 200mg q24h Oral
cefPODOxime (VANTIN) 200 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: 200-400mg q12h
CrCl 10-50ml/min: 200-400mg q24h
CrCl<10ml/min: 200mg q24h Oral
cefPROZil (CEFZIL) 250 mg tablet No Renal Dosing:
CrCl 50-80ml/min: 250-500mg q12h
CrCl 10-50ml/min: 250-500mg q24h
CrCl<10ml/min: 250-500mg q24h Oral
cefPROZil (CEFZIL) 250 mg/5 ml oral liquid No Renal Dosing:
CrCl 50-80ml/min: 250-500mg q12h
CrCl 10-50ml/min: 250-500mg q24h
CrCl<10ml/min: 250-500mg q24h Oral
cefPROZil (CEFZIL) 500 mg tablet No Renal Dosing:
CrCl 50-80ml/min: 250-500mg q12h
CrCl 10-50ml/min: 250-500mg q24h
CrCl<10ml/min: 250-500mg q24h Oral
ceftaziDIME (FORTAZ, TAZICEF) 1 g injection Yes Renal Dosing:
CrCl 50-80ml/min: 1-2gm q8-12h
CrCl 10-50ml/min: 1-2gm q12-24h
CrCl<10ml/min: 0.5-1gm q24h Intravenous
ceftaziDIME (FORTAZ, TAZICEF) 2 g injection Yes Renal Dosing:
CrCl 50-80ml/min: 1-2gm q8-12h
CrCl 10-50ml/min: 1-2gm q12-24h
CrCl<10ml/min: 0.5-1gm q24h Injection
ceftaziDIME (FORTAZ, TAZICEF) 5% (50mg/ml) opththalmic solution Yes Ophthalmic
ceftaziDIME (FORTAZ, TAZICEF) 500 mg injection Yes Renal Dosing:
CrCl 50-80ml/min: 1-2gm q8-12h
CrCl 10-50ml/min: 1-2gm q12-24h
CrCl<10ml/min: 0.5-1gm q24h Injection
ceftazidome (FORTAZ) intravitreal injection Yes Injection
ceftazidome (FORTAZ) subconjunctival injection Yes Injection
ceftiBUTEN (CEDAX) 400 mg capsule No Renal Dosing:
CrCl 50-80ml/min: 400mg q24h
CrCl 10-50ml/min: 200mg q24h
CrCl<10ml/min: 100mg q24h Oral
cefUROXime (CEFTIN) 250 mg tablet No Renal Dosing:
CrCl 50-80ml/min: 250-500mg q12h
CrCl 10-50ml/min: 250-500mg q12h
CrCl<10ml/min: 250mg q24h Oral
cefUROXime (CEFTIN) 250 mg/5 ml oral liquid No Renal Dosing:
CrCl 50-80ml/min: 250-500mg q12h
CrCl 10-50ml/min: 250-500mg q12h
CrCl<10ml/min: 250mg q24h Oral
cefUROXime (CEFTIN) 500 mg tablet No Renal Dosing:
CrCl 50-80ml/min: 250-500mg q12h
CrCl 10-50ml/min: 250-500mg q12h
CrCl<10ml/min: 250mg q24h Oral
ceFURoxime (ZINACEF) 1.5 g injection Yes Renal Dosing:
CrCl 50-80ml/min: 0.75-1.5gm q8h
CrCl 10-50ml/min: 750mg q12h
CrCl<10ml/min: 750mg q24h Injection
ceFURoxime (ZINACEF) 750 mg injection Yes Renal Dosing:
CrCl 50-80ml/min: 0.75-1.5gm q8h
CrCl 10-50ml/min: 750mg q12h
CrCl<10ml/min: 750mg q24h Injection
celecoxib (CELEBREX) 100 mg capsule Yes Oral
celecoxib (CELEBREX) 200 mg capsule Yes Oral
celecoxib (CELEBREX) 400 mg capsule No Dispense 2 x 200mg Oral
CENTRUM PERFORMANCE tablet No Oral
CENTRUM SILVER tablet No Oral
CEPACOL lozenges Yes Mucous Membrane
cephALEXin (KEFLEX) 250 mg capsule Yes Renal Dosing:
CrCl 50-80ml/min: 250-500mg q6h
CrCl 10-50ml/min: 250-500mg q8-12h
CrCl<10ml/min: 250mg q24-48h Oral
cephALEXin (KEFLEX) 250 mg/5 ml oral liquid Yes Renal Dosing:
CrCl 50-80ml/min: 250-500mg q6h
CrCl 10-50ml/min: 250-500mg q8-12h
CrCl<10ml/min: 250mg q24-48h Oral
cephALEXin (KEFLEX) 500 mg capsule Yes Renal Dosing:
CrCl 50-80ml/min: 250-500mg q6h
CrCl 10-50ml/min: 250-500mg q8-12h
CrCl<10ml/min: 250mg q24-48h Oral
cephradine (VELOSEF) 250 mg capsule No Renal Dosing:
CrCl 50-80ml/min: 250-500mg q6h
CrCl 10-50ml/min: 250-500mg q8-12h
CrCl<10ml/min: 250mg q24-48h Oral
cephradine (VELOSEF) 250mg/5ml oral liquid No Renal Dosing:
CrCl 50-80ml/min: 250-500mg q6h
CrCl 10-50ml/min: 250-500mg q8-12h
CrCl<10ml/min: 250mg q24-48h Oral
cephradine (VELOSEF) 500 mg capsule No Renal Dosing:
CrCl 50-80ml/min: 250-500mg q6h
CrCl 10-50ml/min: 250-500mg q8-12h
CrCl<10ml/min: 250mg q24-48h Oral
chloproPAMIDE (DIABINESE) 250 mg tablet Yes Oral
chloral hydrate (AQAUCHLORAL) 500 mg rectal suppository No Renal Dosing:
CrCl<50ml/min: Avoid Rectal
chloral hydrate (AQUACHLORAL) 325 mg rectal suppository Yes Renal Dosing:
CrCl<50ml/min: Avoid Rectal
chloral hydrate (NOCTEC) 500 mg/5 ml oral liquid Yes Renal Dosing:
CrCl<50ml/min: Avoid Oral
chlorambucil (LEUKERAN) 2 mg tablet Yes Oral
chlordiazepoxide (LIBRIUM) 25 mg capsule Yes Renal Dosing:
CrCl<10ml/min: decrease dose by 50% Oral
chlordiazepoxide (LIBRIUM) 5 mg capsule Yes Renal Dosing:
CrCl<10ml/min: decrease dose by 50% Oral
chloroquine (ARALEN) 250 mg tablet Yes Renal Dosing:
CrCl<10ml/min: give 50% of normal dose.
For prolonged treatment, reduce further to 50-100mg/day as
chloroquine base Oral
chloroquine (ARALEN) 500 mg tablet No Dispense 2 x 250mg
Renal Dosing:
CrCl<10ml/min: give 50% of normal dose.
For prolonged treatment, reduce further to 50-100mg/day as
chloroquine base Oral
chlorothiazide (DIURIL) 250 mg tablet Yes Renal Dosing:
Probably ineffective in patients with CrCl 10-50ml/min.
Avoid in patients with CrCl<10ml/min Oral
chlorothiazide (DIURIL) 250 mg/5 ml oral liquid No Renal Dosing:
Probably ineffective in patients with CrCl 10-50ml/min.
Avoid in patients with CrCl<10ml/min Oral
chlorothiazide (DIURIL) 500 mg injection Yes Renal Dosing:
Probably ineffective in patients with CrCl 10-50ml/min.
Avoid in patients with CrCl<10ml/min Injection
chlorothiazide (DIURIL) 500 mg tablet No Dispense 2 x 250mg
Renal Dosing:
Probably ineffective in patients with CrCl 10-50ml/min.
Avoid in patients with CrCl<10ml/min Oral
chlorpropamide 100 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: decrease usual dose 50%
CrCl<50ml/min: Avoid Oral
chlorpropamide 250 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: decrease usual dose 50%
CrCl<50ml/min: Avoid Oral
chlorthalidone (HYGROTON, THALITONE) 100 mg tablet No Dispense 4 x 25mg
Renal Dosing:
Avoid in patients with CrCl<10ml/min or increase dosing interval
to every 48 hours Oral
chlorthalidone (HYGROTON, THALITONE) 15 mg tablet No Renal Dosing:
Avoid in patients with CrCl<10ml/min or increase dosing interval
to every 48 hours Oral
chlorthalidone (HYGROTON, THALITONE) 25 mg tablet Yes Renal Dosing:
Avoid in patients with CrCl<10ml/min or increase dosing interval
to every 48 hours Oral
chlorthalidone (HYGROTON, THALITONE) 50 mg tablet No Dispense 2 x 25mg
Renal Dosing:
Avoid in patients with CrCl<10ml/min or increase dosing interval
to every 48 hours Oral
cidofovir (VISTIDE) injection Yes Renal Dosing:
Contraindicated in patients with Cr>1.5mg/dl or CrCl < or = 55ml/min IVPB
cilostazol (PLETAL) 100 mg tablet Yes Oral
cilostazol (PLETAL) 50 mg tablet No Dispense 1/2 x 100mg Oral
cimetidine (TAGAMET) 300 mg/5 ml oral liquid No Renal Dosing:
CrCl 10-50ml/min: 300mg q12h
CrCl<10ml/min: 200mg q12h Oral
cimetidine (TAGAMET) 200 mg tablet No Renal Dosing:
CrCl 10-50ml/min: 300mg q12h
CrCl<10ml/min: 200mg q12h Oral
cimetidine (TAGAMET) 300 mg tablet No Renal Dosing:
CrCl 10-50ml/min: 300mg q12h
CrCl<10ml/min: 200mg q12h Oral
cimetidine (TAGAMET) 400 mg tablet No Renal Dosing:
CrCl 10-50ml/min: 300mg q12h
CrCl<10ml/min: 200mg q12h Oral
cimetidine (TAGAMET) 800 mg tablet No Renal Dosing:
CrCl 10-50ml/min: 300mg q12h
CrCl<10ml/min: 200mg q12h Oral
cimetidine (TAGAMET) 150 mg/ml injection No May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl 10-50ml/min: 300mg q12h
CrCl<10ml/min: 200mg q12h Injection
ciprofloxacin (CIPRO) 200mg in 100ml D5W injection No Renal Dosing:
CrCl 5-29ml/min: 200-400mg q18-24h Intravenous
ciprofloxacin (CIPRO) 250 mg tablet No Renal Dosing:
CrCl 10-50ml/min: 250-500mg q12-18h
CrCl<10ml/min: 250-500mg q18-24h Oral
ciprofloxacin (CIPRO) 400mg in 200ml D5W injection No Renal Dosing:
CrCl 5-29ml/min: 200-400mg q18-24h Intravenous
ciprofloxacin (CIPRO) 500 mg tablet No Renal Dosing:
CrCl 10-50ml/min: 250-500mg q12-18h
CrCl<10ml/min: 250-500mg q18-24h Oral
ciprofloxacin (CIPRO) 500mg/5ml oral liquid No Renal Dosing:
CrCl 10-50ml/min: 250-500mg q12-18h
CrCl<10ml/min: 250-500mg q18-24h Oral
ciprofloxacin (CIPRO) 750 mg tablet No Renal Dosing:
CrCl 10-50ml/min: 250-500mg q12-18h
CrCl<10ml/min: 250-500mg q18-24h Oral
ciprofloxacin 0.2 % - hydrocortisone 0.1 % (CIPRO HC) otic solution No Otic
ciprofloxacin ER (CIPRO XR, PROQUIN XR) 1000 mg tablet No Renal Dosing:
Do not use extended release porducts in patients with CrCl < 50 ml/min
Dosing for immediate release tablets are as follows:
CrCl 10-50ml/min: 250-500mg q12-18h
CrCl<10ml/min: 250-500mg q18-24h Oral
ciprofloxacin ER (CIPRO XR, PROQUIN XR) 500 mg tablet No Renal Dosing:
Do not use extended release porducts in patients with CrCl < 50 ml/min
Dosing for immediate release tablets are as follows:
CrCl 10-50ml/min: 250-500mg q12-18h
CrCl<10ml/min: 250-500mg q18-24h Oral
cisatracurium (NIMBEX) 10 mg/ml injection Yes Intravenous
cisatracurium (NIMBEX) 2 mg/ml injection Yes Intravenous
cisplatin (PLATINOL AQ) chemo infusion Yes VESICANT
Renal Dosing:
CrCl 10-50ml/min: give 75% of usual dose
CrCl<10ml/min: give 50% of usual dose Chemo
citalopram (celeXA) 10 mg tablet Yes Oral
citalopram (celeXA) 10 mg/5 ml oral liquid No Oral
citalopram (celeXA) 20 mg tablet Yes Oral
citalopram (celeXA) 40 mg tablet No Dispense 2 x 20mg Oral
CITRACAL PRENATAL RX tablet No Oral
citric acid - D gluconic acid (RENACIDIN) irrigation Yes Urologic Irrigation
cladribine (LEUSTATIN) chemo infusion Yes Chemo
clarithromycin (BIAXIN) 250 mg tablet Yes Renal Dosing:
CrCl <30ml/min: Halve the normal dose or double the dosing interval Oral
clarithromycin (BIAXIN) 250 mg/5 ml oral liquid No Renal Dosing:
CrCl <30ml/min: Halve the normal dose or double the dosing interval Oral
clarithromycin (BIAXIN) 500 mg tablet Yes Renal Dosing:
CrCl <30ml/min: Halve the normal dose or double the dosing interval Oral
clarithromycin ER (BIAXIN XL) 1000 mg tablet No Renal Dosing:
CrCl <30ml/min: Halve the normal dose or double the dosing interval Oral
clarithromycin ER (BIAXIN XL) 500 mg tablet No Renal Dosing:
CrCl <30ml/min: Halve the normal dose or double the dosing interval Oral
codeine 15 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
codeine 15 mg/ml injection Yes Renal Dosing:
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Injection
codeine 15mg/5ml oral solution No Renal Dosing:
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
codeine 30 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
codeine 30 mg/ml injection Yes Renal Dosing:
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Injection
codeine 60 mg tablet No Dispense 2 x 30mg
Renal Dosing:
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
COENZYME Q10 100 mg capsule No Dispense 2 x 50mg Oral
COENZYME Q10 30 mg capsule Yes Oral
COENZYME Q10 50 mg capsule Yes Oral
COENZYME Q10 60 mg capsule No Dispense 2 x 30mg Oral
COENZYME Q10 60 mg tablet No Oral
colchicine (COLCRYS) 0.6 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: Max of 2mg IV or 0.6mg po q24-48h
CrCl<10ml/min: contraindicated Oral
colesevelam (WELCHOL) 625 mg tablet Yes Oral
colestipol (COLESTID) 1gm tablet Yes Oral
colestipol (COLESTID) 5 g oral packet Yes Oral
colistimethate (COLY-MYCIN M) nebulizer solution Yes MED NEB
colistimethate (COLYMYCIN-M) IVPB Yes Dosing should be based on IBW in obese patients
May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Cr 1.3-1.5 sugest 2.5-3.8mg/kg/day in 2 divided doses
Cr 1.6-2.5 suggest 2.5mg/kg/day q24h
C Intavenous
cytarabine HIGH dose (CYTOSAR-U) chemo infusion Yes Renal Dosing:
Cr<1.5mg/dl: 2-3gm/m(2)
Cr 1.5-1.9mg/dl: 1gm/m(2)
Cr > or = 2.0mg/dl: 0.1gm/m(2) as continuous infusion Chemo
daptomycin (CUBICIN) injection Yes Dosing based on actual body weight
May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl<30ml/min: 4-6mg/kg q48h IVPB
DAUNOrubicin (CERUBIDINE) chemo infusion Yes VESICANT
Renal Dosing:
For Cr>3mg/dl, reduce usual dose by 50% Chemo
DAUNOrubicin liposomal (DAUNOXOME) chemo infusion Yes Renal Dosing:
For Cr>3mg/dl, reduce usual dose by 50% Chemo
deferoxamine (DESFERAL) 500 mg injection Yes Renal Dosing:
Contraindicated in patients with severe renal disease or anuria Intramuscular
deferoxamine (DESFERAL) injection Yes Renal Dosing:
Contraindicated in patients with severe renal disease or anuria IVPB
demeclocycline (DECLOMYCIN) 150 mg tablet Yes Renal Dosing:
Avoid in patients with renal failure Oral
demeclocycline (DECLOMYCIN) 300 mg tablet No Dispense 2 x 150mg
Renal Dosing:
Avoid in patients with renal failure Oral
desloratadine (CLARINEX) 2.5mg/5 ml oral syrup No Renal Dosing:
In patients with renal impairment, give 5 mg every other day Oral
desloratadine (CLARINEX) 5 mg tablet No Renal Dosing:
In patients with renal impairment, give 5 mg every other day Oral
desloratadine-pseudoephdrine (CLARINEX-D 12 HR) 5-120 mg tablet No Renal Dosing:
In patients with renal impairment, give the 5gm/120mg tab every other day Oral
desloratadine-pseudoephdrine (CLARINEX-D 24 HR) 5-240 mg tablet No Renal Dosing:
In patients with renal impairment, give the 5gm/240mg tab every other day or the 2.5mg/120mg tab every day Oral
desloratidine (CLARINEX REDITAB) 5 mg disintegrating tablet No Renal Dosing:
In patients with renal impairment, give 5 mg every other day Oral
desmopressin (DDAVP) 0.01% nasal solution No Renal Dosing:
Contraindicated in patients with CrCl<50ml/min Nasal
desmopressin (DDAVP) 0.01% nasal spray Yes Renal Dosing:
Contraindicated in patients with CrCl<50ml/min Nasal
desmopressin (DDAVP) 0.1 mg tablet Yes Renal Dosing:
Contraindicated in patients with CrCl<50ml/min Oral
desmopressin (DDAVP) 0.2 mg tablet No Dispense 2 x 0.1mg
Renal Dosing:
Contraindicated in patients with CrCl<50ml/min Oral
desmopressin (DDAVP) 4 mcg/ml injection Yes Renal Dosing:
Contraindicated in patients with CrCl<50ml/min Injection
desmopressin (DDAVP) injection Yes Renal Dosing:
Contraindicated in patients with CrCl<50ml/min IVPB
diclofenac - misoprostol EC (ARTHROTEC 50) 50-0.2 mg tablet No Dispense individual ingredients
Renal Dosing:
CrCl<30ml/min: Contraindicated Oral
diclofenac - misoprostol EC (ARTHROTEC 75) 75-0.2 mg tablet No Dispense individual ingredients
Renal Dosing:
CrCl<30ml/min: Contraindicated Oral
didanosine (VIDEX) 100 mg chewable tablet Yes Renal Dosing:
If wt > 60kg: ORAL TAB VIDEX EC
CrCl 30-59ml/min 100mg twice daily 200mg daily
200mg daily
CrCl 10-29ml/m Oral
didanosine (VIDEX) 10mg/ml oral liquid No Renal Dosing:
If wt > 60kg: ORAL TAB VIDEX EC
CrCl 30-59ml/min 100mg twice daily 200mg daily
200mg daily
CrCl 10-29ml/m Oral
didanosine (VIDEX) 150 mg chewable tablet Yes Renal Dosing:
If wt > 60kg: ORAL TAB VIDEX EC
CrCl 30-59ml/min 100mg twice daily 200mg daily
200mg daily
CrCl 10-29ml/m Oral
didanosine (VIDEX) 200 mg chewable tablet Yes Renal Dosing:
If wt > 60kg: ORAL TAB VIDEX EC
CrCl 30-59ml/min 100mg twice daily 200mg daily
200mg daily
CrCl 10-29ml/m Oral
didanosine EC (VIDEX EC) 125 mg capsule Yes Renal Dosing:
If wt > 60kg: ORAL TAB VIDEX EC
CrCl 30-59ml/min 100mg twice daily 200mg daily
200mg daily
CrCl 10-29ml/m Oral
didanosine EC (VIDEX EC) 200 mg capsule Yes Renal Dosing:
If wt > 60kg: ORAL TAB VIDEX EC
CrCl 30-59ml/min 100mg twice daily 200mg daily
200mg daily
CrCl 10-29ml/m Oral
didanosine EC (VIDEX EC) 250 mg capsule Yes Renal Dosing:
If wt > 60kg: ORAL TAB VIDEX EC
CrCl 30-59ml/min 100mg twice daily 200mg daily
200mg daily
CrCl 10-29ml/m Oral
didanosine EC (VIDEX EC) 400 mg capsule Yes Renal Dosing:
If wt > 60kg: ORAL TAB VIDEX EC
CrCl 30-59ml/min 100mg twice daily 200mg daily
200mg daily
CrCl 10-29ml/m Oral
diethylpropion (TENUATE) 25 mg tablet No Oral
diethylpropion ER (TENUATE DOSPAN) 75 mg tablet No Oral
diflorasone (PSORCON E, APEXICON E) 0.05% topical cream No Topical
diflorasone (PSORCON, MAXIFLOR) 0.05% topical cream No Topical
diflorasone (PSORCON, MAXIFLOR) 0.05% topical ointment No Topical
diflunisal (DOLOBID) 500 mg tablet Yes Renal Dosing:
CrCl<50ml/min: decrease usual dose 50% Oral
diphenhydrAMINE (BENADRYL) 12.5 mg/5 ml oral liquid Yes Renal Dosing:
CrCl 10-50ml/min: give q6-12h
CrCl<10ml/min: give q12-18h Oral
diphenhydrAMINE (BENADRYL) 12.5 mg/5 ml oral elixir No We stock oral liquid
Renal Dosing:
CrCl 10-50ml/min: give q6-12h
CrCl<10ml/min: give q12-18h Oral
diphenhydrAMINE (BENADRYL) 2% topical spray No Topical
diphenhydrAMINE (BENADRYL) 25 mg capsule Yes Renal Dosing:
CrCl 10-50ml/min: give q6-12h
CrCl<10ml/min: give q12-18h Oral
diphenhydrAMINE (BENADRYL) 50 mg capsule Yes Renal Dosing:
CrCl 10-50ml/min: give q6-12h
CrCl<10ml/min: give q12-18h Oral
diphenhydrAMINE (BENADRYL) 50 mg/ml injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl 10-50ml/min: give q6-12h
CrCl<10ml/min: give q12-18h Injection
diphenhydrAMINE(BENADRYL) 1% topical cream No Topical
diphenhydrAMINE(BENADRYL) 2% topical cream Yes Topical
diphenoxylate - atropine (LOMOTIL) 2.5-0.025 mg/5 ml oral liquid No Oral
diphenoxylate - atropine (LOMOTIL, LONOX) 2.5-0.025 mg tablet Yes Oral
dipivefrin (PROPINE) 0.1% ophthalmic solution Yes Ophthalmic
dipyridamole - aspirin (AGGRENOX)n 200-25 mg capsule Yes Renal Dosing:
CrCl < 10ml/min: Avoid Oral
dipyridamole (PERSANTINE) 25 mg tablet Yes Oral
dipyridamole (PERSANTINE) 50 mg tablet No Dispense 2 x 25mg Oral
dipyridamole (PERSANTINE) 75 mg tablet Yes Oral
disopyramide (NORPACE) 100 mg capsule Yes Renal Dosing:
CrCl 10-50ml/min: give q12-24h
CrCl<10ml/min: give q24-48h Oral
disopyramide (NORPACE) 150 mg capsule Yes Renal Dosing:
CrCl 10-50ml/min: give q12-24h
CrCl<10ml/min: give q24-48h Oral
disopyramide ER (NORPACE CR) 100 mg capsule Yes Renal Dosing:
The controlled-release form is not recommended in patients with severe renal impairment
Dosing recommendations for the immeditate-releaee formulation:
CrCl 10-50ml/min: give q12-24h
CrCl<10ml/min: give q24-48h Oral
disopyramide ER (NORPACE CR) 150 mg capsule Yes Renal Dosing:
The controlled-release form is not recommended in patients with severe renal impairment
Dosing recommendations for the immeditate-releaee formulation:
CrCl 10-50ml/min: give q12-24h
CrCl<10ml/min: give q24-48h Oral
dofetilide (TIKOSYN) 125 mcg capsule Yes Renal Dosing:
CrCl 40-60ml/min: 250mcg bid
CrCl 20-40ml/min: 125mcg bid
CrCl<20ml/min: contraindicated Oral
dofetilide (TIKOSYN) 250 mcg capsule Yes Renal Dosing:
CrCl 40-60ml/min: 250mcg bid
CrCl 20-40ml/min: 125mcg bid
CrCl<20ml/min: contraindicated Oral
dofetilide (TIKOSYN) 500 mcg capsule Yes Renal Dosing:
CrCl 40-60ml/min: 250mcg bid
CrCl 20-40ml/min: 125mcg bid
CrCl<20ml/min: contraindicated Oral
dolasetron (ANZEMET) 12.5 mg / 0.625 ml injection No Intravenous
dolastetron (ANZEMET) 100mg tablet No Oral
dolastetron (ANZEMET) 50 mg tablet No Oral
donepezil (ARICEPT ODT) 10 mg oral disinetegrating tablet No Oral
donepezil (ARICEPT ODT) 5 mg oral disinetegrating tablet No Oral
donepezil (ARICEPT) 10 mg tablet Yes Oral
donepezil (ARICEPT) 5 mg tablet Yes Oral
dorzolamide - timolol (COSOPT) 2 - 0.5% ophthalmic solution Yes Renal Dosing:
CrCl<30ml/min: Contraindicated Ophthalmic
dorzolamide (TRUSOPT) 2% ophthalmic solution No Renal Dosing:
Dorzolamide
CrCl<30ml/min: Contraindicated Ophthalmic
duloxetine (CYMBALTA) 20 mg capsule Yes Renal Dosing:
CrCl<30ml/min: Avoid Oral
duloxetine (CYMBALTA) 30 mg capsule Yes Renal Dosing:
CrCl<30ml/min: Avoid Oral
duloxetine (CYMBALTA) 60 mg capsule Yes Renal Dosing:
CrCl<30ml/min: Avoid Oral
DUODERM topical dressing Yes Topical
dutasteride (AVODART) 0.5 mg capsule Yes Oral
d-xylose (XYLOSE) oral powder Yes Oral
econazole (SPECTAZOLE) 1% topical cream No Topical
eculizumab (SOLIRIS) injection Yes IVPB
edetate calcium disodium (CALCIUM DISODIUM VERSENATE) injection Yes Renal Dosing:
Cr of 2-3 mg/dl, give 500mg/m(2) q24h x 5 days
Cr of 3-4 mg/dl, give 500mg/m(2) q48h x 3 doses
Cr >4 mg/dl, give 500mg/m(2) q week IVPB
edetate calcium disodium (CALCIUM DISODIUM) 200mg/ml injection Yes Renal Dosing:
Cr of 2-3 mg/dl, give 500mg/m(2) q24h x 5 days
Cr of 3-4 mg/dl, give 500mg/m(2) q48h x 3 doses
Cr >4 mg/dl, give 500mg/m(2) q week Injection
efavirenz - emtricitabine - tenofovir (ATRIPLA) 600-200-300 mg tablet No Dispense individual ingredients
Renal Dosing:
CrCl<50ml/min: Not Recommended Oral
emtricitabine - tenofovir (TRUVADA) 200-300 mg tablet No Dispense individual ingredients
Renal Dosing:
CrCl 30-49ml/min: 200/300 q48h
CrCl<30ml/min: Avoid Oral
emtricitabine (EMTRIVA) 10 mg/ml oral liquid Yes Not routinely stocked - Order PRN
Renal Dosing:
CrCl 30-49ml/min: 120mg q24h
CrCl 15-29ml/min: 80mg q24h
CrCl<15ml/min: 60mg q24h Oral
emtricitabine (EMTRIVA) 200 mg capsule Yes Renal Dosing:
CrCl 30-49ml/min: 200mg q48h
CrCl 15-29ml/min: 200mg q72h
CrCl<15ml/min: 200mg q96h Oral
enalapril (VASOTEC) 10 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Oral
enalapril (VASOTEC) 2.5 mg tablet No Dispense 1/2 of 5mg
Renal Dosing:
CrCl 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Oral
enalapril (VASOTEC) 20 mg tablet No Dispense 2 x 10mg
Renal Dosing:
CrCl 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Oral
enalapril (VASOTEC) 5 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Oral
enalaprilat (VASOTEC) 1.25 mg/ml injection Yes May be administered in: Non Critical Care Areas (initial dose is 0.625 mg IV every 6 hours, unless the safety of a higher dose has been determined in a critical care area) and all Critical Care Areas
Renal Dosing:
CrCl 10-50ml/min: decrease dose Intravenous
enalapril-HCTZ (VASERETIC 10-25 mg tablet No Dispense individual ingredients
Renal Dosing:
CrCl<30ml/min or Cr > 3mg/dl: Avoid Oral
enalapril-HCTZ (VASERETIC 5-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
CrCl<30ml/min or Cr > 3mg/dl: Avoid Oral
enoxaparin (LOVENOX) 100 mg/ml injection Yes Renal Dosing:
Indication
Prophylaxis in abdominal surgery:
30 mg administered SC q24 hour
Prophylaxis in hip or knee replacement surgery:
30 mg administered SC q24 hour
Prophylaxis in medical patients during acute illness:
Subcutaneous
enoxaparin (LOVENOX) 30 mg/0.3 ml syringe Yes Renal Dosing:
Indication
Prophylaxis in abdominal surgery:
30 mg administered SC q24 hour
Prophylaxis in hip or knee replacement surgery:
30 mg administered SC q24 hour
Prophylaxis in medical patients during acute illness:
Subcutaneous
enoxaparin (LOVENOX) 40 mg/0.4 ml injection Yes Renal Dosing:
Indication
Prophylaxis in abdominal surgery:
30 mg administered SC q24 hour
Prophylaxis in hip or knee replacement surgery:
30 mg administered SC q24 hour
Prophylaxis in medical patients during acute illness:
Subcutaneous
enoxaparin (LOVENOX) 60 mg/0.6 ml injection Yes Renal Dosing:
Indication
Prophylaxis in abdominal surgery:
30 mg administered SC q24 hour
Prophylaxis in hip or knee replacement surgery:
30 mg administered SC q24 hour
Prophylaxis in medical patients during acute illness:
Subcutaneous
enoxaparin (LOVENOX) 80 mg/0.8 ml injection Yes Renal Dosing:
Indication
Prophylaxis in abdominal surgery:
30 mg administered SC q24 hour
Prophylaxis in hip or knee replacement surgery:
30 mg administered SC q24 hour
Prophylaxis in medical patients during acute illness:
Subcutaneous
entacapone (COMTAN) 200 mg tablet Yes Oral
entecavir (BARACLUDE) 0.05 mg/ml oral liquid No Renal Dosing:
Treatment naïve Lamuvidine Refractory
(0.5mg) (1mg)
CrCl 30-50ml/min 0.25mg daily or 0.5mg q48h 0.5mg daily or 1mg q48h
CrCl 10-29ml/min 0.15mg daily or 0.5mg Oral
entecavir (BARACLUDE) 0.5 mg tablet Yes Renal Dosing:
Treatment naïve Lamuvidine Refractory
(0.5mg) (1mg)
CrCl 30-50ml/min 0.25mg daily or 0.5mg q48h 0.5mg daily or 1mg q48h
CrCl 10-29ml/min 0.15mg daily or 0.5mg Oral
entecavir (BARACLUDE) 1 mg tablet No Dispense 2 x 0.5mg
Renal Dosing:
Treatment naïve Lamuvidine Refractory
(0.5mg) (1mg)
CrCl 30-50ml/min 0.25mg daily or 0.5mg q48h 0.5mg daily or 1mg q48h
CrCl 10-29ml/min 0 Oral
ePHEDrine 50 mg/ml injection Yes May be administered in: Critical Care Areas Only Injection
epinastine (ELESTAT) 0.05% ophthalmic solution No Ophthalmic
EPINephrine (ADRENALIN) 0.1% nasal solution Yes Nasal
EPINephrine (ADRENALIN) 1 mg/10 ml prefill IV syringe Yes VESICANT
May be administered in: Critical Care Areas Only Injection
EPINephrine (ADRENALIN) 1 mg/ml injection Yes VESICANT
May be administered in: Non Critical Care Areas (limited to the treatment of anaphylaxis or anaphylactoid reactions (serious hypersensitivity reactions) and Critical Care Areas Only Injection
eptifibatide (INTEGRILIN) drip (conc: 0.75 mg/ml) Yes May be administered in: All Critical Care Areas, Cardiac DOU and Telemetry Areas
Renal Dosing:
Acute Coronary Syndrome :
CrCl<50ml/min or Cr>2mg/dl: bolus dose 180mcg/kg followed by an infusion of 1 mcg/kg/min
Percutaneous Coronary Intervention: Intravenous
ertapenem (INVANZ) 1 g injection Yes Renal Dosing:
CrCl<30ml/min: 500mg q24h Injection
erythromycin (ERY-TAB) 250 mg tablet Yes If converting patient from tablet to liquid (EES) so EES for conversion tablet
Renal Dosing:
CrCl<10ml/min: decrease dose by 25-50%. Maximum daily dose 2gm Oral
erythromycin (ERY-TAB) 333 mg tablet Yes If converting patient from tablet to liquid (EES) so EES for conversion tablet
Renal Dosing:
CrCl<10ml/min: decrease dose by 25-50%. Maximum daily dose 2gm Oral
erythromycin (ERY-TAB) 500 mg tablet Yes If converting patient from tablet to liquid (EES) so EES for conversion tablet
Renal Dosing:
CrCl<10ml/min: decrease dose by 25-50%. Maximum daily dose 2gm Oral
erythromycin - benzoyl peroxide (BENZAMYCIN) 3-5% topical gel Yes Topical
erythromycin - ethanol (ERYDERM, A/T/S) 2% topical solution Yes Topical
erythromycin (AKNE-MYCIN) 2% topical ointment Yes Topical
erythromycin (EMGEL A/T/S) 2% topical gel Yes Topical
erythromycin (ERYDERM, A/T/S) 2% topical solution Yes Topical
erythromycin (ILOTYCIN) 0.5% ophthalmic ointment Yes Ophthalmic
erythromycin 1000mg injection Yes Renal Dosing:
CrCl<10ml/min: decrease dose by 25-50%. Maximum daily dose 2gm IVPB
erythromycin 250mg injection Yes Renal Dosing:
CrCl<10ml/min: decrease dose by 25-50%. Maximum daily dose 2gm IVPB
erythromycin 500mg injection Yes Renal Dosing:
CrCl<10ml/min: decrease dose by 25-50%. Maximum daily dose 2gm IVPB
erythromycin ethylsuccinate (E.E.S.) 400 mg tablet No Dispense 400mg oral liquid
Renal Dosing:
CrCl<10ml/min: decrease dose by 25-50%. Maximum daily dose 2gm Oral
erythromycin ethylsuccinate (E.E.S.) 400 mg/5 ml oral liquid Yes See note regarding tablet to liquid conversion
Renal Dosing:
CrCl<10ml/min: decrease dose by 25-50%. Maximum daily dose 2gm Oral
erythromycin stearate (ERYTHROCIN) 250 mg tablet Yes If converting patient from tablet to liquid (EES) so EES for conversion tablet
Renal Dosing:
CrCl<10ml/min: decrease dose by 25-50%. Maximum daily dose 2gm Oral
ethacrynate (EDECRIN) 50 mg injection Yes Renal Dosing:
CrCl 10-50ml/min: increase dosing interval to q8-12h
CrCl<10ml/min: Avoid Injection
ethacrynic acid (EDECRIN) 25 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: increase dosing interval to q8-12h
CrCl<10ml/min: Avoid Oral
ethambutol (MYAMBUTOL) 100 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: q24-36h
CrCl<10ml/min: q48h Oral
ethambutol (MYAMBUTOL) 400 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: q24-36h
CrCl<10ml/min: q48h Oral
ethionamide (TRECATOR) 250 mg tablet Yes Renal Dosing:
CrCl<10ml/min: decrease dose by 50% Oral
ethosuximide (ZARONTIN) 250 mg capsule Yes Oral
ethosuximide (ZARONTIN) 250 mg/5 ml oral liquid Yes Oral
ethyl alcohol 50% nebulizer solution Yes MED NEB
ethyl chloride topical spray Yes Topical
etidronate (DIDRONEL) 200 mg tablet No Dispense 1/2 x 400mg
Renal Dosing:
Creatinine 2.5-5mg/dl: use cautiously
Creatinine >5mg/dl: Avoid Oral
etidronate (DIDRONEL) 400 mg tablet Yes Renal Dosing:
Creatinine 2.5-5mg/dl: use cautiously
Creatinine >5mg/dl: Avoid Oral
etodolac (LODINE) 200 mg capsule Yes Oral
etodolac (LODINE) 300 mg capsule Yes Oral
etoposide (VEPESID) 50 mg chemo capsule Yes Renal Dosing:
CrCl 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Oral
etoposide (VEPESID) chemo infusion Yes Renal Dosing:
CrCl 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Chemo
exenatide (BYETTA) 10 mcg /0.4 ml injection No Renal Dosing:
CrCl<30ml/min: Avoid Subcutaneous
exenatide (BYETTA) 5 mcg /0.2 ml injection No Renal Dosing:
CrCl<30ml/min: Avoid Subcutaneous
eye patch Yes Miscell. (Med.Supl.;Non-Drugs)
ezetimibe - simvastatin (VYTORIN) 10-10 mg tablet No Dispense individual ingredients
Renal Dosing:
CrCl<10ml/min: avoid unless patient has previously tolerated
simvastatin treatment at a dose of 5mg or higher Oral
ezetimibe - simvastatin (VYTORIN) 10-20 mg tablet No Dispense individual ingredients
Renal Dosing:
CrCl<10ml/min: avoid unless patient has previously tolerated
simvastatin treatment at a dose of 5mg or higher Oral
ezetimibe - simvastatin (VYTORIN) 10-40 mg tablet No Dispense individual ingredients
Renal Dosing:
CrCl<10ml/min: avoid unless patient has previously tolerated
simvastatin treatment at a dose of 5mg or higher Oral
ezetimibe (ZETIA) 10 mg tablet Yes Oral
ezetimibe-simvastatin (VYTORIN) 10-80 mg tablet No Dispense individual ingredients Oral
famciclovir (FAMVIR) 250 mg tablet No Dispense 1/2 of 500mg
Renal Dosing:
CrCl 50-80ml/min: 500mg q12h
CrCl 10-50ml/min: 500mg q24h
CrCl<10ml/min: 500mg q48h Oral
famciclovir (FAMVIR) 500 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: 500mg q12h
CrCl 10-50ml/min: 500mg q24h
CrCl<10ml/min: 500mg q48h Oral
famotidine (PEPCID) 10 mg tablet No Dispense 1/2 of 20mg
Renal Dosing:
CrCl<50ml/min: decrease dose by 50% or increase dosing interval to q36-48h Oral
famotidine (PEPCID) 20 mg tablet Yes Renal Dosing:
CrCl<50ml/min: decrease dose by 50% or increase dosing interval to q36-48h Oral
famotidine (PEPCID) 20 mg/ 2 ml injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl<50ml/min: decrease dose by 50% or increase dosing interval to q36-48h Intravenous
famotidine (PEPCID) 40 mg tablet No Dispense 2 x 20mg
Renal Dosing:
CrCl<50ml/min: decrease dose by 50% or increase dosing interval to q36-48h Oral
famotidine (PEPCID) 40 mg/5 ml oral liquid No Renal Dosing:
CrCl<50ml/min: decrease dose by 50% or increase dosing interval to q36-48h Oral
famotidine (PEPCID) drip (conc: 0.16 mg/ml) Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl<50ml/min: decrease dose by 50% or increase dosing interval to q36-48h Drips
fat emulsion (INTRALIPID, LIPOSYN) 20% IV solution Yes Intravenous
febuxostat (ULORIC) 40 mg tablet No Oral
febuxostat (ULORIC) 80 mg tablet No Oral
felbamate (FELBATOL) 400 mg tablet Yes Renal Dosing:
CrCl<50ml/min: decrease dose by 50% Oral
felbamate (FELBATOL) 600 mg tablet No Dispense 1.5 x 400mg
Renal Dosing:
CrCl<50ml/min: decrease dose by 50% Oral
felbamate (FELBATOL) 600 mg/5 ml oral liquid No Renal Dosing:
CrCl<50ml/min: decrease dose by 50% Oral
fentanyl (FENTORA) 100 mcg buccal tablet No Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Buccal
fentanyl (FENTORA) 200 mcg buccal tablet No Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Buccal
fentanyl (FENTORA) 400 mcg buccal tablet No Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Buccal
fentanyl (FENTORA) 600 mcg buccal tablet No Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Buccal
fentanyl (FENTORA) 800 mcg buccal tablet No Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Buccal
fentanyl (ONSOLIS) 1200 mcg buccal film No Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Buccal
fentanyl (ONSOLIS) 200 mcg buccal film No Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Buccal
fentanyl (ONSOLIS) 400 mcg buccal film No Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Buccal
fentanyl (ONSOLIS) 600 mcg buccal film No Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Buccal
fentanyl (ONSOLIS) 800 mcg buccal film No Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Buccal
fentanYL (ACTIQ) 1,200 mcg lollipop No Dispense 1 x 800mcg + 1 x 400mcg
Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Oral
fentanYL (ACTIQ) 1,600 mcg lollipop No Dispense 2 x 800mcg
Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Oral
fentanYL (ACTIQ) 200 mcg lollipop Yes Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Oral
fentanYL (ACTIQ) 400 mcg lollipop Yes Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Oral
fentanYL (ACTIQ) 600 mcg lollipop Yes Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Oral
fentanYL (ACTIQ) 800 mcg lollipop No Dispense 2 x 400mcg
Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Oral
fentanYL (DURAGESIC) 100 mcg/24 hr transdermal patch Yes Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50%
ALL Patches should be removed prior to MRI Transdermal
fentanYL (DURAGESIC) 12 mcg/24 hr transdermal patch Yes Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50%
ALL Patches should be removed prior to MRI Transdermal
fentanYL (DURAGESIC) 25 mcg/24 hr transdermal patch Yes Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50%
ALL Patches should be removed prior to MRI Transdermal
fentanYL (DURAGESIC) 50 mcg/24 hr transdermal patch Yes Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50%
ALL Patches should be removed prior to MRI Transdermal
fentanYL (DURAGESIC) 75 mcg/24 hr transdermal patch Yes Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50%
ALL Patches should be removed prior to MRI Transdermal
fentanYL (SUBLIMAZE) 0.05 mg/ml injection Yes May be administered in: Non Critical Care Areas (PCA infusion Only), All Critical Care Areas and DOU/Telemetry Unit
Renal Dosing:
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Injection
fentanYL (SUBLIMAZE) 50 mcg/ml in no diluent (straight drug) 100ml PCA Yes Drips
fentanYL 10 mcg/ml - BUpivacaine 0.05 % epidural (non OB) Yes Drips
fentanYL 2 mcg/ml - BUpivacain 0.1 % epidural (OB) Yes Drips
fentanyl drip Yes May be administered in: Non Critical Care Areas (PCA infusion Only), All Critical Care Areas and DOU/Telemetry Unit
Renal Dosing:
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Drips
fentanyl syringe drip Yes May be administered in: Non Critical Care Areas (PCA infusion Only), All Critical Care Areas and DOU/Telemetry Unit
Renal Dosing:
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Drips
fexofenadine - pseudoephedrine ER (ALLEGRA-D 12 HR) 60-120 mg tablet No Renal Dosing:
CrCr<50ml/min: 60mg q24h Oral
fexofenadine - pseudoephedrine ER (ALLEGRA-D 24 HR) 180-240 mg tablet No Renal Dosing:
CrCr<50ml/min: 60mg q24h Oral
fexofenadine (ALLEGRA ODT) 30 mg disintegrating tablet No Renal Dosing:
CrCr<50ml/min: 60mg q24h Oral
fexofenadine (ALLEGRA) 180 mg tablet No Renal Dosing:
CrCr<50ml/min: 60mg q24h Oral
fexofenadine (ALLEGRA) 30 mg tablet No Renal Dosing:
CrCr<50ml/min: 60mg q24h Oral
fexofenadine (ALLEGRA) 60 mg tablet No Renal Dosing:
CrCr<50ml/min: 60mg q24h Oral
fexofenadine (ALLEGRA) 6mg/ml oral liquid No Renal Dosing:
CrCr<50ml/min: 60mg q24h Oral
flecainide (TAMBOCOR) 100 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: q12-24h
CrCl<10ml/min: q24h Oral
flecainide (TAMBOCOR) 150 mg tablet No Dispense 1 x 50mg + 1 x 100mg
Renal Dosing:
CrCl 10-50ml/min: q12-24h
CrCl<10ml/min: q24h Oral
flecainide (TAMBOCOR) 50 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: q12-24h
CrCl<10ml/min: q24h Oral
floxuridine (FUDR) chemo infusion Yes Chemo
fluconazole (DIFLUCAN) 100 mg tablet Yes Renal Dosing:
CrCl <50ml/min: decrease dose by 50% Oral
fluconazole (DIFLUCAN) 100mg in 50ml NS syringe Yes Renal Dosing:
CrCl <50ml/min: decrease dose by 50% Intravenous
fluconazole (DIFLUCAN) 150 mg tablet No Dispense 1x 50mg + 1 x 100mg
Renal Dosing:
CrCl <50ml/min: decrease dose by 50% Oral
fluconazole (DIFLUCAN) 200 mcg tablet Yes Renal Dosing:
CrCl <50ml/min: decrease dose by 50% Oral
fluconazole (DIFLUCAN) 200 mg in 100ml NS injection Yes Renal Dosing:
CrCl <50ml/min: decrease dose by 50% Intravenous
fluconazole (DIFLUCAN) 40 mg/ml oral liquid No Renal Dosing:
CrCl <50ml/min: decrease dose by 50% Oral
fluconazole (DIFLUCAN) 400 mg in 100ml NS injection Yes Renal Dosing:
CrCl <50ml/min: decrease dose by 50% Intravenous
fluconazole (DIFLUCAN) 50 mg tablet Yes Renal Dosing:
CrCl <50ml/min: decrease dose by 50% Oral
flucytosine (ANCOBON) 250 mg capsule Yes Renal Dosing:
CrCl 10-50ml/min: q12-24h
CrCl<10ml/min: q24-48h Oral
flucytosine (ANCOBON) 500 mg capsule No Dispense 2 x 250mg
Renal Dosing:
CrCl 10-50ml/min: q12-24h
CrCl<10ml/min: q24-48h Oral
fludarabine (FLUDARA) chemo infusion Yes Renal Dosing:
CrCl 30-70ml/min/1.73 m(2): decrease the usual dose 20-50%
CrCl<30ml/min/1.73 m(2): Avoid Chemo
fondaparinux (ARIXTRA) 2.5 mg/0.5 ml syringe Yes Renal Dosing:
CrCl<30ml/min: Contraindicated Subcutaneous
formoterol (FORADIL) 12 mcg inhalation capsule No Inhalation
formoterol (PERFOROMIST) 20mg/2ml nebulizer solution No Inhalation
fosamprenavir (LEXIVA) 700 mg tablet Yes Oral
fosaprepitant (EMEND) 115mg injection Yes Injection
foscarnet (FOSCAVIR) IVPB Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patients with renal impairment IVPB
fosinopril - hydrochlorothiazide (MONOPRIL-HCT) 10 - 12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usualy ineffective in patients with CrCl < 30ml/min Oral
fosinopril - hydrochlorothiazide (MONOPRIL-HCT) 20 - 12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
gabapentin (NEURONTIN) 100 mg capsule Yes Renal Dosing:
CrCl 60ml/min or greater: 300-900 q8h
CrCl 30-59ml/min: 200-700 q12h
CrCl 15-29ml/min: 200-700 daily
CrCl 15ml/min or less: 100-300mg daily Oral
gabapentin (NEURONTIN) 250 mg/5 ml oral liquid Yes Renal Dosing:
CrCl 60ml/min or greater: 300-900 q8h
CrCl 30-59ml/min: 200-700 q12h
CrCl 15-29ml/min: 200-700 daily
CrCl 15ml/min or less: 100-300mg daily Oral
gabapentin (NEURONTIN) 300 mg capsule Yes Renal Dosing:
CrCl 60ml/min or greater: 300-900 q8h
CrCl 30-59ml/min: 200-700 q12h
CrCl 15-29ml/min: 200-700 daily
CrCl 15ml/min or less: 100-300mg daily Oral
gabapentin (NEURONTIN) 400 mg capsule Yes Renal Dosing:
CrCl 60ml/min or greater: 300-900 q8h
CrCl 30-59ml/min: 200-700 q12h
CrCl 15-29ml/min: 200-700 daily
CrCl 15ml/min or less: 100-300mg daily Oral
gabapentin (NEURONTIN) 600 mg tablet No Dispense 2 x 300mg caps
Renal Dosing:
CrCl 60ml/min or greater: 300-900 q8h
CrCl 30-59ml/min: 200-700 q12h
CrCl 15-29ml/min: 200-700 daily
CrCl 15ml/min or less: 100-300mg daily Oral
gabapentin (NEURONTIN) 800 mg tablet No Dispense 2 x 400mg caps
Renal Dosing:
CrCl 60ml/min or greater: 300-900 q8h
CrCl 30-59ml/min: 200-700 q12h
CrCl 15-29ml/min: 200-700 daily
CrCl 15ml/min or less: 100-300mg daily Oral
gadodiamide (OMNISCAN) 287 mg/ml injection No Radiology Only Intravenous
galantamine (RAZADYNE) 12 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: maximum daily dose 16mg
CrCl<9ml/min: Avoid Oral
galantamine (RAZADYNE) 4 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: maximum daily dose 16mg
CrCl<9ml/min: Avoid Oral
galantamine (RAZADYNE) 4mg/ml oral liquid No Renal Dosing:
CrCl 10-50ml/min: maximum daily dose 16mg
CrCl<9ml/min: Avoid Oral
galantamine (RAZADYNE) 8 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: maximum daily dose 16mg
CrCl<9ml/min: Avoid Oral
galantamine ER (RAZADYNE ER) 16 mg capsule No Renal Dosing:
CrCl 10-50ml/min: maximum daily dose 16mg
CrCl<9ml/min: Avoid Oral
galantamine ER (RAZADYNE ER) 24 mg capsule No Renal Dosing:
CrCl 10-50ml/min: maximum daily dose 16mg
CrCl<9ml/min: Avoid Oral
galantamine ER (RAZADYNE ER) 8 mg capsule No Renal Dosing:
CrCl 10-50ml/min: maximum daily dose 16mg
CrCl<9ml/min: Avoid Oral
gallium (GANITE) 25 mg/ml injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas Intravenous
ganciclovir (CYTOVENE) injection Yes Use cytotoxic agent precautions when handling
May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Induction Dosing Maintenance Dosing
CrCl 50-69ml/min: 2.5mg/kg q IVPB
ganciclovir (CYTOVENE, DHPG) 500 mg capsule Yes Renal Dosing:
CrCl 50-69ml/min: 1500mg daily or 500mg tid
CrCl 24-49ml/min: 1000mg daily or 500mg bid
CrCl 10-24ml/min: 500mg daily
CrCl<10ml/min: 500mg 3 times/week after hemodialysis Oral
gentamicin (GARAMYCIN) 100mg in 25ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
gentamicin (GARAMYCIN) 110mg in 27.5ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
gentamicin (GARAMYCIN) 120mg in 30ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
gentamicin (GARAMYCIN) 130mg in 32.5ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
gentamicin (GARAMYCIN) 140mg in 35ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
gentamicin (GARAMYCIN) 150mg in 37.5ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
gentamicin (GARAMYCIN) 160mg in 40ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
gentamicin (GARAMYCIN) 170mg in 42.5ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
gentamicin (GARAMYCIN) 180mg in 45ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
gentamicin (GARAMYCIN) 190mg in 47.5ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
gentamicin (GARAMYCIN) 40mg in 10ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
gentamicin (GARAMYCIN) 50mg in 12.5ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
gentamicin (GARAMYCIN) 60mg in 15ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
gentamicin (GARAMYCIN) 70mg in 17.5ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
gentamicin (GARAMYCIN) 80mg in 20ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
gentamicin (GARAMYCIN) 90mg in 22.5ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
glipizide - metformin (METAGLIP) 2.5 - 250 mg tablet No Dispense individual ingredients
Renal Dosing:
Glipizide
The initial and maintenance dosing should be conservative
to avoid hypoglycemic reactions
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine Oral
glipizide - metformin (METAGLIP) 2.5 - 500 mg tablet No Dispense individual ingredients
Renal Dosing:
Glipizide
The initial and maintenance dosing should be conservative
to avoid hypoglycemic reactions
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine Oral
glipizide - metformin (METAGLIP) 5 - 500 mg tablet No Dispense individual ingredients
Renal Dosing:
Glipizide
The initial and maintenance dosing should be conservative
to avoid hypoglycemic reactions
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine Oral
glipiZIDE (GLUCOTROL) 10 mg tablet Yes Renal Dosing:
The initial and maintenance dosing should be conservative to avoid hypoglycemic reactions Oral
glipiZIDE (GLUCOTROL) 5 mg tablet Yes Renal Dosing:
The initial and maintenance dosing should be conservative to avoid hypoglycemic reactions Oral
glipiZIDE ER (GLUCOTROL XL) 10 mg tablet No Dispense 2 x 5mg
Renal Dosing:
The initial and maintenance dosing should be conservative to avoid hypoglycemic reactions Oral
glipiZIDE ER (GLUCOTROL XL) 2.5 mg tablet Yes Renal Dosing:
The initial and maintenance dosing should be conservative to avoid hypoglycemic reactions Oral
glipiZIDE ER (GLUCOTROL XL) 5 mg tablet Yes Renal Dosing:
The initial and maintenance dosing should be conservative to avoid hypoglycemic reactions Oral
glyBURIDE (DIABETA, MICRONASE) 1.25 mg tablet No Dispense 1/2 of 2.5mg
Renal Dosing:
The initial and maintenance dosing should be conservative to avoid hypoglycemic reactions Oral
glyBURIDE (DIABETA, MICRONASE) 2.5 mg tablet Yes Renal Dosing:
The initial and maintenance dosing should be conservative to avoid hypoglycemic reactions Oral
glyBURIDE (DIABETA, MICRONASE) 5 mg tablet Yes Renal Dosing:
The initial and maintenance dosing should be conservative to avoid hypoglycemic reactions Oral
glyBURIDE micronized (GLYNASE) 1.5 mg tablet No Renal Dosing:
The initial and maintenance dosing should be conservative to avoid hypoglycemic reactions Oral
glyBURIDE micronized (GLYNASE) 3 mg tablet No Renal Dosing:
The initial and maintenance dosing should be conservative to avoid hypoglycemic reactions Oral
glyBURIDE micronized (GLYNASE) 4.5 mg tablet No Renal Dosing:
The initial and maintenance dosing should be conservative to avoid hypoglycemic reactions Oral
glyBURIDE micronized (GLYNASE) 6 mg tablet No Renal Dosing:
The initial and maintenance dosing should be conservative to avoid hypoglycemic reactions Oral
glyBURIDE-metformin (GLUCOVANCE) 1.25-250 mg tablet No Dispense individual ingredients
Renal Dosing:
Glyburide
The initial and maintenance dosing should be conservative
to avoid hypoglycemic reactions
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine Oral
glyBURIDE-metformin (GLUCOVANCE) 2.5-500 mg tablet No Dispense individual ingredients
Renal Dosing:
Glyburide
The initial and maintenance dosing should be conservative
to avoid hypoglycemic reactions
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine Oral
glyBURIDE-metformin (GLUCOVANCE) 5-500 mg tablet No Dispense individual ingredients
Renal Dosing:
Glyburide
The initial and maintenance dosing should be conservative
to avoid hypoglycemic reactions
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine Oral
gold (AUROLATE) 50 mg/ml injection Yes Renal Dosing:
CrCl<50ml/min: Avoid Injection
guaifenesin - codeine (GUIATUSS AC, ROBITUSSIN AC) 100 - 10 mg/5 ml oral liquid Yes Renal Dosing:
Codeine
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
hydralazine - hydrochlorothiazide 50-50 mg tablet No Withdrawn From the Market (Mach 2007)
Renal Dosing:
Hydralazine
CrCl 10-50ml/min: q8h
CrCl<10ml/min: q12-24h
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
hydrALAZINE (APRESOLINE) 10 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: q8h
CrCl<10ml/min: q12-24h Oral
hydrALAZINE (APRESOLINE) 100 mg tablet No Dispense 2 x 50mg
Renal Dosing:
CrCl 10-50ml/min: q8h
CrCl<10ml/min: q12-24h Oral
hydrALAZINE (APRESOLINE) 20 mg/ml injection Yes May be administered in: All Critical Care Areas, Cardiac DOU and L&D/Perinatal Special Care Unit (PSCU) (Intermittent direct IV push only)
Renal Dosing:
CrCl 10-50ml/min: q8h
CrCl<10ml/min: q12-24h Injection
hydrALAZINE (APRESOLINE) 25 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: q8h
CrCl<10ml/min: q12-24h Oral
hydrALAZINE (APRESOLINE) 50 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: q8h
CrCl<10ml/min: q12-24h Oral
hydrochlorothiazide (HCTZ, HYDRODIURIL) 100 mg tablet No Dispense 2 x 50mg
Renal Dosing:
Usually ineffective in patients with CrCl < 30ml/min Oral
hydrochlorothiazide (HCTZ, HYDRODIURIL) 25 mg tablet Yes Renal Dosing:
Usually ineffective in patients with CrCl < 30ml/min Oral
hydrochlorothiazide (HCTZ, HYDRODIURIL) 50 mg tablet Yes Renal Dosing:
Usually ineffective in patients with CrCl < 30ml/min Oral
hydrochlorothiazide (HCTZ, HYDRODIURIL) 50 mg/5 ml oral liquid No Renal Dosing:
Usually ineffective in patients with CrCl < 30ml/min Oral
hydrochlorothiazide (HCTZ, MICROZIDE) 12.5 mg capsule Yes Renal Dosing:
Usually ineffective in patients with CrCl < 30ml/min Oral
hydrocodone - acetaminophen (ANEXIA) 7.5-650 mg tablet No Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (ANEXIA, LORCET-PLUS) 7.5-650 mg tablet No Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (LORCET) 10-650 mg tablet No Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (LORCET-HD) 5-500 mg capsule No Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (LORTAB) 10-500 mg tablet No Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (LORTAB) 2.5-167 mg/5 ml oral liquid Yes Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (LORTAB) 2.5-500 mg tablet No Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (LORTAB) 7.5-500 mg tablet No Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (LORTAB, VICODIN, ANEXSIA) 5-500 mg tablet No Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (MAXIDONE) 10-750 mg tablet No Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (NORCO) 10-325 mg tablet Yes Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (NORCO) 5-325 mg tablet Yes Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (NORCO) 7.5-325 mg tablet Yes Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (VICODIN ES) 7.5-750 mg tablet No Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (VICODIN HP, ANEXSIA) 10-660 mg tablet No Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (XODOL) 10-300 mg tablet No Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (XODOL) 5-300 mg tablet No Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (XODOL) 7.5-300 mg tablet No Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (ZYDONE) 10-400 mg tablet No Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (ZYDONE) 5-400 mg tablet No Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (ZYDONE) 7.5-400 mg tablet No Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - ibuprofen (IBUDONE/REPREXAIN) 10-200 mg tablet Yes Renal Dosing:
Use with caution and monitor kidney function in patients with advanced kidney disease
Administer separately in patients with renal impairment
Hydrocodone
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - ibuprofen (REPREXAIN) 2.5-200 mg tablet Yes Renal Dosing:
Use with caution and monitor kidney function in patients with advanced kidney disease
Administer separately in patients with renal impairment
Hydrocodone
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - ibuprofen (REPREXAIN, IBUDONE) 5-200 mg tablet Yes Renal Dosing:
Use with caution and monitor kidney function in patients with advanced kidney disease
Administer separately in patients with renal impairment
Hydrocodone
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - ibuprofen (VICOPROFEN, IBUDONE) 7.5-200 mg tablet Yes Renal Dosing:
Use with caution and monitor kidney function in patients with advanced kidney disease
Administer separately in patients with renal impairment
Hydrocodone
CrCl < 10ml/min - dose q8-12h Oral
hydroxyurea (DROXIA, HYDREA) 200 mg capsule Yes Renal Dosing:
CrCl > 50ml/min: 20-30 mg/kg q24h
CrCl 10-50ml/min: 10-15 mg/kg q24h
CrCl < 10ml/min: 4-6 mg/kg q24h Oral
hydroxyurea (DROXIA, HYDREA) 400 mg capsule No Dispense 2 x 200mg
Renal Dosing:
CrCl > 50ml/min: 20-30 mg/kg q24h
CrCl 10-50ml/min: 10-15 mg/kg q24h
CrCl < 10ml/min: 4-6 mg/kg q24h Oral
hydroxyurea (DROXIA, HYDREA) 500 mg capsule Yes Renal Dosing:
CrCl > 50ml/min: 20-30 mg/kg q24h
CrCl 10-50ml/min: 10-15 mg/kg q24h
CrCl < 10ml/min: 4-6 mg/kg q24h Oral
ibandronate (BONIVA) 150 mg oral tablet (monthly) Yes Renal Dosing:
CrCl<30ml/min: Avoid Oral
ibandronate (BONIVA) 2.5 mg oral tablet Yes Renal Dosing:
CrCl<30ml/min: Avoid Oral
ibandronate (BONIVA) 3mg intravenous Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl<30ml/min: Avoid Intravenous
Ibutilide (CORVERT) 0.1 mg/ml injection Yes May be administered in: All Critical Care Areas, Cardiac DOU and Cardiac Telemetry Units Intravenous
imipenem-cilastatin (PRIMAXIN) 250 mg injection Yes Renal Dosing:
CrCl 50-80ml/min: 500mg q6-8h
CrCl 10-50ml/min: 500mg Q8-12h
CrCl<10ml/min: 250-500mg q12-24h Intravenous
imipenem-cilastatin (PRIMAXIN) 500 mg injection Yes Renal Dosing:
CrCl 50-80ml/min: 500mg q6-8h
CrCl 10-50ml/min: 500mg Q8-12h
CrCl<10ml/min: 250-500mg q12-24h Intravenous
imipramine (TOFRANIL) 10 mg tablet Yes Oral
imipramine (TOFRANIL) 25 mg tablet Yes Oral
imipramine (TOFRANIL) 50 mg tablet Yes Oral
imipramine ER (TOFRANIL PM) 100 mg capsule No Oral
imipramine ER (TOFRANIL PM) 125 mg capsule No Oral
imipramine ER (TOFRANIL PM) 150 mg capsule No Oral
imipramine ER (TOFRANIL PM) 75 mg capsule No Oral
imiquimod (ALDARA) 5% topical cream Yes Topical
immune globulin (IGG) (CARIMUNE) intravenous No May be administered in: Non Critical Care Areas and all Critical Care Areas Intravenous
immune globulin (IGG) (FLEBOGAMMA) 5% intrtavenous No May be administered in: Non Critical Care Areas and all Critical Care Areas Intravenous
immune globulin (IGG) (GAMMAGARD) injection No May be administered in: Non Critical Care Areas and all Critical Care Areas Intravenous
immune globulin (IGG) (GAMUNEX) 10% intravenous Yes May be administered in: Non Critical Care Areas and all Critical Care Areas Intravenous
immune globulin (IGG) (VENOGLOBULIN-S) 10% injection No May be administered in: Non Critical Care Areas and all Critical Care Areas LVP
immune globulin (IGG) intravenous Yes Dispense immune globulin (GAMUNEX) 10% intravenous
May be administered in: Non Critical Care Areas and all Critical Care Areas Intravenous
immune globulin IM (GaMaSTAN S/D) injection Yes Intramuscular
inamrinone (INOCOR) drip Yes Drips
incontenent wash (SENSICARE) topical cleanser Yes Topical
indapamide (LOZOL) 1.25 mg tablet No Dispense 1/2 x 2.5 mg
Renal Dosing:
Usually ineffective in patients with CrCl < 30ml/min Oral
indapamide (LOZOL) 2.5 mg tablet Yes Dispense 2 x 1.25mg
Renal Dosing:
Usually ineffective in patients with CrCl < 30ml/min Oral
insulin aspart & insulin aspart protamine (NOVOLOG MIX) 50-50 mix injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Renal metabolism of insulin decreased with increasing azothemia Subcutaneous
insulin aspart & insulin aspart protamine (NOVOLOG MIX) 70-30 mix injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Renal metabolism of insulin decreased with increasing azothemia Subcutaneous
insulin aspart (NOVOlog) injection No May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Renal metabolism of insulin decreased with increasing azothemia Subcutaneous
insulin detemir (LEVEMIR) injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Renal metabolism of insulin decreased with increasing azothemia Subcutaneous
insulin glargine (LANTUS) injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Renal metabolism of insulin decreased with increasing azothemia Subcutaneous
insulin glulisine (APIDRA) injection No May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Renal metabolism of insulin decreased with increasing azothemia Subcutaneous
insulin infusuion per pharmacy guideline Yes Per Pharmacy
insulin lispro & insulin lispro protamine (HUMAlog MIX 75/25) 75/25 mix injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Renal metabolism of insulin decreased with increasing azothemia Subcutaneous
insulin lispro (HUMAlog) injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Renal metabolism of insulin decreased with increasing azothemia Subcutaneous
insulin NPH (NOVOLIN N/HUMULIN N) injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Renal metabolism of insulin decreased with increasing azothemia Subcutaneous
insulin NPH / Reg Human (HUMULIN 50/50) 50/50 injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Renal metabolism of insulin decreased with increasing azothemia Subcutaneous
insulin NPH / Reg Human (NOVOLIN 70/30, HUMULIN 70/30) 70/30 injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Renal metabolism of insulin decreased with increasing azothemia Subcutaneous
insulin R drip Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Renal metabolism of insulin decreased with increasing azothemia Drips
insulin, reg human (HUMULIN R/NOVOLIN R) injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Renal metabolism of insulin decreased with increasing azothemia Injection
irbesartan - hydrochlorothiazide (AVALIDE) 150-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
irbesartan - hydrochlorothiazide (AVALIDE) 300-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
irbesartan - hydrochlorothiazide (AVALIDE) 300-25 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
isoniazid (NYDRAZID) 100 mg tablet Yes Renal Dosing:
CrCl<10ml/min: decrease dose by 50% Oral
isoniazid (NYDRAZID) 300 mg tablet Yes Renal Dosing:
CrCl<10ml/min: decrease dose by 50% Oral
isoniazid (NYDRAZID) 50 mg/ml oral liquid No Renal Dosing:
CrCl<10ml/min: decrease dose by 50% Oral
ketorolac (TORADOL) 15 mg/ml injection Yes There is an automatic 72-hour stop order for ketorolac IV or IM. Continued therapy requires a physician order to continue for up to an additional 48 hours.
May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Do Injection
ketorolac (TORADOL) 30 mg/ml injection Yes There is an automatic 72-hour stop order for ketorolac IV or IM. Continued therapy requires a physician order to continue for up to an additional 48 hours.
May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Do Injection
ketorolac (TORADOL) 60 mg/2 ml injection Yes May be administer IM only for one time dosing
May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Dosage adjustment based upon patient's age, weight, and creatinine clearance (CrCl).
One-time IM dose
< 50 Intramuscular
lamivudine - zidovudine (COMBIVIR) 150-300 mg tablet No Renal Dosing:
Use separate ingredients:
Lamivudine
CrCl 30-49ml/min: 150mg daily
CrCl 15-29ml/min: 150mg x1, then 100mg daily
CrCl 5-14ml/min: 150mg x 1, then 50mg daily
CrCl<5ml/min: 50mg x 1, then 25mg daily
Zidovudine
Oral
lamivudine (EPIVIR, EPIVIR HBV) 10 mg/ml oral liquid No Renal Dosing:
For HIV Infection For Chronic Hepatitis B
CrCl 30-49ml/min: 150mg daily 100mg x 1, then 50mg daily
CrCl 15-29ml/min: 150mg x1, then 100mg daily 100mg x 1, then 25mg daily
CrCl 5-14ml/min: 150mg Oral
lamivudine (EVIVIR, EPIVIR HBV) 100 mg tablet Yes Renal Dosing:
For HIV Infection For Chronic Hepatitis B
CrCl 30-49ml/min: 150mg daily 100mg x 1, then 50mg daily
CrCl 15-29ml/min: 150mg x1, then 100mg daily 100mg x 1, then 25mg daily
CrCl 5-14ml/min: 150mg Oral
lamivudine (EVIVIR, EPIVIR HBV) 150 mg tablet Yes Renal Dosing:
For HIV Infection For Chronic Hepatitis B
CrCl 30-49ml/min: 150mg daily 100mg x 1, then 50mg daily
CrCl 15-29ml/min: 150mg x1, then 100mg daily 100mg x 1, then 25mg daily
CrCl 5-14ml/min: 150mg Oral
lamivudine (EVIVIR, EPIVIR HBV) 300 mg tablet No Dispense 2 x 150mg
Renal Dosing:
For HIV Infection For Chronic Hepatitis B
CrCl 30-49ml/min: 150mg daily 100mg x 1, then 50mg daily
CrCl 15-29ml/min: 150mg x1, then 100mg daily 100mg x 1, then 25mg daily
CrCl Oral
lepirudin (REFLUDAN) drip Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Initial dose: CrCl<60ml/min: decrease to 0.2mg/kg
Infusion dose: CrCl 45-60ml/min: give 50% of usual dose
CrCl 30-44ml/min: give 30% of Drips
lepirudin (REFLUDAN) injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Initial dose: CrCl<60ml/min: decrease to 0.2mg/kg
Infusion dose: CrCl 45-60ml/min: give 50% of usual dose
CrCl 30-44ml/min: give 30% of Intravenous
letrozole (FEMARA) 2.5 mg tablet Yes Oral
leucovorin (WELLCOVORIN) 10 mg tablet No Dispense 2 x 5mg Oral
leucovorin (WELLCOVORIN) 25 mg tablet Yes Oral
leucovorin (WELLCOVORIN) 5 mg tablet Yes Oral
levetiracetam (KEPPRA) 100 mg/ml oral liquid No Renal Dosing:
CrCl 50-80ml/min: 500-1000mg q12h
CrCl 30-50ml/min: 250-750mg q12h
CrCl<30ml/min: 250-500mg q 24h
Dialysis patients: 500-1000mg q24h Oral
levetiracetam (KEPPRA) 1000 mg tablet No Dispense 2 x 500mg
Renal Dosing:
CrCl 50-80ml/min: 500-1000mg q12h
CrCl 30-50ml/min: 250-750mg q12h
CrCl<30ml/min: 250-500mg q 24h
Dialysis patients: 500-1000mg q24h Oral
levetiracetam (KEPPRA) 250 mg tablet No Dispense 1/2 of 500mg
Renal Dosing:
CrCl 50-80ml/min: 500-1000mg q12h
CrCl 30-50ml/min: 250-750mg q12h
CrCl<30ml/min: 250-500mg q 24h
Dialysis patients: 500-1000mg q24h Oral
levetiracetam (KEPPRA) 500 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: 500-1000mg q12h
CrCl 30-50ml/min: 250-750mg q12h
CrCl<30ml/min: 250-500mg q 24h
Dialysis patients: 500-1000mg q24h Oral
levetiracetam (KEPPRA) 750 mg tablet No Dispense 1.5 x 500mg
Renal Dosing:
CrCl 50-80ml/min: 500-1000mg q12h
CrCl 30-50ml/min: 250-750mg q12h
CrCl<30ml/min: 250-500mg q 24h
Dialysis patients: 500-1000mg q24h Oral
levetiracetam (KEPPRA) injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl 50-80ml/min: 500-1000mg q12h
CrCl 30-50ml/min: 250-750mg q12h
CrCl<30ml/min: 250-500mg q 24h
Dialysis patients: 500-1000mg q24h IVPB
levetiracetam ER (KEPPRA XR) 500 mg tablet No Renal Dosing:
CrCl 50-80ml/min: 1000 - 2000mg q24h
CrCl 30-50ml/min: 500-1500mg q24h
CrCl<30ml/min: 500-1000mg q 24h Oral
levetiracetam ER (KEPPRA XR) 750 mg tablet No Renal Dosing:
CrCl 50-80ml/min: 1000 - 2000mg q24h
CrCl 30-50ml/min: 500-1500mg q24h
CrCl<30ml/min: 500-1000mg q 24h Oral
levocetirizine (XYZAL) 0.5mg/ml oral liquid No Renal Dosing:
CrCl 50-80ml/min: 2.5mg daily
CrCl 30-50ml/min: 2.5mg every other day
CrCl 10-30ml/min: 2.5mg twice a week
CrCl<10ml/min: Avoid Oral
levocetirizine (XYZAL) 5 mg tablet No Renal Dosing:
CrCl 50-80ml/min: 2.5mg daily
CrCl 30-50ml/min: 2.5mg every other day
CrCl 10-30ml/min: 2.5mg twice a week
CrCl<10ml/min: Avoid Oral
levofloxacin (LEVAQUIN) 250 mg in 50ml D5W injection Yes Renal Dosing:
If dosage in normal renal fuction is:
750mg q24h
CrCl 20-49ml/min: 750mg q48h
CrC 10-19ml/min: 750mg x 1, then 500mg q48h
HD pt: 750mg x 1, then 500mg q48h
500mg q24h
CrCl 20-49ml/min: 500mg x 1, then 250mg q2 Intravenous
levofloxacin (LEVAQUIN) 250 mg tablet Yes Renal Dosing:
If dosage in normal renal fuction is:
750mg q24h
CrCl 20-49ml/min: 750mg q48h
CrC 10-19ml/min: 750mg x 1, then 500mg q48h
HD pt: 750mg x 1, then 500mg q48h
500mg q24h
CrCl 20-49ml/min: 500mg x 1, then 250mg q2 Oral
levofloxacin (LEVAQUIN) 250 mg/10 ml oral liquid No Renal Dosing:
If dosage in normal renal fuction is:
750mg q24h
CrCl 20-49ml/min: 750mg q48h
CrC 10-19ml/min: 750mg x 1, then 500mg q48h
HD pt: 750mg x 1, then 500mg q48h
500mg q24h
CrCl 20-49ml/min: 500mg x 1, then 250mg q2 Oral
levofloxacin (LEVAQUIN) 500 mg in 100ml D5W injection Yes Renal Dosing:
If dosage in normal renal fuction is:
750mg q24h
CrCl 20-49ml/min: 750mg q48h
CrC 10-19ml/min: 750mg x 1, then 500mg q48h
HD pt: 750mg x 1, then 500mg q48h
500mg q24h
CrCl 20-49ml/min: 500mg x 1, then 250mg q2 Intravenous
levofloxacin (LEVAQUIN) 500 mg tablet Yes Renal Dosing:
If dosage in normal renal fuction is:
750mg q24h
CrCl 20-49ml/min: 750mg q48h
CrC 10-19ml/min: 750mg x 1, then 500mg q48h
HD pt: 750mg x 1, then 500mg q48h
500mg q24h
CrCl 20-49ml/min: 500mg x 1, then 250mg q2 Oral
levofloxacin (LEVAQUIN) 750 mg in 150nl D5W injection Yes Renal Dosing:
If dosage in normal renal fuction is:
750mg q24h
CrCl 20-49ml/min: 750mg q48h
CrC 10-19ml/min: 750mg x 1, then 500mg q48h
HD pt: 750mg x 1, then 500mg q48h
500mg q24h
CrCl 20-49ml/min: 500mg x 1, then 250mg q2 Intravenous
levofloxacin (LEVAQUIN) 750 mg tablet No Renal Dosing:
If dosage in normal renal fuction is:
750mg q24h
CrCl 20-49ml/min: 750mg q48h
CrC 10-19ml/min: 750mg x 1, then 500mg q48h
HD pt: 750mg x 1, then 500mg q48h
500mg q24h
CrCl 20-49ml/min: 500mg x 1, then 250mg q2 Oral
lisinopril - hydrochlorothiazide (ZESTORETIC) 10-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Lisinopril
CrCl 10-50ml/min: initial dose should be 2.5-7.5mg
CrCl<10ml/min: initial dose should be 1.25-2.5mg
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
lisinopril - hydrochlorothiazide (ZESTORETIC) 20-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Lisinopril
CrCl 10-50ml/min: initial dose should be 2.5-7.5mg
CrCl<10ml/min: initial dose should be 1.25-2.5mg
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
lisinopril - hydrochlorothiazide (ZESTORETIC) 20-25 mg tablet No Dispense individual ingredients
Renal Dosing:
Lisinopril
CrCl 10-50ml/min: initial dose should be 2.5-7.5mg
CrCl<10ml/min: initial dose should be 1.25-2.5mg
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
lisinopril (ZESTRIL, PRINIVIL) 10 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: initial dose should be 2.5-7.5mg
CrCl<10ml/min: initial dose should be 1.25-2.5mg Oral
lisinopril (ZESTRIL, PRINIVIL) 2.5 mg tablet No Dispense 1/2 of 5mg
Renal Dosing:
CrCl 10-50ml/min: initial dose should be 2.5-7.5mg
CrCl<10ml/min: initial dose should be 1.25-2.5mg Oral
lisinopril (ZESTRIL, PRINIVIL) 20 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: initial dose should be 2.5-7.5mg
CrCl<10ml/min: initial dose should be 1.25-2.5mg Oral
lisinopril (ZESTRIL, PRINIVIL) 30 mg tablet No Dispense 1 x 20mg + 1 x 30mg
Renal Dosing:
CrCl 10-50ml/min: initial dose should be 2.5-7.5mg
CrCl<10ml/min: initial dose should be 1.25-2.5mg Oral
lisinopril (ZESTRIL, PRINIVIL) 40 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: initial dose should be 2.5-7.5mg
CrCl<10ml/min: initial dose should be 1.25-2.5mg Oral
lisinopril (ZESTRIL, PRINIVIL) 5 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: initial dose should be 2.5-7.5mg
CrCl<10ml/min: initial dose should be 1.25-2.5mg Oral
lithium carbonate (ESKALITH) 150 mg capsule Yes Renal Dosing:
CrCl 10-50ml/min: decrease normal dose by 25-50%
CrCl<10ml/min: decrease normal dose by 50-75% Oral
lithium carbonate (ESKALITH) 300 mg capsule Yes Renal Dosing:
CrCl 10-50ml/min: decrease normal dose by 25-50%
CrCl<10ml/min: decrease normal dose by 50-75% Oral
lithium carbonate (ESKALITH) 600 mg capsule No Dispense 2 x 300mg
Renal Dosing:
CrCl 10-50ml/min: decrease normal dose by 25-50%
CrCl<10ml/min: decrease normal dose by 50-75% Oral
lithium carbonate (LITHOTABS) 300 mg tablet No Renal Dosing:
CrCl 10-50ml/min: decrease normal dose by 25-50%
CrCl<10ml/min: decrease normal dose by 50-75% Oral
lithium carbonate 300mg/5ml oral liquid Yes Renal Dosing:
CrCl 10-50ml/min: decrease normal dose by 25-50%
CrCl<10ml/min: decrease normal dose by 50-75% Oral
lithium carbonate ER (ESKALITH CR, LITHOBID) 300 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: decrease normal dose by 25-50%
CrCl<10ml/min: decrease normal dose by 50-75% Oral
lithium carbonate ER (ESKALITH CR, LITHOBID) 450 mg tablet No Dispense 1.5 x 300mg
Renal Dosing:
CrCl 10-50ml/min: decrease normal dose by 25-50%
CrCl<10ml/min: decrease normal dose by 50-75% Oral
lithium citrate 8 mEq/5ml oral liquid Yes Renal Dosing:
CrCl 10-50ml/min: decrease normal dose by 25-50%
CrCl<10ml/min: decrease normal dose by 50-75% Oral
l-methylfolate - vitamin B6 - vitamine B12 (MENTAX) 2.8-2-25 mg tablet No Oral
l-methylfolate (DEPLIN) 7.5 mg tablet No Not routinely stocked - Order PRN Oral
lodoxamide (ALOMIDE) 0.1% ophthalmic solution No Ophthalmic
lomefloxacin (MAXAQUIN) 400 mg tablet No Withdrawn from the Market (April 2009)
Renal Dosing:
CrCl<40ml/min: 400mg, then 200mg q24h Oral
loratadine - pseudoephedrine SR (CLARITIN D 24 HR) 10-240 mg tablet Yes Renal Dosing:
CrCl<30ml/min:10/240mg every other day Oral
loratadine - pseudoephedrine SR (CLARITIN D 12 HR) 5-120 mg tablet No Renal Dosing:
CrCl<30ml/min:10/240mg every other day Oral
loratadine (CLARITIN REDITAB) 5 mg disintegrating tablet No Renal Dosing:
CrCl<30ml/min: 10mg every other day Oral
loratadine (CLARITIN REDITAB, ALAVERT) 10 mg disintegrating tablet No Renal Dosing:
CrCl<30ml/min: 10mg every other day Oral
loratadine (CLARITIN) 5 mg/5 ml oral liquid No Renal Dosing:
CrCl<30ml/min: 10mg every other day Oral
loratadine (CLARITIN, ALAVERT) 10 mg tablet Yes Renal Dosing:
CrCl<30ml/min: 10mg every other day Oral
losartan - hydrochlorothiazide (HYZAAR) 100-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
losartan - hydrochlorothiazide (HYZAAR) 100-25 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
losartan - hydrochlorothiazide (HYZAAR) 50-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
magnesium chloride SR (SLO-MAG, MAG DELAY) tablet Yes Renal Dosing:
Administer with caution to patients with renal impairment Oral
magnesium citrate (CITRATE OF MAGNESIA) oral liquid Yes Oral
magnesium ER (MAG-TAB) 84 mg tablet No Renal Dosing:
Administer with caution to patients with renal impairment Oral
magnesium gluconate (MAGONATE) 1000 mg/5 ml oral liquid No Renal Dosing:
Administer with caution to patients with renal impairment Oral
magnesium gluconate (MAGONATE) 500 mg tablet No Renal Dosing:
Administer with caution to patients with renal impairment Oral
magnesium gluconate 30 mg tablet No Renal Dosing:
Administer with caution to patients with renal impairment Oral
magnesium hydroxide - calcium carbonate (MYLANTA) 150-350mg tablet No Oral
magnesium hydroxide - calcium carbonate (ROLAID) 110-550mg tablet No Oral
magnesium hydroxide (MILK OF MAGNESIA) 800 mg/5 ml oral liquid Yes Oral
magnesium hydroxide in mineral oil (HALEY'S MO) oral liquid No Oral
magnesium oxide (MAG-OX) 250 mg tablet No Renal Dosing:
Administer with caution to patients with renal impairment Oral
magnesium oxide (MAG-OX) 400 mg tablet Yes Renal Dosing:
Administer with caution to patients with renal impairment Oral
magnesium oxide (URO-MAG) 140 mg tablet No Renal Dosing:
Administer with caution to patients with renal impairment Oral
magnesium salicylate (MAGAN) 545 mg tablet Yes Renal Dosing:
Administer with caution to patients with renal impairment Oral
magnesium sulfate (EPSOM SALTS) topical solution Yes Miscell. (Med.Supl.;Non-Drugs)
magnesium sulfate 1gm in 50ml D5W injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Administer with caution to patients with renal impairment Intravenous
magnesium sulfate 20gm in 250ml D5W injection Yes May be administered in: OB Areas only
Renal Dosing:
Administer with caution to patients with renal impairment Intravenous
magnesium sulfate 2gm in 50ml D5W injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Administer with caution to patients with renal impairment Intravenous
magnesium sulfate 4gm in 100ml D5W injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Administer with caution to patients with renal impairment Intravenous
mefenamic (PONSTEL) 250 mg capsule Yes Renal Dosing:
Avoid in patients with renal impairment Oral
meloxicam (MOBIC) 15 mg tablet No Dispense 2 x 7.5mg
Renal Dosing:
CrCl<20ml/min: reduce dose to 7.5mg daily Oral
meloxicam (MOBIC) 7.5 mg tablet Yes Renal Dosing:
CrCl<20ml/min: reduce dose to 7.5mg daily Oral
meloxicam (MOBIC) 7.5 mg/5ml oral suspension No Renal Dosing:
CrCl<20ml/min: reduce dose to 7.5mg daily Oral
melphalan (ALKERAN) 2 mg tablet Yes Renal Dosing:
Consider decreasing dose by 50% in patients with creatinine >1.5mg/dl Oral
melphalan (ALKERAN) chemo-infusion Yes Renal Dosing:
Consider decreasing dose by 50% in patients with creatinine >1.5mg/dl Chemo
memantine (NAMENDA) 10 mg tablet No Dispense 2 x 5mg
Renal Dosing:
CrCl 5-29ml/min: reduce dose to 5mg bid Oral
memantine (NAMENDA) 2mg/ml oral liquid No Renal Dosing:
CrCl 5-29ml/min: reduce dose to 5mg bid Oral
memantine (NAMENDA) 5 mg tablet Yes Renal Dosing:
CrCl 5-29ml/min: reduce dose to 5mg bid Oral
meperidine (DEMEROL) 100 mg injection syringe Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl 10-50ml/min: decrease normal dose by 25%
CrCl<10ml/min: decrease normal dose by 50%
Normeperidine, an active metabolite, accumulates in ESRD an Injection
meperidine (DEMEROL) 100 mg tablet No Dispense 2 x 50mg
Renal Dosing:
CrCl 10-50ml/min: decrease normal dose by 25%
CrCl<10ml/min: decrease normal dose by 50%
Normeperidine, an active metabolite, accumulates in ESRD and may cause seizures Oral
meperidine (DEMEROL) 10mg/ml oral liquid No Renal Dosing:
CrCl 10-50ml/min: decrease normal dose by 25%
CrCl<10ml/min: decrease normal dose by 50%
Normeperidine, an active metabolite, accumulates in ESRD and may cause seizures Oral
meperidine (DEMEROL) 25 mg injection syringe Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl 10-50ml/min: decrease normal dose by 25%
CrCl<10ml/min: decrease normal dose by 50%
Normeperidine, an active metabolite, accumulates in ESRD an Injection
meperidine (DEMEROL) 50 mg injection syringe Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl 10-50ml/min: decrease normal dose by 25%
CrCl<10ml/min: decrease normal dose by 50%
Normeperidine, an active metabolite, accumulates in ESRD an Injection
meperidine (DEMEROL) 50 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: decrease normal dose by 25%
CrCl<10ml/min: decrease normal dose by 50%
Normeperidine, an active metabolite, accumulates in ESRD and may cause seizures Oral
meperidine (DEMEROL) 75 mg injection syringe Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl 10-50ml/min: decrease normal dose by 25%
CrCl<10ml/min: decrease normal dose by 50%
Normeperidine, an active metabolite, accumulates in ESRD an Injection
meprobamate (EQUANIL, MILTOWN) 200 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: give q8-12h
CrCl<10ml/min: give q12-18h Oral
meprobamate (EQUANIL, MILTOWN) 400 mg tablet No Dispense 2 x 200mg
Renal Dosing:
CrCl 10-50ml/min: give q8-12h
CrCl<10ml/min: give q12-18h Oral
mercaptopurine (PURINETHOL, 6-MP) 50 mg tablet Yes Oral
meropenem (MERREM) 1 g injection Yes Renal Dosing:
CrCl 50-80ml/min: 1-2gm q8h
CrCl 10-50ml/min: 0.5-1gm q12h
CrCl<10ml/min: 0.5-1gm q24h Intravenous
meropenem (MERREM) 500 mg injection Yes Renal Dosing:
CrCl 50-80ml/min: 1-2gm q8h
CrCl 10-50ml/min: 0.5-1gm q12h
CrCl<10ml/min: 0.5-1gm q24h Intravenous
metformin (GLUCOPHAGE) 1000 mg tablet Yes Renal Dosing:
Avoid in patients with creatinine>1.5mg/dl (males) or creatinine>1.4mg/dl (females) due to risk of lactic acidosis Oral
metformin (GLUCOPHAGE) 100mg/ml oral liquid No Renal Dosing:
Avoid in patients with creatinine>1.5mg/dl (males) or creatinine>1.4mg/dl (females) due to risk of lactic acidosis Oral
metformin (GLUCOPHAGE) 500 mg tablet Yes Renal Dosing:
Avoid in patients with creatinine>1.5mg/dl (males) or creatinine>1.4mg/dl (females) due to risk of lactic acidosis Oral
metformin (GLUCOPHAGE) 850 mg tablet Yes Renal Dosing:
Avoid in patients with creatinine>1.5mg/dl (males) or creatinine>1.4mg/dl (females) due to risk of lactic acidosis Oral
metformin ER (GLUCOPHAGE XR, FORTAMET) 500 mg tablet Yes Renal Dosing:
Avoid in patients with creatinine>1.5mg/dl (males) or creatinine>1.4mg/dl (females) due to risk of lactic acidosis Oral
metformin ER (GLUCOPHAGE XR, FORTAMET) 750 mg tablet No Dispense 1.5 x 500mg
Renal Dosing:
Avoid in patients with creatinine>1.5mg/dl (males) or creatinine>1.4mg/dl (females) due to risk of lactic acidosis Oral
metformin ER (GLUCOPHAGE XR, FORTAMET, GLUMETZA) 1000 mg tablet No Dispense 2 x 500mg
Renal Dosing:
Avoid in patients with creatinine>1.5mg/dl (males) or creatinine>1.4mg/dl (females) due to risk of lactic acidosis Oral
methadone (DOLOPHINE) 10 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: q6h
CrCl 10-50ml/min: q8h
CrCl<10ml/min: q8-12h Oral
methadone (DOLOPHINE) 10 mg/ml injection Yes Renal Dosing:
CrCl 50-80ml/min: q6h
CrCl 10-50ml/min: q8h
CrCl<10ml/min: q8-12h Injection
methadone (DOLOPHINE) 5 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: q6h
CrCl 10-50ml/min: q8h
CrCl<10ml/min: q8-12h Oral
methadone (DOLOPHINE) 5 mg/5 ml oral liquid No Renal Dosing:
CrCl 50-80ml/min: q6h
CrCl 10-50ml/min: q8h
CrCl<10ml/min: q8-12h Oral
methenamine compound (DARPAZ) tablet No Renal Dosing:
CrCl <50ml/min: Avoid Oral
methenamine compound (URIMAR-T) tablet No Renal Dosing:
CrCl <50ml/min: Avoid Oral
methenamine compound (URIMAX) tablet No Renal Dosing:
CrCl <50ml/min: Avoid Oral
methenamine compound (URISED) tablet No Renal Dosing:
CrCl <50ml/min: Avoid Oral
methenamine compound (UROGESIC BLUE) tablet No Renal Dosing:
CrCl <50ml/min: Avoid Oral
methenamine compound (UROQUID # 2) tablet No Renal Dosing:
CrCl <50ml/min: Avoid Oral
methenamine compound (UTICAP) capsule No Renal Dosing:
CrCl <50ml/min: Avoid Oral
methenamine compound (UTRONA-C) tablet No Renal Dosing:
CrCl <50ml/min: Avoid Oral
methenamine hippurate (UREX,HIPREX) 1 g tablet No Renal Dosing:
CrCl <50ml/min: Avoid Oral
methenamine mandelate (MANDELAMINE) 1 g tablet No Withdrawn from the Market (April 2009)
Renal Dosing:
CrCl <50ml/min: Avoid Oral
methocarbamol (ROBAXIN) 100 mg/ml injection No Renal Dosing:
Avoid in patients with renal dysfunction due to the presence of propylene glycol in the vehicle Injection
methocarbamol (ROBAXIN) 500 mg tablet Yes Oral
methocarbamol (ROBAXIN) 750 mg tablet No Dispense 1.5 x 500mg Oral
methotrexate (TREXALL) 2.5 mg chemo tablet Yes Renal Dosing:
CrCl<10ml/min: decrease normal dose by 50% Oral
methotrexate (TREXALL) chemotherapy intrathecal injection Yes Chemo
methotrexate high dose (MTX) chemo infusion (LBM) Yes Renal Dosing:
CrCl<10ml/min: decrease normal dose by 50% Chemo
methotrexate(MTX) chemo infusion (LBM) Yes Renal Dosing:
CrCl<10ml/min: decrease normal dose by 50% Chemo
methyldopa (ALDOMET) 250 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: q8h
CrCl 10-50ml/min: q8-12h
CrCl<10ml/min: q12-24h Oral
methyldopa (ALDOMET) 500 mg tablet No Dispense 2 x 250mg
Renal Dosing:
CrCl 50-80ml/min: q8h
CrCl 10-50ml/min: q8-12h
CrCl<10ml/min: q12-24h Oral
methyldopa-hydrochlorothiazide (ALDORIL-15) 250-15 mg tablet No Withdrawn from the Market (March 2008)
Renal Dosing:
Methyldopa
CrCl 50-80ml/min: q8h
CrCl 10-50ml/min: q8-12h
CrCl<10ml/min: q12-24h
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
methyldopa-hydrochlorothiazide (ALDORIL-25) 250-25 mg tablet No Withdrawn from the Market (March 2008)
Renal Dosing:
Methyldopa
CrCl 50-80ml/min: q8h
CrCl 10-50ml/min: q8-12h
CrCl<10ml/min: q12-24h
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
methyldopa-hydrochlorothiazide (ALDORIL-50) 500-50 mg tablet No Withdrawn from the Market (March 2008)
Renal Dosing:
Methyldopa
CrCl 50-80ml/min: q8h
CrCl 10-50ml/min: q8-12h
CrCl<10ml/min: q12-24h
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
methyldopate (ALDOMET) IVPB Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl 50-80ml/min: q8h
CrCl 10-50ml/min: q8-12h
CrCl<10ml/min: q12-24h IVPB
metoclopramide (METOZOLV) 10 mg disintegrating tablet No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
metoclopramide (METOZOLV) 5 mg disintegrating tablet No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
metoclopramide (REGLAN) 10 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
metoclopramide (REGLAN) 5 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
metoclopramide (REGLAN) 5 mg/5 ml oral liquid No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
metoclopramide (REGLAN) 5 mg/ml injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Injection
metoprolol-hydrochlorothiazide (LOPRESSOR HCT) 100-25 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
metoprolol-hydrochlorothiazide (LOPRESSOR HCT) 100-50 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
metoprolol-hydrochlorothiazide (LOPRESSOR HCT) 50-25 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
metronidazole (FLAGYL) 1gm in 1000mls sterile water topical irrigation solution Yes Topical Irrigation
metronidazole (FLAGYL) 250 mg in 50ml NS injection Yes Renal Dosing:
CrCl<10ml/min: 500mg q12h intravenous
metronidazole (FLAGYL) 250 mg tablet Yes Renal Dosing:
CrCl<10ml/min: 500mg q12h Oral
metronidazole (FLAGYL) 500 mg in 100ml NS injection Yes Renal Dosing:
CrCl<10ml/min: 500mg q12h Intravenous
metronidazole (FLAGYL) 500 mg tablet Yes Renal Dosing:
CrCl<10ml/min: 500mg q12h Oral
metronidazole (FLAGYL) 500mg/10mg oral liquid No Renal Dosing:
CrCl<10ml/min: 500mg q12h Oral
metronidazole ER (FLAGYL ER) 375 mg tablet No Renal Dosing:
Recommend using immediate-release product in patients with ESRD as follows:
CrCl<10ml/min: 500mg q12h Oral
metronidazole ER (FLAGYL ER) 750 mg tablet No Renal Dosing:
Recommend using immediate-release product in patients with ESRD as follows:
CrCl<10ml/min: 500mg q12h Oral
midazolam (VERSED) 1 mg/ml injection Yes May be administered in: All Critical Care Areas and DOU (limited use)
Renal Dose:
CrCl<10ml/min: decrease usual dose by 50% Injection
midazolam (VERSED) 5 mg/ml injection Yes May be administered in: All Critical Care Areas and DOU (limited use)
Renal Dose:
CrCl<10ml/min: decrease usual dose by 50% Injection
midazolam (VERSED) drip Yes May be administered in: All Critical Care Areas and DOU (limited use)
Renal Dose:
CrCl<10ml/min: decrease usual dose by 50% Drips
moexipril - hydrochlorothiazide (UNIRETIC) 15-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Moexipril
CrCl<40ml/min/1.73 m(2):
initial dose 3.75mg daily,
usual dose 3.75-15mg daily
maximum dose 15mg daily
Hydrochlorothiazide
Oral
moexipril - hydrochlorothiazide (UNIRETIC) 15-25 mg tablet No Dispense individual ingredients
Renal Dosing:
Moexipril
CrCl<40ml/min/1.73 m(2):
initial dose 3.75mg daily,
usual dose 3.75-15mg daily
maximum dose 15mg daily
Hydrochlorothiazide
Oral
moexipril - hydrochlorothiazide (UNIRETIC) 7.5-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Moexipril
CrCl<40ml/min/1.73 m(2):
initial dose 3.75mg daily,
usual dose 3.75-15mg daily
maximum dose 15mg daily
Hydrochlorothiazide
Oral
moexipril (UNIVASC) 15 mg tablet Yes Renal Dosing:
CrCl<40ml/min/1.73 m(2):
initial dose 3.75mg daily,
usual dose 3.75-15mg daily
maximum dose 15mg daily Oral
moexipril (UNIVASC) 7.5 mg tablet No Dispense 1/2 of 15mg
Renal Dosing:
CrCl<40ml/min/1.73 m(2):
initial dose 3.75mg daily,
usual dose 3.75-15mg daily
maximum dose 15mg daily Oral
morphine – naltrexone ER (EMBEDA) 100-4 mg oral capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine – naltrexone ER (EMBEDA) 20-0.8 mg oral capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine – naltrexone ER (EMBEDA) 30-1.3 mg oral capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine – naltrexone ER (EMBEDA) 50-2 mg oral capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine – naltrexone ER (EMBEDA) 60-2.4 mg oral capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine – naltrexone ER (EMBEDA) 80-3.2 mg oral capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine (MSIR) 10 mg/5 ml oral liquid Yes Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine (MSIR) 30 mg soluble tablet No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine 1 mg/ml in NS 250ml PCA Yes Drips
morphine 10 mg/ml injection syringe Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Injection
morphine 15 mg tablet no Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine 15 mg/ml injection syringe Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Injection
morphine 2 mg injection syringe Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Injection
morphine 30 mg tablet No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine 4 mg/ml injection syringe Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Injection
morphine 8 mg/ml injection syringe Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Injection
morphine concentrate (ROXANOL) 20 mg/ml oral liquid Yes Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine CR (MS CONTIN) 100 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine drip Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Drips
morphine epidural Yes May be administered in: Non Critical Care Areas and all Critical Care Areas Drips
morphine ER (AVINZA) 120 mg capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine ER (AVINZA) 30 mg capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine ER (AVINZA) 45 mg capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine ER (AVINZA) 60 mg capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine ER (AVINZA) 75 mg capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine ER (AVINZA) 90 mg capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine ER (KADIAN) 100 mg capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine ER (KADIAN) 20 mg capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine ER (KADIAN) 200 mg capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine ER (KADIAN) 30 mg capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine ER (KADIAN) 50 mg capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine ER (KADIAN) 60 mg capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine ER (KADIAN) 80 mg capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine ER (MS CONTIN) 15 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine ER (MS CONTIN) 30 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine ER (MS CONTIN) 90 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
nabumetone (RELAFEN) 500 mg tablet Yes Renal Dosing:
CrCl 30-49ml/min: maximum starting dose should be 750mg daily
CrCl<30ml/min: maximum starting dose should be 500mg daily Oral
nabumetone (RELAFEN) 750 mg tablet No Dispense 1.5 of 500mg
Renal Dosing:
CrCl 30-49ml/min: maximum starting dose should be 750mg daily
CrCl<30ml/min: maximum starting dose should be 500mg daily Oral
nadolol (CORGARD) 120 mg tablet No Dispense 1 x 40mg + 1 x 80mg
Renal Dosing:
CrCl 31-50ml/min: q24-36h
CrCl 10-31ml/min: q24-48h
CrCl<10ml/min: q40-60h Oral
nadolol (CORGARD) 160 mg tablet No Dispense 2 x 80mg
Renal Dosing:
CrCl 31-50ml/min: q24-36h
CrCl 10-31ml/min: q24-48h
CrCl<10ml/min: q40-60h Oral
nadolol (CORGARD) 20 mg tablet No Dispense 1/2 x 40mg
Renal Dosing:
CrCl 31-50ml/min: q24-36h
CrCl 10-31ml/min: q24-48h
CrCl<10ml/min: q40-60h Oral
nadolol (CORGARD) 40mg tablet Yes Renal Dosing:
CrCl 31-50ml/min: q24-36h
CrCl 10-31ml/min: q24-48h
CrCl<10ml/min: q40-60h Oral
nadolol (CORGARD) 80 mg tablet Yes Renal Dosing:
CrCl 31-50ml/min: q24-36h
CrCl 10-31ml/min: q24-48h
CrCl<10ml/min: q40-60h Oral
naratriptan (AMERGE) 1 mg tablet No Renal Dosing:
CrCl 15-50ml/min: initial dose 1mg, maximum dose 2.5mg/24hours
CrCl<15ml/min: Contraindicated Oral
naratriptan (AMERGE) 2.5 mg tablet No Renal Dosing:
CrCl 15-50ml/min: initial dose 1mg, maximum dose 2.5mg/24hours
CrCl<15ml/min: Contraindicated Oral
neomycin (MYCIFRADIN) 25mg/ml oral liquid No Renal Dosing:
CrCl 50-80ml/min: q6h
CrCl 10-50ml/min: q12-18h
CrCl<10ml/min: q18-24h Oral
neomycin (MYCIGUENT) 0.5% topical ointment Yes Topical
neomycin 500mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: q6h
CrCl 10-50ml/min: q12-18h
CrCl<10ml/min: q18-24h Oral
nitrofurantoin macrocrystal (MACRODANTIN) 100 mg capsule No Renal Dosing:
CrCl<50ml/min: Avoid Oral
nitrofurantoin macrocrystal (MACRODANTIN) 25 mg capsule No Renal Dosing:
CrCl<50ml/min: Avoid Oral
nitrofurantoin macrocrystal (MACRODANTIN) 50 mg capsule No Renal Dosing:
CrCl<50ml/min: Avoid Oral
nitrofurantoin monohydrate - macrocrystal (MACROBID) 100 mg capsule Yes Renal Dosing:
CrCl<50ml/min: Avoid Oral
nitroprusside (NIPRIDE) drip Yes May be administered in: Critical Care Areas Only
Renal Dosing:
CrCl <10ml/min: Avoid
Thiocyanate, a toxi metabolite, accumulates causing seizures, coma
Thiocyanate is hemodialyzable - measure thiocyanate levels Drips
nitroprusside (NIPRIDE) syringe drip (conc: 1 mg/ml) Yes May be administered in: Critical Care Areas Only
Renal Dosing:
CrCl <10ml/min: Avoid
Thiocyanate, a toxi metabolite, accumulates causing seizures, coma
Thiocyanate is hemodialyzable - measure thiocyanate levels Drips
nizatidine (AXID) 150 mg capsule No Renal Dosing:
Treatment dosing:
CrCl 20-50ml/min: 150mg daily
CrCl<20ml/min: 150mg every other day
Maintenance dosing:
CrCl 20-50ml/min: 150mg every other day
Oral
nizatidine (AXID) 300 mg capsule No Renal Dosing:
Treatment dosing:
CrCl 20-50ml/min: 150mg daily
CrCl<20ml/min: 150mg every other day
Maintenance dosing:
CrCl 20-50ml/min: 150mg every other day
Oral
norfloxacin (NOROXIN) 400 mg tablet No Renal Dosing:
CrCl 10-50ml/min: 400mg q24h
CrCl<10ml/min: 200mg q24h Oral
ofloxacin (FLOXIN) 200mg tablet No Renal Dosing:
CrCl 10-50ml/min: 200-400mg q 24h
CrCl<10ml/min: 200mg q24h Oral
ofloxacin (FLOXIN) 400 mg in 100ml D5W injection No Renal Dosing:
CrCl 10-50ml/min: 200-400mg q 24h
CrCl<10ml/min: 200mg q24h Intravenous
ofloxacin (FLOXIN) 400 mg tablet No Renal Dosing:
CrCl 10-50ml/min: 200-400mg q 24h
CrCl<10ml/min: 200mg q24h Oral
ofloxacin (OCUFLOX) 0.3% ophthalmic solution No Ophthalmic
ofloxacin(FLOXIN) 300 mg tablet No Renal Dosing:
CrCl 10-50ml/min: 200-400mg q 24h
CrCl<10ml/min: 200mg q24h Oral
olmesartan - hydrochlorothiazide (BENICAR HCT) 20 - 12.5 mg tablet No Dispense individual ingredients
Renal Dosing
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
olmesartan - hydrochlorothiazide (BENICAR HCT) 40 - 12.5 mg tablet No Dispense individual ingredients
Renal Dosing
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
olmesartan - hydrochlorothiazide (BENICAR HCT) 40-25 mg tablet No Dispense individual ingredients
Renal Dosing
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
orphenadrine-aspirin-caffeine (NORGESIC) 25-385-30 mg tablet Yes Renal Dosing:
Aspirin
Reduce dose in impaired renal function.
Avoid in patients with end stage renal disease. Oral
oseltamivir (TAMIFLU) 12 mg/ml oral liquid Yes Renal Dosing:
CrCl 10-30ml/min: 75mg daily x 5 days for treatment; 75mg every other day for prophylaxis Oral
oseltamivir (TAMIFLU) 75 mg capsule Yes Renal Dosing:
CrCl 10-30ml/min: 75mg daily x 5 days for treatment; 75mg every other day for prophylaxis Oral
oxaprozin (DAYPRO) 600 mg tablet Yes Renal Dosing:
Initiate therapy at 600mg daily in azotemic patients Oral
oxaprozin potassion (DAYPRO ALTA) 678 mg tablet No Renal Dosing:
Initiate therapy at 678mg daily in azotemic patients Oral
oxcarbazepine (TRILEPTAL) 150 mg tablet No Dispense 1/2 of 300mg
Renal Dosing:
CrCl<30ml/min: initiate therapy with 300mg daily Oral
oxcarbazepine (TRILEPTAL) 300 mg tablet Yes Renal Dosing:
CrCl<30ml/min: initiate therapy with 300mg daily Oral
oxcarbazepine (TRILEPTAL) 300 mg/5 ml oral suspension No Renal Dosing:
CrCl<30ml/min: initiate therapy with 300mg daily Oral
oxcarbazepine (TRILEPTAL) 600 mg tablet No Dispense 2 x 300mg
Renal Dosing:
CrCl<30ml/min: initiate therapy with 300mg daily Oral
oxycodone - aspirin (PERCODAN) 4.88-325 mg tablet No Renal Dosing:
Aspirin
Reduce dose in impaired renal function.
Avoid in patients with end stage renal disease. Oral
oxymorphone (OPANA) 10 mg tablet No Renal Dosing:
CrCl<50ml/min: reduce doses Oral
oxymorphone (OPANA) 1mg/ml injection No Renal Dosing:
CrCl<50ml/min: reduce doses Injection
oxymorphone (OPANA) 5 mg tablet No Renal Dosing:
CrCl<50ml/min: reduce doses Oral
oxymorphone ER (OPANA ER) 10 mg tablet No Renal Dosing:
CrCl<50ml/min: reduce doses Oral
oxymorphone ER (OPANA ER) 15 mg tablet No Renal Dosing:
CrCl<50ml/min: reduce doses Oral
oxymorphone ER (OPANA ER) 20 mg tablet No Renal Dosing:
CrCl<50ml/min: reduce doses Oral
oxymorphone ER (OPANA ER) 30 mg tablet No Renal Dosing:
CrCl<50ml/min: reduce doses Oral
oxymorphone ER (OPANA ER) 40 mg tablet No Renal Dosing:
CrCl<50ml/min: reduce doses Oral
oxymorphone ER (OPANA ER) 5 mg tablet No Renal Dosing:
CrCl<50ml/min: reduce doses Oral
oxymorphone ER (OPANA ER) 7.5 mg tablet No Renal Dosing:
CrCl<50ml/min: reduce doses Oral
paliperidone (INVEGA) 3 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: 6mg/day maximum dose
CrCl 10-50ml/min: 3mg/day maximum dose Oral
paliperidone (INVEGA) 6 mg tablet No Dispense 2 x 3mg
Renal Dosing:
CrCl 50-80ml/min: 6mg/day maximum dose
CrCl 10-50ml/min: 3mg/day maximum dose Oral
paliperidone (INVEGA) 9 mg tablet No Dispense 3 x 3mg
Renal Dosing:
CrCl 50-80ml/min: 6mg/day maximum dose
CrCl 10-50ml/min: 3mg/day maximum dose Oral
pancuronium (PAVULON) 1 mg/ml injection Yes May be administered in: Critical Care Areas Only
Renal Dosing:
CrCl <10ml/min: Avoid Intravenous
pancuronium (PAVULON) drip Yes May be administered in: Critical Care Areas Only
Renal Dosing:
CrCl <10ml/min: Avoid Drips
paroxetine (PAXIL, PEXEVA) 10 mg tablet Yes Renal Dosing:
In patients with renal failure, the initial dose is 10mg daily to a maximum of 40mg/day Oral
paroxetine (PAXIL, PEXEVA) 10 mg/5 ml oral liquid No Renal Dosing:
In patients with renal failure, the initial dose is 10mg daily to a maximum of 40mg/day Oral
paroxetine (PAXIL, PEXEVA) 20 mg tablet Yes Renal Dosing:
In patients with renal failure, the initial dose is 10mg daily to a maximum of 40mg/day Oral
paroxetine (PAXIL, PEXEVA) 30 mg tablet No Dispense 1 x 10 + 1 x 20mg
Renal Dosing:
In patients with renal failure, the initial dose is 10mg daily to a maximum of 40mg/day Oral
paroxetine (PAXIL, PEXEVA) 40 mg tablet No Dispense 2 x 20mg
Renal Dosing:
In patients with renal failure, the initial dose is 10mg daily to a maximum of 40mg/day Oral
paroxetine CR (PAXIL CR) 12 .5 mg tablet No Renal Dosing:
In patients with renal failure, the initial dose is 12.5mg daily to a maximum of 50mg/day Oral
paroxetine CR (PAXIL CR) 25 mg tablet No Renal Dosing:
In patients with renal failure, the initial dose is 12.5mg daily to a maximum of 50mg/day Oral
paroxetine CR (PAXIL CR) 37.5 mg tablet No Renal Dosing:
In patients with renal failure, the initial dose is 12.5mg daily to a maximum of 50mg/day Oral
peginterferon alfa-2a (PEGASYS) 180 mcg/ml injection Yes Renal Dosing:
CrCl<10ml/min: reduce dose to 135mcg Subcutaneous
pemetrexed (ALIMTA) chemo infusion Yes Renal Dosing:
CrCl<45 ml/min: Avoid Chemo
pemirolast (ALAMAST) 0.1% ophthalmic solution No Ophthalmic
penbutolol (LEVATOL) 20mg tablet Yes Oral
penciclovir (DENAVIR) 1% topical cream Yes Topical
penicillamine (CUPRIMINE) 250 mg capsule Yes Renal Dosing:
CrCl<50ml/min: Avoid Oral
penicillamine (DEPEN) 250 mg tablet No Renal Dosing:
CrCl<50ml/min: Avoid Oral
penicillin G potassium (PFIZERPEN-G, PEN GK) 2 MU in 50ml D5W injection Yes Renal Dosing:
CrCl 50-80ml/min: 2-4 MU q4-6h
CrCl 10-50ml/min: 1-2 MU q4-6h
CrCl<10ml/min: 1 MU q6h Intravenous
penicillin G potassium (PFIZERPEN-G, PEN GK) 3 MU in 50ml D5W injection Yes Renal Dosing:
CrCl 50-80ml/min: 2-4 MU q4-6h
CrCl 10-50ml/min: 1-2 MU q4-6h
CrCl<10ml/min: 1 MU q6h Intravenous
penicillin G procaine - benzathine (BICILLIN CR) 1,200,000 units/2 ml syringe Yes Intramuscular
penicillin G procaine - benzathine (BICILLIN CR) 2,400,000 units/4 ml syringe Yes Intramuscular
penicillin G procaine (WYCILLIN) 1,200,000 units syringe Yes Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50-80% Intramuscular
penicillin G procaine (WYCILLIN) 600,000 units syringe Yes Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50-80% Intramuscular
penicillin G sodium 5 million units injection Yes Renal Dosing:
CrCl 50-80ml/min: 2-4 MU q4-6h
CrCl 10-50ml/min: 1-2 MU q4-6h
CrCl<10ml/min: 1 MU q6h Injection
penicillin V potassium (V-CILLIN, PEN VK) 250 mg tablet Yes Oral
penicillin V potassium (V-CILLIN, PEN VK) 500 mg tablet Yes Oral
pentamidine (NEBUPENT) 300 mg inhalation solution Yes Inhalation
pentamidine (PENTAM) 300 mg injection (for IM use) Yes Renal Dosing:
CrCl 10-50ml/min: 4mg/kg q24-36h
CrCl<10ml/min: 4mg/kg q48h Injection
pentamidine (PENTAM) injection Yes Renal Dosing:
CrCl 10-50ml/min: 4mg/kg q24-36h
CrCl<10ml/min: 4mg/kg q48h IVPB
pentazocine - naloxone (TALWIN NX) 50-0.5 mg tablet Yes Oral
pentazocine - acetaminophen (TALACEN) 25-650 mg tablet No Renal Dosing:
Pentazocine
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
pentazocine - aspirin (TALWIN COMPOUND) 12.5-325 mg tablet No Renal Dosing:
Aspirin
Reduce dose in impaired renal function.
Avoid in patients with end stage renal disease
Pentazocine
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
pentazocine (TALWIN) 30 mg/ml injection No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Injection
pentobarbital (NEMBUTAL) drip Yes May be administered in: Critical Care Areas Only Drips
pentobarbital (NEMBUTAL) infusion per pharmacy guideline Yes Per Pharmacy
pentobarbital (NEMBUTAL) injection Yes May be administered in: Critical Care Areas Only Injection
pentosan polysulfate (ELMIRON) 100mg capsule Yes Oral
pentostatin (NIPENT) injection Yes Intravenous
pentoxyfylline ER (TRENTAL) 400 mg tablet Yes Renal Dosing:
CrCl 30-80ml/min: 400mg bid
CrCl<30ml/min: 400mg daily or Avoid Oral
PEPCID COMPLETE 10 mg chewable tablet No Oral
perindopril (ACEON) 2 mg tablet No Dispense 1/2 of 4mg
Renal Dosing:
CrCl 10-50ml/min: give 75% of usual dose
CrCl<10ml/min: give 50% of usual dose Oral
perindopril (ACEON) 4 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: give 75% of usual dose
CrCl<10ml/min: give 50% of usual dose Oral
perindopril (ACEON) 8 mg tablet No Dispense 2 x 4mg
Renal Dosing:
CrCl 10-50ml/min: give 75% of usual dose
CrCl<10ml/min: give 50% of usual dose Oral
permethrin (ELIMITE) 5% topical cream Yes Topical
permethrin (NIX) 1% topical shampoo Yes Topical
perphenazine - amitriptyline (TRIAVIL, ETRAFON) 2-10 mg tablet No Dispense individual ingredients Oral
perphenazine - amitriptyline (TRIAVIL, ETRAFON) 2-25 mg tablet No Dispense individual ingredients Oral
perphenazine - amitriptyline (TRIAVIL, ETRAFON) 4-10 mg tablet No Dispense individual ingredients Oral
perphenazine - amitriptyline (TRIAVIL, ETRAFON) 4-25 mg tablet No Dispense individual ingredients Oral
phenazopyridine (PYRIDIUM) 100 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: q8-16h
CrCl<50ml/min: Avoid Oral
phenazopyridine (PYRIDIUM) 200 mg tablet No Dispense 2 x 100mg
Renal Dosing:
CrCl 50-80ml/min: q8-16h
CrCl<50ml/min: Avoid Oral
phenazopyridine (URISAT, REAZO) 95 mg tablet No Renal Dosing:
CrCl 50-80ml/min: q8-16h
CrCl<50ml/min: Avoid Oral
phenobarbital 100 mg tablet Yes Renal Dosing:
ClCr<10ml/min: q12-16h Oral
phenobarbital 130 mg/ml injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
ClCr<10ml/min: q12-16h Injection
phenobarbital 15 mg tablet No Dispense 1/2 of 30mg
Renal Dosing:
ClCr<10ml/min: q12-16h Oral
phenobarbital 20mg/5ml oral liquid No Renal Dosing:
ClCr<10ml/min: q12-16h Oral
phenobarbital 30 mg tablet Yes Renal Dosing:
ClCr<10ml/min: q12-16h Oral
phenobarbital 60 mg tablet No Dispense 2 x 30mg
Renal Dosing:
ClCr<10ml/min: q12-16h Oral
phenobarbital 65 mg/ml injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
ClCr<10ml/min: q12-16h Injection
phenylephrine-promethazine-codeine(Phenergan VC w/ Codeine) 5-6.25-10mg/5ml oral liquid No Renal Dosing:
Codeine
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
pioglitazone - metformin (ACTOPLUS MET) 15-500 mg tablet No Dispense individual ingredients
Renal Dosing:
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine>1.4mg/dl (females) due to risk of lactic acidosis Oral
pioglitazone - metformin (ACTOPLUS MET) 15-850 mg tablet No Dispense individual ingredients
Renal Dosing:
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine>1.4mg/dl (females) due to risk of lactic acidosis Oral
pioglitazone - metformin ER (ACTOPLUS MET XT) 15-1000 mg tablet No Dispense individual ingredients
Renal Dosing:
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine>1.4mg/dl (females) due to risk of lactic acidosis Oral
pioglitazone - metformin ER (ACTOPLUS MET XT) 30-1000 mg tablet No Dispense individual ingredients
Renal Dosing:
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine>1.4mg/dl (females) due to risk of lactic acidosis Oral
pioglitazone (ACTOS) 15 mg tablet Yes Oral
pioglitazone (ACTOS) 30 mg tablet Yes Oral
pioglitazone (ACTOS) 45 mg tablet Yes Oral
piperacillin (PIPRACIL) 2 g injection No Renal Dosing:
CrCl 10-50ml/min: 3gm q8h
CrCl<10ml/min: 2gm q8h Intravenous
piperacillin (PIPRACIL) 3 g injection No Renal Dosing:
CrCl 10-50ml/min: 3gm q8h
CrCl<10ml/min: 2gm q8h Intravenous
piperacillin (PIPRACIL) 4 g injection No Renal Dosing:
CrCl 10-50ml/min: 3gm q8h
CrCl<10ml/min: 2gm q8h Intravenous
piperacillin-tazobactam (ZOSYN) 2.25 g intravenous Yes Renal Dosing:
CrCl 10-50ml/min: 3.375gm q8h
CrCl<10ml/min: 2.25gm q8h Intravenous
piperacillin-tazobactam (ZOSYN) 3.375 g intravenous Yes Renal Dosing:
CrCl 10-50ml/min: 3.375gm q8h
CrCl<10ml/min: 2.25gm q8h Intravenous
piperacillin-tazobactam (ZOSYN) 4.5 g intravenous Yes Renal Dosing:
CrCl 10-50ml/min: 3.375gm q8h
CrCl<10ml/min: 2.25gm q8h Intravenous
pirbuterol (MAXAIR) 200 mcg/actuation inhaler No Inhalation
piroxicam (FELDENE) 10 mg capsule Yes Oral
piroxicam (FELDENE) 20 mg capsule No Dispense 2 x 10mg Oral
pitavastatin (LIVALO) 1 mg tablet Yes Renal Dosing:
In patients with significant renal dysfunction, start therapy with 1mg daily Oral
pitavastatin (LIVALO) 2 mg tablet Yes Renal Dosing:
In patients with significant renal dysfunction, start therapy with 1mg daily Oral
pitavastatin (LIVALO) 4 mg tablet Yes Renal Dosing:
In patients with significant renal dysfunction, start therapy with 1mg daily Oral
pramipexole (MIRAPEX) 0.125 mg tablet No Dispense 1/2 of 0.25mg
Renal Dosing:
CrCl 35-59ml/min: 0.125-1.5 mg bid
CrCl 15-34ml/min: 0.125-1.5 daily
CrCl<15ml/min: Avoid Oral
pramipexole (MIRAPEX) 0.25 mg tablet Yes Renal Dosing:
CrCl 35-59ml/min: 0.125-1.5 mg bid
CrCl 15-34ml/min: 0.125-1.5 daily
CrCl<15ml/min: Avoid Oral
pramipexole (MIRAPEX) 0.5 mg tablet No Dispense 2 x 0.25mg
Renal Dosing:
CrCl 35-59ml/min: 0.125-1.5 mg bid
CrCl 15-34ml/min: 0.125-1.5 daily
CrCl<15ml/min: Avoid Oral
pramipexole (MIRAPEX) 1 mg tablet Yes Renal Dosing:
CrCl 35-59ml/min: 0.125-1.5 mg bid
CrCl 15-34ml/min: 0.125-1.5 daily
CrCl<15ml/min: Avoid Oral
pramipexole (MIRAPEX) 1.5 mg tablet No Dispense 1.5 of 1mg
Renal Dosing:
CrCl 35-59ml/min: 0.125-1.5 mg bid
CrCl 15-34ml/min: 0.125-1.5 daily
CrCl<15ml/min: Avoid Oral
pravastatin (PRAVACHOL) 10 mg tablet Yes Renal Dosing:
In patients with significant renal dysfunction, start therapy with 10mg daily Oral
pravastatin (PRAVACHOL) 20 mg tablet Yes Renal Dosing:
In patients with significant renal dysfunction, start therapy with 10mg daily Oral
pravastatin (PRAVACHOL) 40 mg tablet Yes Renal Dosing:
In patients with significant renal dysfunction, start therapy with 10mg daily Oral
pravastatin (PRAVACHOL) 80 mg tablet No Dispense 2 x 40mg
Renal Dosing:
In patients with significant renal dysfunction, start therapy with 10mg daily Oral
pregabalin (LYRICA) 100 mcg capsule Yes Renal Dosing:
CrCl Total daily dose (mg/day) Dosage regimen
>60ml/min 150 300 450 600 divided bid-tid
30-60ml/min 75 150 225 300 divided bid-tid
15-30ml/min 25-50 75 100-15 Oral
pregabalin (LYRICA) 150 mg capsule No Dispense 2 x 75mg
Renal Dosing:
CrCl Total daily dose (mg/day) Dosage regimen
>60ml/min 150 300 450 600 divided bid-tid
30-60ml/min 75 150 225 300 divided bid-tid
15-30ml/min 25-50 Oral
pregabalin (LYRICA) 200 mg capsule No Dispense 2 x 100mg
Renal Dosing:
CrCl Total daily dose (mg/day) Dosage regimen
>60ml/min 150 300 450 600 divided bid-tid
30-60ml/min 75 150 225 300 divided bid-tid
15-30ml/min 25-5 Oral
pregabalin (LYRICA) 225 mg capsule No Dispense 3 x 75mg
Renal Dosing:
CrCl Total daily dose (mg/day) Dosage regimen
>60ml/min 150 300 450 600 divided bid-tid
30-60ml/min 75 150 225 300 divided bid-tid
15-30ml/min 25-50 Oral
pregabalin (LYRICA) 25 mg capsule Yes Renal Dosing:
CrCl Total daily dose (mg/day) Dosage regimen
>60ml/min 150 300 450 600 divided bid-tid
30-60ml/min 75 150 225 300 divided bid-tid
15-30ml/min 25-50 75 100-15 Oral
pregabalin (LYRICA) 300 mg capsule No Dispense 3 x 100mg
Renal Dosing:
CrCl Total daily dose (mg/day) Dosage regimen
>60ml/min 150 300 450 600 divided bid-tid
30-60ml/min 75 150 225 300 divided bid-tid
15-30ml/min 25-5 Oral
pregabalin (LYRICA) 50 mg capsule Yes Renal Dosing:
CrCl Total daily dose (mg/day) Dosage regimen
>60ml/min 150 300 450 600 divided bid-tid
30-60ml/min 75 150 225 300 divided bid-tid
15-30ml/min 25-50 75 100-15 Oral
pregabalin (LYRICA) 75 mg capsule Yes Renal Dosing:
CrCl Total daily dose (mg/day) Dosage regimen
>60ml/min 150 300 450 600 divided bid-tid
30-60ml/min 75 150 225 300 divided bid-tid
15-30ml/min 25-50 75 100-15 Oral
primidone (MYSOLINE) 250 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: q8h
CrCl 10-50ml/min: q8-12h
CrCl<10ml/min: q12-24h Oral
primidone (MYSOLINE) 50 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: q8h
CrCl 10-50ml/min: q8-12h
CrCl<10ml/min: q12-24h Oral
primidone (MYSOLINE) 50 mg/ml oral liquid No Renal Dosing:
CrCl 50-80ml/min: q8h
CrCl 10-50ml/min: q8-12h
CrCl<10ml/min: q12-24h Oral
procainamide (PRONESTYL) 250 mg capsule Yes Renal Dosing:
CrCl 50-80ml/min: q4h
CrCl 10-50ml/min: q6-12h
CrCl<10ml/min: q8-24h Oral
procainamide (PRONESTYL) 500 mg capsule No Dispense 2 x 250mg
Renal Dosing:
CrCl 50-80ml/min: q4h
CrCl 10-50ml/min: q6-12h
CrCl<10ml/min: q8-24h Oral
procainamide (PRONESTYL) drip Yes May be administered in: All Critical Care Areas and DOU/ Telemetry Unit (limited use)
Renal Dosing:
Dose should be adjusted for weight, age and renal function Drips
procainamide (PRONESTYL) IM injection Yes May be administered in: All Critical Care Areas and DOU/ Telemetry Unit (limited use)
Renal Dosing:
Dose should be adjusted for weight, age and renal function Injection
procainamide (PRONESTYL) IV Push Yes May be administered in: All Critical Care Areas and DOU/ Telemetry Unit (limited use)
Renal Dosing:
Dose should be adjusted for weight, age and renal function Injection
procainamide (PRONESTYL) syringe drip (conc: 40 mg/ml) Yes May be administered in: All Critical Care Areas and DOU/ Telemetry Unit (limited use)
Renal Dosing:
Dose should be adjusted for weight, age and renal function Drips
procainamide ER (PROCANBID) 1000 mg tablet No Dispense 2 x 500mg
Renal Dosing:
Dose should be adjusted for weight, age and renal function Oral
procainamide ER (PROCANBID) 500 mg tablet Yes Renal Dosing:
Dose should be adjusted for weight, age and renal function Oral
procainamide SR (PRONESTYL SR) (6 hour) 500 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: q4h
CrCl 10-50ml/min: q6-12h
CrCl<10ml/min: q8-24h Oral
promethazine - codeine (PHENERGAN W/CODEINE) 6.25-10mg/5 ml oral liquid Yes Renal Dosing:
Codeine
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
propoxyphene - aspirin - caffeine (DARVON COMPOUND) 65-389-32 mg capsule No Withdrawn From the Market (July 2008)
Renal Dosing:
Aspirin
Reduce dose in impaired renal function.
Avoid in patients with end stage renal disease.
Propoxyphene
CrCl < 10ml/min: Avoid Oral
propoxyphene (DARVON) 65 mg capsule No Renal Dosing:
CrCl<10ml/min: Avoid Oral
propoxyphene N - acetaminophen (BALCET, TRYCET) 100-325 mg tablet No Renal Dosing:
Propoxyphene
CrCl<10ml/min: Avoid Oral
propoxyphene N - acetaminophen (DARVOCET N-100) 100-650 mg tablet Yes Renal Dosing:
Propoxyphene
CrCl<10ml/min: Avoid Oral
propoxyphene N - acetaminophen (DARVOCET N-50) 50-325 mg tablet No Renal Dosing:
Propoxyphene
CrCl<10ml/min: Avoid Oral
propoxyphene napsylate (DARVON-N) 100 mg tablet No Renal Dosing:
CrCl<10ml/min: Avoid Oral
propranolol (INDERAL) 1 mg/ml injection Yes May be administered in: All Critical Care Areas and DOU/ Telemetry Unit Intravenous
pyrazinamide 500 mg tablet Yes Renal Dosing:
CrCl<10ml/min: 12-20mg/kg daily Oral
quinapril - hydrochlorothiazide (ACCURETIC, QUINARETIC) 10-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Quinapril
CrCl 10-50ml/min: 75-100% of usual dose daily
CrCl<10ml/min: 75% of usual dose daily
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
quinapril - hydrochlorothiazide (ACCURETIC, QUINARETIC) 20-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Quinapril
CrCl 10-50ml/min: 75-100% of usual dose daily
CrCl<10ml/min: 75% of usual dose daily
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
quinapril - hydrochlorothiazide (ACCURETIC, QUINARETIC) 20-25 mg tablet No Dispense individual ingredients
Renal Dosing:
Quinapril
CrCl 10-50ml/min: 75-100% of usual dose daily
CrCl<10ml/min: 75% of usual dose daily
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
quinapril (ACCUPRIL) 10 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: 75-100% of usual dose daily
CrCl<10ml/min: 75% of usual dose daily Oral
quinapril (ACCUPRIL) 20 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: 75-100% of usual dose daily
CrCl<10ml/min: 75% of usual dose daily Oral
quinapril (ACCUPRIL) 40 mg tablet No Dispense 2 x 20mg
Renal Dosing:
CrCl 10-50ml/min: 75-100% of usual dose daily
CrCl<10ml/min: 75% of usual dose daily Oral
quinapril (ACCUPRIL) 5 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: 75-100% of usual dose daily
CrCl<10ml/min: 75% of usual dose daily Oral
ramipril (ALTACE) 1.25 mg capsule Yes Renal Dosing:
CrCl 10-50ml/min: give 50-75% of usual dose daily
CrCl<10ml/min: give 25-50% of usual dose daily Oral
ramipril (ALTACE) 10 mg capsule No Dispense 2 x 5mg
Renal Dosing:
CrCl 10-50ml/min: give 50-75% of usual dose daily
CrCl<10ml/min: give 25-50% of usual dose daily Oral
ramipril (ALTACE) 2.5 mg capsule Yes Renal Dosing:
CrCl 10-50ml/min: give 50-75% of usual dose daily
CrCl<10ml/min: give 25-50% of usual dose daily Oral
ramipril (ALTACE) 5 mg capsule Yes Renal Dosing:
CrCl 10-50ml/min: give 50-75% of usual dose daily
CrCl<10ml/min: give 25-50% of usual dose daily Oral
ranitidine (ZANTAC) 15 mg/ml oral liquid No Renal Dosing:
CrCl 50-80ml/min: 150mg q12h
CrCl 10-50ml/min: 150mg q24h
CrCl<10ml/min: 150mg q24-48h Oral
ranitidine (ZANTAC) 150 mg tablet No Renal Dosing:
CrCl 50-80ml/min: 150mg q12h
CrCl 10-50ml/min: 150mg q24h
CrCl<10ml/min: 150mg q24-48h Oral
ranitidine (ZANTAC) 25 mg/ml injection No Renal Dosing:
CrCl 50-80ml/min: 50mg q8h
CrCl 10-50ml/min: 50mg q12h
CrCl<10ml/min: 50mg q18-24h Injection
ranitidine (ZANTAC) 75 mg tablet No Renal Dosing:
CrCl 50-80ml/min: 150mg q12h
CrCl 10-50ml/min: 150mg q24h
CrCl<10ml/min: 150mg q24-48h Oral
repaglinide - metformin (PRANDIMET) 1-500 mg tablet No Dispense individual ingredients
Renal Dosing:
Repaglinide
CrCl 20-40ml/min: initial dose should be 0.5mg
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine>1.4mg/dl (females) due to risk of lactic acidosis Oral
repaglinide - metformin (PRANDIMET) 2-500 mg tablet No Dispense individual ingredients
Renal Dosing:
Repaglinide
CrCl 20-40ml/min: initial dose should be 0.5mg
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine>1.4mg/dl (females) due to risk of lactic acidosis Oral
repaglinide (PRANDIN) 0.5 mg tablet Yes Renal Dosing:
CrCl 20-40ml/min: initial dose should be 0.5mg Oral
repaglinide (PRANDIN) 1 mg tablet No Dispense 2 x 0.5mg
Renal Dosing:
CrCl 20-40ml/min: initial dose should be 0.5mg Oral
repaglinide (PRANDIN) 2 mg tablet Yes Renal Dosing:
CrCl 20-40ml/min: initial dose should be 0.5mg Oral
reserpine 0.1 mg tablet Yes Renal Dosing:
CrCl<10ml/min: Avoid Oral
reserpine 0.25 mg tablet Yes Renal Dosing:
CrCl<10ml/min: Avoid Oral
retapamulin (ALTABAX) 1% topical ointment No Not routinely stocked - Order PRN Topical
ribavirin (COPEGUS, RIBASHPERES) 200 mg tablet Yes Renal Dosing:
CrCl<50ml/min: Avoid Oral
ribavirin (REBETROL, RIBASHPERES) 200 mg capsule Yes Renal Dosing:
CrCl<50ml/min: Avoid Oral
ribavirin (RIBATAB, RIBASPHERES) 400 mg tablet No Dispense 2 x 200mg tablets
Renal Dosing:
CrCl<50ml/min: Avoid Oral
ribavirin (RIBATAB, RIBASPHERES) 500 mg tablet Yes Renal Dosing:
CrCl<50ml/min: Avoid Oral
ribavirin (RIBATAB, RIBASPHERES) 600 mg tablet No Dispense 3 x 200mg tab
Renal Dosing:
CrCl<50ml/min: Avoid Oral
rifabutin (MYCOBUTIN) 150 mg capsule Yes Renal Dosing:
CrCl<30ml/min: reduce dose by 50% Oral
rimantadine (FLUMADINE) 100 mg tablet No Renal Dosing:
CrCl 10-50ml/min: 100mg q12-24h
CrCl<10ml/min: 100mg q24h Oral
rimantadine (FLUMADINE) 50 mg/5 ml oral liquid No Renal Dosing:
CrCl 10-50ml/min: 100mg q12-24h
CrCl<10ml/min: 100mg q24h Oral
rimexolone (VEXOL) 1% ophthalmic suspension No Ophthalmic
ringers irrigation Yes Topical Irrigation
risedronate (ACTONEL) 150 mg monthly tablet Yes Renal Dosing:
CrCl<30ml/min: Avoid Oral
risedronate (ACTONEL) 30 mg daily tablet Yes Renal Dosing:
CrCl<30ml/min: Avoid Oral
risedronate (ACTONEL) 35 mg weekly tablet Yes Renal Dosing:
CrCl<30ml/min: Avoid Oral
risedronate (ACTONEL) 5 mg daily tablet Yes Renal Dosing:
CrCl<30ml/min: Avoid Oral
risperidone (RISPERDAL M) 0.5 mg disintegrating tablet No Renal Dosing:
CrCl<10ml/min: 0.5mg bid to a maximum dose of 3mg/day Oral
risperidone (RISPERDAL M) 1 mg disintegrating tablet No Renal Dosing:
CrCl<10ml/min: 0.5mg bid to a maximum dose of 3mg/day Oral
risperidone (RISPERDAL M) 2 mg disintegrating tablet No Renal Dosing:
CrCl<10ml/min: 0.5mg bid to a maximum dose of 3mg/day Oral
risperidone (RISPERDAL M) 4 mg disintegrating tablet No Dispense 2 x 2mg immediate-release tablets
Renal Dosing:
CrCl<10ml/min: 0.5mg bid to a maximum dose of 3mg/day Oral
risperidone (RISPERDAL) 0.25 mg tablet Yes Renal Dosing:
CrCl<10ml/min: 0.5mg bid to a maximum dose of 3mg/day Oral
risperidone (RISPERDAL) 0.5 mg tablet Yes Renal Dosing:
CrCl<10ml/min: 0.5mg bid to a maximum dose of 3mg/day Oral
risperidone (RISPERDAL) 1 mg tablet Yes Renal Dosing:
CrCl<10ml/min: 0.5mg bid to a maximum dose of 3mg/day Oral
risperidone (RISPERDAL) 1 mg/ml oral solution No Renal Dosing:
CrCl<10ml/min: 0.5mg bid to a maximum dose of 3mg/day Oral
risperidone (RISPERDAL) 2 mg tablet Yes Renal Dosing:
CrCl<10ml/min: 0.5mg bid to a maximum dose of 3mg/day Oral
risperidone (RISPERDAL) 3 mg tablet No Dispense 1 x 2mg + 1 x 1 mg
Renal Dosing:
CrCl<10ml/min: 0.5mg bid to a maximum dose of 3mg/day Oral
risperidone (RISPERDAL) 4 mg tablet No Dispense 2 x 2mg
Renal Dosing:
CrCl<10ml/min: 0.5mg bid to a maximum dose of 3mg/day Oral
rosiglitazone - metformin (AVANDAMET) 2-1000 mg tablet No Dispense individual ingredients
Renal Dosing:
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine>1.4mg/dl (females) due to risk of lactic acidosis Oral
rosiglitazone - metformin (AVANDAMET) 2-500 mg tablet No Dispense individual ingredients
Renal Dosing:
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine>1.4mg/dl (females) due to risk of lactic acidosis Oral
rosiglitazone - metformin (AVANDAMET) 4-1000 mg tablet No Dispense individual ingredients
Renal Dosing:
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine>1.4mg/dl (females) due to risk of lactic acidosis Oral
rosiglitazone - metformin (AVANDAMET) 4-500 mg tablet No Dispense individual ingredients
Renal Dosing:
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine>1.4mg/dl (females) due to risk of lactic acidosis Oral
rosuvastatin (CRESTOR) 10 mg tablet Yes Renal Dosing:
CrCl<30ml/min/1.73 m(2): initial dose 5mg daily to max of 10mg daily Oral
rosuvastatin (CRESTOR) 20 mg tablet Yes Renal Dosing:
CrCl<30ml/min/1.73 m(2): initial dose 5mg daily to max of 10mg daily Oral
rosuvastatin (CRESTOR) 40 mg tablet No Dispense 2 x 40mg
Renal Dosing:
CrCl<30ml/min/1.73 m(2): initial dose 5mg daily to max of 10mg daily Oral
rosuvastatin (CRESTOR) 5 mg tablet Yes Renal Dosing:
CrCl<30ml/min/1.73 m(2): initial dose 5mg daily to max of 10mg daily Oral
saxagliptin (ONGLYZA) 2.5 mg tablet Yes Renal Dosing:
CrCl >50ml/min: 5mg daily
CrCl<50ml/min: 2.5mg daily Oral
saxagliptin (ONGLYZA) 5 mg tablet Yes Renal Dosing:
CrCl >50ml/min: 5mg daily
CrCl<50ml/min: 2.5mg daily Oral
sibutramine (MERIDIA) 10 mg capsule No Renal Dosing:
CrCl<10ml/min: Avoid Oral
sibutramine (MERIDIA) 15 mg capsule No Renal Dosing:
CrCl<10ml/min: Avoid Oral
sibutramine (MERIDIA) 5 mg capsule No Renal Dosing:
CrCl<10ml/min: Avoid Oral
sildenafil (REVATIO, VIAGRA) 2.5mg/ml oral liquid No Oral
sildenafil (REVATIO, VIAGRA) 20 mg tablet Yes Oral
sildenafil (VIAGRA) 100 mg tablet No Oral
sildenafil (VIAGRA) 25 mg tablet No Oral
sildenafil (VIAGRA) 50 mg tablet No Oral
silodosic (RAPAFLO) 4 mg capsule No Renal Dosing:
CrCl 30-50ml/min - 4mg daily
CrCl < 30ml/min - contraindicated Oral
silodosic (RAPAFLO) 8 mg capsule No Renal Dosing:
CrCl 30-50ml/min - 4mg daily
CrCl < 30ml/min - contraindicated Oral
simvastatin (ZOCOR) 10 mg tablet Yes Renal Dosing:
CrCl<10ml/min: initial dose should be 5mg daily Oral
simvastatin (ZOCOR) 20 mg tablet Yes Renal Dosing:
CrCl<10ml/min: initial dose should be 5mg daily Oral
simvastatin (ZOCOR) 40 mg tablet Yes Renal Dosing:
CrCl<10ml/min: initial dose should be 5mg daily Oral
simvastatin (ZOCOR) 5 mg tablet Yes Renal Dosing:
CrCl<10ml/min: initial dose should be 5mg daily Oral
simvastatin (ZOCOR) 80 mg tablet Yes Renal Dosing:
CrCl<10ml/min: initial dose should be 5mg daily Oral
sitagliptin - metformin (JANUMET) 50-1000 mg tablet No Dispense individual ingredients
Renal Dosing:
Sitagliptin
CrCl 30-50ml/min: 50mg daily
CrCl<30ml/min: 25mg daily
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine>1.4mg/dl (females) due to risk of Oral
sitagliptin - metformin (JANUMET) 50-500 mg tablet No Dispense individual ingredients
Renal Dosing:
Sitagliptin
CrCl 30-50ml/min: 50mg daily
CrCl<30ml/min: 25mg daily
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine>1.4mg/dl (females) due to risk of Oral
sitagliptin (JANUVIA) 100 mg tablet Yes Renal Dosing:
CrCl 30-50ml/min: 50mg daily
CrCl<30ml/min: 25mg daily Oral
sitagliptin (JANUVIA) 25 mg tablet Yes Renal Dosing:
CrCl 30-50ml/min: 50mg daily
CrCl<30ml/min: 25mg daily Oral
sitagliptin (JANUVIA) 50 mg tablet Yes Renal Dosing:
CrCl 30-50ml/min: 50mg daily
CrCl<30ml/min: 25mg daily Oral
solifenacin (VESICARE) 10 mg tablet No Renal Dosing:
CrCl<30ml/min: max recommended dose 5mg daily Oral
solifenacin (VESICARE) 5 mg tablet No Renal Dosing:
CrCl<30ml/min: max recommended dose 5mg daily Oral
sotalol (BETAPACE, BETAPACE AF) 120 mg tablet No Dispense 1.5 x 80mg
Renal Dosing:
CrCl 30-60ml/min: q24h
CrCl 10-30ml/min: q36-48h
CrCl<10ml/min: individualize Oral
sotalol (BETAPACE, BETAPACE AF) 160 mg tablet No Dispense 2 x 80mg
Renal Dosing:
CrCl 30-60ml/min: q24h
CrCl 10-30ml/min: q36-48h
CrCl<10ml/min: individualize Oral
sotalol (BETAPACE, BETAPACE AF) 240 mg tablet No Dispense 3 x 80mg
Renal Dosing:
CrCl 30-60ml/min: q24h
CrCl 10-30ml/min: q36-48h
CrCl<10ml/min: individualize Oral
sotalol (BETAPACE, BETAPACE AF) 80 mg tablet Yes Renal Dosing:
CrCl 30-60ml/min: q24h
CrCl 10-30ml/min: q36-48h
CrCl<10ml/min: individualize Oral
spironolactone - hydrochlorothiazide (ALDACTAZIDE) 25-25 mg tablet No Dispense individual ingredients
Renal Dosing:
Spironolactone
CrCl 50-80ml/min: q6-12h
CrCl 10-50ml/min: q12-24h
CrCl<10ml/min: avoid
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
spironolactone - hydrochlorothiazide (ALDACTAZIDE) 50-50 mg tablet No Dispense individual ingredients
Renal Dosing:
Spironolactone
CrCl 50-80ml/min: q6-12h
CrCl 10-50ml/min: q12-24h
CrCl<10ml/min: avoid
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
spironolactone (ALDACTONE) 100 mg tablet No Dispense 2 x 50mg
Renal Dosing:
CrCl 50-80ml/min: q6-12h
CrCl 10-50ml/min: q12-24h
CrCl<10ml/min: avoid Oral
spironolactone (ALDACTONE) 25 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: q6-12h
CrCl 10-50ml/min: q12-24h
CrCl<10ml/min: avoid Oral
spironolactone (ALDACTONE) 50 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: q6-12h
CrCl 10-50ml/min: q12-24h
CrCl<10ml/min: avoid Oral
starch (TUCKS , ANUSOL) 51 % rectal suppository Yes Rectal
stavudine (ZERIT) 1 mg/ml oral liquid Yes Renal Dosing:
Weight >60kg Weight <60kg
CrCl 26-50ml/min 20mg q12h 15mg q12h
CrCl 10-25ml/min 20mg q48h 15mg q24h
CrCl<10ml/min 20mg q48h 15mg q24h Oral
stavudine (ZERIT) 15 mg capsule Yes Renal Dosing:
Weight >60kg Weight <60kg
CrCl 26-50ml/min 20mg q12h 15mg q12h
CrCl 10-25ml/min 20mg q48h 15mg q24h
CrCl<10ml/min 20mg q48h 15mg q24h Oral
stavudine (ZERIT) 20 mg capsule Yes Renal Dosing:
Weight >60kg Weight <60kg
CrCl 26-50ml/min 20mg q12h 15mg q12h
CrCl 10-25ml/min 20mg q48h 15mg q24h
CrCl<10ml/min 20mg q48h 15mg q24h Oral
stavudine (ZERIT) 30 mg capsule No Dispense 2 x 15mg
Renal Dosing:
Weight >60kg Weight <60kg
CrCl 26-50ml/min 20mg q12h 15mg q12h
CrCl 10-25ml/min 20mg q48h 15mg q24h
CrCl<10ml/min 20mg q48h 15mg q24h Oral
stavudine (ZERIT) 40 mg capsule No Dispense 2 x 20mg
Renal Dosing:
Weight >60kg Weight <60kg
CrCl 26-50ml/min 20mg q12h 15mg q12h
CrCl 10-25ml/min 20mg q48h 15mg q24h
CrCl<10ml/min 20mg q48h 15mg q24h Oral
streptomycin 1 g injection No Not routinely stocked - Order PRN
Renal Dosing:
CrCl 10-50ml/min: q24-72h
CrCl<10ml/min: q72-96h Intramuscular
telbivudine (TYZEKA) 600 mg tablet Yes Renal Dosing:
CrCl 30-49ml/min: 600mg q48h
CrCl<30ml/min: 600mg q72h
Hemodialysis patients: 600mg q96h Oral
telithromycin (KETEK) 400 mg tablet No Renal Dosing:
CrCl<30ml/min: 600mg daily Oral
telmisartan - hydrochlorothiazide (MICARDIS HCT) 40-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
telmisartan - hydrochlorothiazide (MICARDIS HCT) 80-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
telmisartan - hydrochlorothiazide (MICARDIS HCT) 80-25 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
tenofovir (VIREAD) 300 mg tablet Yes Renal Dosing:
CrCl>50ml/min: 300mg q24h
CrCl 30-49ml/min: 300mg q48h
CrCl 10-29ml/min: 300mg twice weekly Oral
terbinafine (LAMISIL) 250 mg tablet Yes Renal Dosing:
CrCl<50ml/min: Avoid Oral
terbinafine (LAMISIL, DESENEX MAX) 1% topical cream No Topical
terbutaline (BRETHINE) 2.5 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 50%
CrCl<10ml/min: Avoid Oral
terbutaline (BRETHINE) 5 mg tablet No Dispense 2 x 2.5mg
Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 50%
CrCl<10ml/min: Avoid Oral
terbutaline (BRETHINE) injection Yes Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 50%
CrCl<10ml/min: Avoid Subcutaneous
tetracycline (SUMYCIN) 250 mg capsule Yes Renal Dosing:
CrCl 50-80ml/min: q8-12h
CrCl 10-50ml/min: q12-24h
CrCl<10ml/min q24h Oral
tetracycline (SUMYCIN) 500 mg capsule No Dispense 2 x 250mg
Renal Dosing:
CrCl 50-80ml/min: q8-12h
CrCl 10-50ml/min: q12-24h
CrCl<10ml/min q24h Oral
tetracycline 125mg/5ml oral liquid Yes Renal Dosing:
CrCl 50-80ml/min: q8-12h
CrCl 10-50ml/min: q12-24h
CrCl<10ml/min q24h Oral
thiopental (PENTOTHAL) 500 mg IV syringe Yes Renal Dosing:
CrCl<10ml/min: decrease usual dose by 25% Intravenous
ticarcillin - clavulanate (TIMENTIN) 3.1 g intravenous No Renal Dosing:
CrCl 50-80ml/min: 3.1gm q4-6h
CrCl 10-50ml/min: 3.1gm q8h
CrCl<10ml/min: 3.1gm q12h Intravenous
ticarcillin (TICAR) 3 g injection No Withdrawn from the Market (March 2009)
Renal Dosing:
CrCl 50-80ml/min: 2-4gm q4-6h (Max 24 gm/day)
CrCl 10-50ml/min: 2-3gm q6-8h
CrCl<10ml/min: 2gm q8h Intravenous
tigecycline (TYGACIL) injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas IVPB
tiludronate (SKELID) 200mg (equivalent to 240mg tiludronate disodium) tablet Yes Renal Dosing:
CrCl<30ml/min: Avoid Oral
timolol - brimonidine (COMBIGAN) 0.5 - 0.2% ophthalmic solution No Ophthalmic
timolol - hydrochlorothiazide (TIMOLIDE) 10-25mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
tobramycin (NEBCIN) 100mg in 25ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
tobramycin (NEBCIN) 110mg in 27.5ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
tobramycin (NEBCIN) 120mg in 30ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
tobramycin (NEBCIN) 130mg in 32.5ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
tobramycin (NEBCIN) 140mg in 35ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
tobramycin (NEBCIN) 150mg in 37.5ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
tobramycin (NEBCIN) 160mg in 40ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
tobramycin (NEBCIN) 170mg in 42.5ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
tobramycin (NEBCIN) 180mg in 45ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
tobramycin (NEBCIN) 200mg in 50ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Injection
tobramycin (NEBCIN) 40mg in 10ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
tobramycin (NEBCIN) 50mg in 12.5ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
tobramycin (NEBCIN) 60mg in 15ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
tobramycin (NEBCIN) 70mg in 17.5ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
tobramycin (NEBCIN) 80mg in 20ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
tobramycin (NEBCIN) 90mg in 22.5ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
tobramycin (NEBCIN) dosing per pharmacy guideline Yes Per Pharmacy
tolterodine (DETROL) 1 mg tablet No Renal Dosing:
CrCl 10-30ml/min: 1mg bid Oral
tolterodine (DETROL) 2 mg tablet No Renal Dosing:
CrCl 10-30ml/min: 1mg bid Oral
tolterodine ER (DETROL LA) 2 mg capsule No Renal Dosing:
CrCl 10-30ml/min: 2mg daily Oral
tolterodine ER (DETROL LA) 4 mg capsule No Renal Dosing:
CrCl 10-30ml/min: 2mg daily Oral
topiramate (TOPAMAX) 100 mg tablet Yes Renal Dosing:
CrCl<70ml/min: give half the usual dose Oral
topiramate (TOPAMAX) 200 mg tablet No Dispense 2 x 100mg
Renal Dosing:
CrCl<70ml/min: give half the usual dose Oral
topiramate (TOPAMAX) 25 mg tablet Yes Renal Dosing:
CrCl<70ml/min: give half the usual dose Oral
topiramate (TOPAMAX) 50 mg tablet No Dispense 2 x 25mg
Renal Dosing:
CrCl<70ml/min: give half the usual dose Oral
tramadol - acetaminophen (ULTRACET) 37.5-325 mg tablet No Renal Dosing:
Tramadol
CrCl 10-30ml/min: q12h with maximum daily dose of 200mg
CrCl<10ml/min: 50mg q12h Oral
tramadol (ULTRAM) 50 mg tablet Yes Renal Dosing:
CrCl 10-30ml/min: q12h with maximum daily dose of 200mg
CrCl<10ml/min: 50mg q12h Oral
tramadol ER (ULTRAM ER/RYZOLT) 100 mg tablets No Renal Dosing
Extended release product – Do not use in severe renal impairment
Regular release product dosaing recommendations:
CrCl 10-30ml/min: q12h with maximum daily dose of 200mg
CrCl<10ml/min: 50mg q12h Oral
tramadol ER (ULTRAM ER/RYZOLT) 200 mg tablets No Renal Dosing
Extended release product – Do not use in severe renal impairment
Regular release product dosaing recommendations:
CrCl 10-30ml/min: q12h with maximum daily dose of 200mg
CrCl<10ml/min: 50mg q12h Oral
tramadol ER (ULTRAM ER/RYZOLT) 300 mg tablets No Renal Dosing
Extended release product – Do not use in severe renal impairment
Regular release product dosaing recommendations:
CrCl 10-30ml/min: q12h with maximum daily dose of 200mg
CrCl<10ml/min: 50mg q12h Oral
trandolapril - verapamil (TARKA) 1-240 mg tablet No Dispense individual ingredients
Renal Dosing:
Avoid fixed combination product in patients with renal impairment. Oral
trandolapril - verapamil (TARKA) 2-180 mg tablet No Dispense individual ingredients
Renal Dosing:
Avoid fixed combination product in patients with renal impairment. Oral
trandolapril - verapamil (TARKA) 2-240 mg tablet No Dispense individual ingredients
Renal Dosing:
Avoid fixed combination product in patients with renal impairment. Oral
trandolapril - verapamil (TARKA) 4-240 mg tablet No Dispense individual ingredients
Renal Dosing:
Avoid fixed combination product in patients with renal impairment. Oral
trandolapril (MAVIK) 1 mg tablet Yes Renal Dosing:
CrCl<30ml/min: initial dose should be 0.5mg Oral
trandolapril (MAVIK) 2 mg tablet Yes Renal Dosing:
CrCl<30ml/min: initial dose should be 0.5mg Oral
trandolapril (MAVIK) 4 mg tablet Yes Renal Dosing:
CrCl<30ml/min: initial dose should be 0.5mg Oral
triamterene - hydrochlorothiazide 50-25 mg capsule Yes Renal Dosing:
Avoid in patients with creatinine >2.5 mg/dl Oral
triamterene - hydrochlorothiazide (DYAZIDE) 37.5-25 mg capsule Yes Renal Dosing:
Avoid in patients with creatinine >2.5 mg/dl Oral
triamterene - hydrochlorothiazide (MAXZIDE) 75-50 mg tablet No Renal Dosing:
Avoid in patients with creatinine >2.5 mg/dl Oral
triamterene - hydrochlorothiazide (MAXZIDE-25) 37.5-25 mg tablet No Renal Dosing:
Avoid in patients with creatinine >2.5 mg/dl Oral
triamterene (DYRENIUM) 100 mg capsule No Dispense 2 x 50mg
Renal Dosing:
CrCl<10ml/min: Avoid Oral
triamterene (DYRENIUM) 50 mg capsule Yes Renal Dosing:
CrCl<10ml/min: Avoid Oral
trimethoprim - sulfamethoxazole DS (BACTRIM DS, SEPTRA DS) 160-800 mg tablet Yes Renal Dosing:
For gram negative infection
CrCl 50-80ml/min: 10mg TMP/kg/day div. q8-12h
CrCl 10-50ml/min: 5-7.5mg TMP/kg/day div. q12-24h
CrCl<10ml/min: 2.5-5mg TMP/kg/day q24h
For Pneumocystis carinii pneumonia
CrCl 5 Oral
trimethoprim - sulfamethoxazole (BACTRIM, SEPTRA) 80-400 mg tablet Yes Renal Dosing:
For gram negative infection
CrCl 50-80ml/min: 10mg TMP/kg/day div. q8-12h
CrCl 10-50ml/min: 5-7.5mg TMP/kg/day div. q12-24h
CrCl<10ml/min: 2.5-5mg TMP/kg/day q24h
For Pneumocystis carinii pneumonia
CrCl 5 Oral
trimethoprim - sulfamethoxazole (SEPTRA) intravenous Yes Renal Dosing:
For gram negative infection
CrCl 50-80ml/min: 10mg TMP/kg/day div. q8-12h
CrCl 10-50ml/min: 5-7.5mg TMP/kg/day div. q12-24h
CrCl<10ml/min: 2.5-5mg TMP/kg/day q24h
For Pneumocystis carinii pneumonia
CrCl 5 Intravenous
trimethoprim - sulfamethoxazole (SULFATRIM) 40-200 mg/5 ml oral suspension No Renal Dosing:
For gram negative infection
CrCl 50-80ml/min: 10mg TMP/kg/day div. q8-12h
CrCl 10-50ml/min: 5-7.5mg TMP/kg/day div. q12-24h
CrCl<10ml/min: 2.5-5mg TMP/kg/day q24h
For Pneumocystis carinii pneumonia
CrCl 5 Oral
trimethoprim (TRIMPEX, PROLOPRIM)100 mg tablet Yes Renal Dosing:
CrCl 15-30ml/min: 50mg q12h
CrCl<15ml/min: Avoid Oral
trospium (SANCTURA) 20 mg tablet No Renal Dosing:
CrCl<30ml/min: 20mg qhs Oral
trospium ER (SANCTURA XR) 60 mg tablet No Renal Dosing:
Avoid extended-release product in patients with renal impairment.
CrCl<30ml/min: 20mg qhs Oral
valacyclovir (VALTREX) 1 g tablet No Dispense 2 x 500mg
Renal Dosing:
CrCl 10-50ml/min: 1gm q12-24h
CrCl<10ml/min: 0.5gm q24h Oral
valacyclovir (VALTREX) 500 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: 1gm q12-24h
CrCl<10ml/min: 0.5gm q24h Oral
valganciclovir (VALCYTE) 450 mg tablet Yes Renal Dosing:
Induction dose:
CrCl>60ml/min: 900mg bid
CrCl 40-59ml/min: 450mg bid
CrCl 25-39ml/min: 450mg daily
CrCl 10-24ml/min: 450mg every 2 days
Maintenance dose
CrCl>60ml/min: 900mg daily
CrC Oral
valproic acid (DEPAKENE) 250 mg capsule Yes Oral
valproic acid (DEPAKENE) 250 mg/5 ml oral liquid Yes Oral
valproic acid dosing per pharmacy guideline Yes Per Pharmacy
valsartan - hydrochlorothiazide (DIOVAN HCT) 160-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
valsartan - hydrochlorothiazide (DIOVAN HCT) 160-25 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
valsartan - hydrochlorothiazide (DIOVAN HCT) 320-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
valsartan - hydrochlorothiazide (DIOVAN HCT) 320-25 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
valsartan - hydrochlorothiazide (DIOVAN HCT) 80-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
valsartan (DIOVAN) 160 mg tablet Yes Oral
valsartan (DIOVAN) 320 mg tablet Yes Oral
valsartan (DIOVAN) 40 mg tablet Yes Oral
valsartan (DIOVAN) 80 mg tablet Yes Oral
vancomycin (VANCOCIN) 1000 mg intravenous Yes Renal Dosing:
Contact pharmacist for dosage recommendation in patient with renal impairment Advantage
vancomycin (VANCOCIN) 125 mg capsule No Oral
vancomycin (VANCOCIN) 1250 mg injection Yes Renal Dosing:
Contact pharmacist for dosage recommendation in patient with renal impairment IVPB
vancomycin (VANCOCIN) 1500 mg injection Yes Renal Dosing:
Contact pharmacist for dosage recommendation in patient with renal impairment IVPB
vancomycin (VANCOCIN) 2000 mg injection Yes Renal Dosing:
Contact pharmacist for dosage recommendation in patient with renal impairment IVPB
vancomycin (VANCOCIN) 500 mg intravenous Yes Renal Dosing:
Contact pharmacist for dosage recommendation in patient with renal impairment Advantage
vancomycin (VANCOCIN) 750 mg injection Yes Renal Dosing:
Contact pharmacist for dosage recommendation in patient with renal impairment IVPB
vancomycin (VANCOCIN) dosing per pharmacy guideline Yes Per Pharmacy
vancomycin (VANCOCIN) intravenous Yes Renal Dosing:
Contact pharmacist for dosage recommendation in patient with renal impairment Intravenous
varenicline (CHANTIX) 0.5 mg tablets Yes Renal Dosing:
CrCl<30ml/min: initial dose should be 0.5mg daily
Hemodialysis patients: maximum dose is 0.5mg daily Oral
varenicline (CHANTIX) 1 mg tablets No Dispense 2 x 0.5mg
Renal Dosing:
CrCl<30ml/min: initial dose should be 0.5mg daily
Hemodialysis patients: maximum dose is 0.5mg daily Oral
venlafaxine (EFFEXOR) 100 mg tablet No Dispense 2 X 50mg
Renal Dosing:
CrCl 10-70ml/min: reduce dose 25-50%
CrCl<10ml/min: reduce dose 50% Oral
venlafaxine (EFFEXOR) 25 mg tablet No Dispense 1/2 of 50mg
Renal Dosing:
CrCl 10-70ml/min: reduce dose 25-50%
CrCl<10ml/min: reduce dose 50% Oral
venlafaxine (EFFEXOR) 37.5 mg tablet Yes Renal Dosing:
CrCl 10-70ml/min: reduce dose 25-50%
CrCl<10ml/min: reduce dose 50% Oral
venlafaxine (EFFEXOR) 50 mg tablet Yes Renal Dosing:
CrCl 10-70ml/min: reduce dose 25-50%
CrCl<10ml/min: reduce dose 50% Oral
venlafaxine (EFFEXOR) 75 mg tablet Yes Renal Dosing:
CrCl 10-70ml/min: reduce dose 25-50%
CrCl<10ml/min: reduce dose 50% Oral
venlafaxine XR (EFFEXOR XR) 150 mg capsule No Dispense 2 X 75mg
Renal Dosing:
CrCl 10-70ml/min: reduce dose 25-50%
CrCl<10ml/min: reduce dose 50% Oral
venlafaxine XR (EFFEXOR XR) 37.5 mg capsule Yes Renal Dosing:
CrCl 10-70ml/min: reduce dose 25-50%
CrCl<10ml/min: reduce dose 50% Oral
venlafaxine XR (EFFEXOR XR) 75 mg capsule Yes Renal Dosing:
CrCl 10-70ml/min: reduce dose 25-50%
CrCl<10ml/min: reduce dose 50% Oral
zidovudine (RETROVIR, AZT) 10 mg/ml oral liquid Yes Renal Dosing:
CrCl<15ml/min: 100mg q6-8h Oral
zidovudine (RETROVIR, AZT) 100 mg capsule Yes Renal Dosing:
CrCl<15ml/min: 100mg q6-8h Oral
zidovudine (RETROVIR, AZT) 300 mg tablet No Dispense 3 x 100mg
Renal Dosing:
CrCl<15ml/min: 100mg q6-8h Oral
zoledronic (RECLAST) injection No May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl<35ml/min: Avoid IVPB
zonisamide (ZONEGRAN) 100 mg capsule Yes Renal Dosing:
Avoid in patients with CrCl < 50ml/min - insufficient experience concerning drug dosing and toxicity. Patients with renal disease should be treated with caution and might require slower titration and more frequent monitoring. Oral
zoster vaccine live (ZOSTAVAX) injection Yes Injection
abacavir - lamivudine - zidovudine (TRIZIVIR) 300-150-300 mg tablet Yes Renal Dosing:
CrCl<50ml/min: avoid – use separate products
Abacavir component - no adjustment needed
Lamivudine component
CrCl 30-49ml/min: 150mg daily
CrCl 15-29ml/min: 150mg x1, then 100mg daily
Cr Oral
abacavir - lamivudine (EPZICOM) 600-300 mg tablet Yes Renal Dosing:
CrCl<50ml/min: avoid – use separate products
Abacavir component - no adjustment needed
Lamivudine component
CrCl 30-49ml/min: 150mg daily
CrCl 15-29ml/min: 150mg x1, then 100mg daily
CrCl 5-14ml/ Oral
acamprosate (CAMPRAL) 333 mg tablet Yes Renal Dosing:
CrCl 30-50ml/min: initial dose 333mg po tid
CrCl<30ml/min: avoid Oral
acarbose (PRECOSE) 100 mg tablet No Dispense 2 x 50mg
Renal Dosing:
CrCl < 50ml/min: Avoid Oral
acarbose (PRECOSE) 25 mg tablet No Dispense 1/2 of 50mg Oral
acarbose (PRECOSE) 50mg tablet Yes Oral
acebutolol (SECTRAL) 200 mg capsule Yes Renal Dosing:
CrCl 25-50ml/min: decrease usual dose 50%
CrCl<25ml/min: decrease usual dose by 75% Oral
acebutolol (SECTRAL) 400 mg capsule No Dispense 2 x 200mg
Renal Dosing:
CrCl 25-50ml/min: decrease usual dose 50%
CrCl<25ml/min: decrease usual dose by 75% Oral
acetaminophen - asprin - caffeine (EXCEDRIN ES, EXCEDRIN MIGRAINE) 250-250-65 mg tablet Yes Oral
acetaminophen - butalbital - caffeine - codeine (FIORICET with CODEINE #3) 325-50-40-30 mg capsule Yes Renal Dosing:
Codeine
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
acetaminophen - codeine (COCET) 650-30 mg tablet No Renal Dosing:
Codeine
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
acetaminophen - codeine (TYLENOL #2) 300-15 mg tablet Yes Renal Dosing:
Codeine
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
acetaminophen - codeine (TYLENOL #3) 300-30 mg tablet Yes Renal Dosing:
Codeine
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
acetaminophen - codeine (TYLENOL #4) 300-60 mg tablet Yes Renal Dosing:
Codeine
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
acetaminophen - codeine (TYLENOL WITH CODEINE) 120-12 mg/5 ml oral liquid Yes Renal Dosing:
Codeine
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
acetaminophen - codeine (VOPAC) 650-30 mg tablet No Renal Dosing:
Codeine
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
acetaZOLAMIDE (DIAMOX) 125 mg tablet No Dispense 1/2 of 250mg
Renal Dosing:
CrCl >50ml/min: q6h
CrCl 10-50ml/min: q12h
CrCl <10ml/min: Avoid Oral
acetaZOLAMIDE (DIAMOX) 250 mg tablet Yes Renal Dosing:
CrCl >50ml/min: q6h
CrCl 10-50ml/min: q12h
CrCl <10ml/min: Avoid Oral
acetaZOLAMIDE (DIAMOX) 500 mg injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl >50ml/min: q6h
CrCl 10-50ml/min: q12h
CrCl <10ml/min: Avoid Injection
acetaZOLAMIDE ER (DIAMOX SEQUELS) 500 mg capsule Yes Renal Dosing:
CrCl >50ml/min: q6h
CrCl 10-50ml/min: q12h
CrCl <10ml/min: Avoid Oral
acyclovir (ZOVIRAX) 200 mg capsule Yes Renal Dosing:
Normal dose CrCl Adjusted dose
200mg q4h >10ml/min 200mg q4h, 5xdaily
0-10ml/min 200mg q12
400mg q12h >10ml/min 400mg q12h
0-10ml/min 200mg q12h
800m Oral
acyclovir (ZOVIRAX) 200 mg/5 ml oral liquid No Renal Dosing:
Normal dose CrCl Adjusted dose
200mg q4h >10ml/min 200mg q4h, 5xdaily
0-10ml/min 200mg q12
400mg q12h >10ml/min 400mg q12h
0-10ml/min 200mg q12h
800m Oral
acyclovir (ZOVIRAX) 400 mg tablet No Dispense 2 x 200mg capsule
Renal Dosing:
Normal dose CrCl Adjusted dose
200mg q4h >10ml/min 200mg q4h, 5xdaily
0-10ml/min 200mg q12
400mg q12h >10ml/min 400mg q12h
0-10m Oral
acyclovir (ZOVIRAX) 5% topical cream No Topical
acyclovir (ZOVIRAX) 5% topical ointment Yes Topical
acyclovir (ZOVIRAX) 800 mg tablet Yes Renal Dosing:
Normal dose CrCl Adjusted dose
200mg q4h >10ml/min 200mg q4h, 5xdaily
0-10ml/min 200mg q12
400mg q12h >10ml/min 400mg q12h
0-10ml/min 200mg q12h
800m Oral
acyclovir (ZOVIRAX) injection Yes Dosing should be based on IBW in obese patients
Renal Dosing:
CrCl % of Usual Dose Dosing Interval
>50ml/min 100 q8h
25-50ml/min 100 q12h
10-25ml/min 100 IVPB
adalimumab (HUMIRA) 40mg injection Yes Subcutaneous
adapalene (DIFFERIN) 0.1% topical cream No Not routinely stocked - Order PRN Topical
adapalene (DIFFERIN) 0.1% topical gel No Not routinely stocked - Order PRN Topical
adapalene (DIFFERIN) 0.1% topical solution No Not routinely stocked - Order PRN Topical
adapalene (DIFFERIN) 0.3% topical gel No Not routinely stocked - Order PRN Topical
adefovir (HEPSERA) 10 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: 10mg q24h
CrCl 20-49ml/min: 10mg q48h
CrCl 10-19ml/min: 10mg q72h
CrCl<10ml/min: 10mg q week Oral
alendronate - cholecalciferol (FOSAMAX PLUS D) 70mg-2800 unit tablet No Renal Dosing:
CrCl < 35ml/min: Avoid Oral
alendronate (FOSAMAX ) 35 mg weekly tablet Yes Renal Dosing:
CrCl < 35ml/min: Avoid Oral
alendronate (FOSAMAX ) 70 mg weekly tablet Yes Renal Dosing:
CrCl < 35ml/min: Avoid Oral
alendronate (FOSAMAX) 10 mg tablet Yes Renal Dosing:
CrCl < 35ml/min: Avoid Oral
alendronate (FOSAMAX) 40 mg tablet No Dispense 4 x 10mg
Renal Dosing:
CrCl < 35ml/min: Avoid Oral
alendronate (FOSAMAX) 5 mg tablet Yes Renal Dosing:
CrCl < 35ml/min: Avoid Oral
alendronate (FOSAMAX) 70 mg/75 ml oral liquid No Renal Dosing:
CrCl < 35ml/min: Avoid Oral
allopurinol (ALOPRIM) IVPB Yes Renal Dosing:
CrCl >20ml/min: 300mg daily
CrCl 10-20ml/min: 200mg daily
CrCl <10ml/min: 100mg daily IVPB
allopurinol (ZYLOPRIM) 100 mg tablet Yes Renal Dosing:
CrCl >20ml/min: 300mg daily
CrCl 10-20ml/min: 200mg daily
CrCl <10ml/min: 100mg daily Oral
allopurinol (ZYLOPRIM) 300 mg tablet Yes Renal Dosing:
CrCl >20ml/min: 300mg daily
CrCl 10-20ml/min: 200mg daily
CrCl <10ml/min: 100mg daily Oral
almotriptan (AXERT) 12.5 mg tablet No Renal Dosing:
CrCl<10ml/min: initial dose 6.26mg, may repeat in 2 hours.
Maximum 24 hour dose 12.5mg Oral
almotriptan (AXERT) 6.25 mg tablet No Renal Dosing:
CrCl<10ml/min: initial dose 6.26mg, may repeat in 2 hours.
Maximum 24 hour dose 12.5mg Oral
amantadine (SYMMETREL) 50 mg/5ml oral liquid Yes Renal Dosing:
CrCl 30-50ml/min: 100mg daily
CrCl 15-29ml/min: 100mg qod
CrCl<15ml/min: 200mg qwk Oral
amantadine (SYMMETREL) 100 mg capsule Yes Renal Dosing:
CrCl 30-50ml/min: 100mg daily
CrCl 15-29ml/min: 100mg qod
CrCl<15ml/min: 200mg qwk Oral
amantadine (SYMMETREL) 100 mg tablet No Renal Dosing:
CrCl 30-50ml/min: 100mg daily
CrCl 15-29ml/min: 100mg qod
CrCl<15ml/min: 200mg qwk Oral
amikacin (AMIKIN) injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment IVPB
amikacin (AMIKIN) intravitreal injection Yes Injection
amiloride - hydrochlorothiazide (MODURETIC) 5-50 mg tablet No Dispense individual ingredients
Renal Dosing:
Amiloride
CrCl 10-50ml/min: reduce dose by 50%
CrCl <10ml/min: avoid
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
amiloride (MIDAMOR) 5 mg tablet Yes Renal Dosing:
Amiloride
CrCl 10-50ml/min: reduce dose by 50%
CrCl <10ml/min: avoid Oral
aminocaproic acid (AMICAR) 250mg/ml oral liquid No Renal Dosing:
Reduce dose by 15-25% in patients with renal disease Oral
aminocaproic acid (AMICAR) 5 g (Loading dose) Yes Renal Dosing:
Reduce dose by 15-25% in patients with renal disease IVPB
aminocaproic acid (AMICAR) 500 mg tablet Patients with renal impairment and HIV: Renal Dosing:
Reduce dose by 15-25% in patients with renal disease Oral
aminocaproic acid (AMICAR) drip Yes Renal Dosing:
Reduce dose by 15-25% in patients with renal disease Drips
aminocaproic acid (AMICAR) syringe drip (conc: 250 mg/ml) Yes Renal Dosing:
Reduce dose by 15-25% in patients with renal disease Drips
amoxicillin - clarithromycin - lansoprazole (PREVPAC) 500-500-30 mg pack No Renal Dosing:
Amoxicillin
CrCl 10-30ml/min: 250-500mg q12h
CrCl<10ml/min: 250-500mg q24h
Clarithromycin
CrCl <30ml/min: Halve the normal dose or double
the dosing interval. Oral
amoxicillin - clavulanate (AUGMENTIN ES) 600-42.9 mg/5 ml oral liquid No Renal Dosing:
CrCl 10-30ml/min: 250-500mg q12h
CrCl<10ml/min: 250-500mg q24h Oral
amoxicillin - clavulanate (AUGMENTIN) 250-125 mg tablet Yes Renal Dosing:
CrCl 10-30ml/min: 250-500mg q12h
CrCl<10ml/min: 250-500mg q24h Oral
amoxicillin - clavulanate (AUGMENTIN) 250-62.5 mg/5 ml oral liquid Yes Renal Dosing:
CrCl 10-30ml/min: 250-500mg q12h
CrCl<10ml/min: 250-500mg q24h Oral
amoxicillin - clavulanate (AUGMENTIN) 400-57 mg/5 ml oral liquid Yes Renal Dosing:
CrCl 10-30ml/min: 250-500mg q12h
CrCl<10ml/min: 250-500mg q24h Oral
amoxicillin - clavulanate (AUGMENTIN) 500-125 mg tablet Yes Renal Dosing:
CrCl 10-30ml/min: 250-500mg q12h
CrCl<10ml/min: 250-500mg q24h Oral
amoxicillin - clavulanate (AUGMENTIN) 875-125 mg tablet Yes Renal Dosing:
CrCl 10-30ml/min: 250-500mg q12h
CrCl<10ml/min: 250-500mg q24h Oral
amoxicillin - clavulanate ER (AUGMENTIN XR) 1000-62.5 mg tablet Yes Renal Dosing:
Do not use the extended release products in patients with CrCl < 30ml/min Oral
amoxicillin (AMOXIL, TRIMOX) 250 mg capsule Yes Renal Dosing:
CrCl 10-30ml/min: 250-500mg q12h
CrCl<10ml/min: 250-500mg q24h Oral
amoxicillin (AMOXIL, TRIMOX) 400 mg/5 ml oral liquid Yes Renal Dosing:
CrCl 10-30ml/min: 250-500mg q12h
CrCl<10ml/min: 250-500mg q24h Oral
amoxicillin (AMOXIL, TRIMOX) 500 mg capsule Yes Renal Dosing:
CrCl 10-30ml/min: 250-500mg q12h
CrCl<10ml/min: 250-500mg q24h Oral
amoxicillin (AMOXIL, TRIMOX) 875 mg tablet No Renal Dosing:
Do not use the 875 mg tablet in patients with CrCl < 30ml/min Oral
amphotericin B (FUNGIZONE) IVPB Yes Renal Dosing:
CrCl <10ml/min, extend dosing interval to q36h IVPB
amphotericin B cholesteryl sulfate complex (AMPHOTEC) injection No Renal Dosing:
Consider reducing dose if creatinine increases to 2.5-3.0mg/dl during therapy. If the creatinine increases beyond 3.0mg/dl, therapy may need to be interrupted until the creatinine decreases to <2.5.mg/dl. IVPB
amphotericin B lipid complex (ABELCET) injection No Renal Dosing:
Consider reducing dose if creatinine increases to 2.5-3.0mg/dl during therapy. If the creatinine increases beyond 3.0mg/dl, therapy may need to be interrupted until the creatinine decreases to <2.5.mg/dl. IVPB
amphotericin B liposomal (AMBISOME) injection Yes Renal Dosing:
Consider reducing dose if creatinine increases to 2.5-3.0mg/dl during therapy. If the creatinine increases beyond 3.0mg/dl, therapy may need to be interrupted until the creatinine decreases to <2.5.mg/dl. IVPB
ampicillin - sulbactam (UNASYN) 1.5 g injection Yes Renal Dosing:
CrCl >29ml/min: 1.5-3gm q6-8h
CrCl 15-29ml/min: 1.5-3gm q12h
CrCl 5-14ml/min: 1.5-3gm q24h Intravenous
ampicillin - sulbactam (UNASYN) 3 g injection Yes Renal Dosing:
CrCl >29ml/min: 1.5-3gm q6-8h
CrCl 15-29ml/min: 1.5-3gm q12h
CrCl 5-14ml/min: 1.5-3gm q24h Injection
ampicillin (POLYCILLIN, OMNIPEN) 1 g injection Yes Renal Dosing:
CrCl>50ml/min: dose ampicillin q6h
CrCl 10-50ml/min: dose ampicillin q6-12h
CrCl<10ml/min: dose ampicillin q12-16h Intravenous
ampicillin (POLYCILLIN, OMNIPEN) 2 g injection Yes Renal Dosing:
CrCl>50ml/min: dose ampicillin q6h
CrCl 10-50ml/min: dose ampicillin q6-12h
CrCl<10ml/min: dose ampicillin q12-16h Injection
ampicillin (POLYCILLIN, OMNIPEN) 250 mg capsule Yes Renal Dosing:
CrCl>50ml/min: dose ampicillin q6h
CrCl 10-50ml/min: dose ampicillin q6-12h
CrCl<10ml/min: dose ampicillin q12-16h Oral
ampicillin (POLYCILLIN, OMNIPEN) 250 mg/5 ml oral liquid Yes Renal Dosing:
CrCl>50ml/min: dose ampicillin q6h
CrCl 10-50ml/min: dose ampicillin q6-12h
CrCl<10ml/min: dose ampicillin q12-16h Oral
ampicillin (POLYCILLIN, OMNIPEN) 500 mg capsule Yes Renal Dosing:
CrCl>50ml/min: dose ampicillin q6h
CrCl 10-50ml/min: dose ampicillin q6-12h
CrCl<10ml/min: dose ampicillin q12-16h Oral
ampicillin (POLYCILLIN, OMNIPEN) 500 mg injection Yes Renal Dosing:
CrCl>50ml/min: dose ampicillin q6h
CrCl 10-50ml/min: dose ampicillin q6-12h
CrCl<10ml/min: dose ampicillin q12-16h Intravenous
amprenavir (AGENERASE) 15 mg/ml oral solution No Withdranw from the Market (December 2007)
Renal Dosing:
Contraindicated in patients with renal failure due to accumulation of propylene glycol in the vehicle. Oral
apomorphine (APOKYN) 10 mg/ml injection No Renal Dosing:
The test dose and the initial dose should be decreased to 1mg in patients with mild to moderate renal impairment. Subcutaneous
aspirin - caffeine - butalbital - codeine (FIORINAL - CODEINE #3) 325-40-50-30 mg capsule No Renal Dosing:
Aspirin
Reduce dose in impaired renal function.
Avoid in patients with end stage renal disease
Codeine
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
aspirin (ALKA-SELTZER) EFFERVESCENT 325 mg tablet No Renal Dosing:
Reduce dose in impaired renal function. Avoid in patients with end stage renal disease. Oral
aspirin (BAYER CHILDRENS ASPIRIN) 81 mg chewable tablet Yes Renal Dosing:
Reduce dose in impaired renal function. Avoid in patients with end stage renal disease. Oral
aspirin 325 mg tablet Yes Renal Dosing:
Reduce dose in impaired renal function. Avoid in patients with end stage renal disease. Oral
aspirin desentization solution Yes Oral
aspirin desentization tablet Yes Oral
aspirin EC (ECOTRIN) 325 mg tablet Yes Renal Dosing:
Reduce dose in impaired renal function. Avoid in patients with end stage renal disease. Oral
aspirin EC (ECOTRIN, HALFPRIN) 162 mg tablet Yes Renal Dosing:
Reduce dose in impaired renal function. Avoid in patients with end stage renal disease. Oral
aspirin EC (ECOTRIN, HALFPRIN) 81 mg tablet Yes Renal Dosing:
Reduce dose in impaired renal function. Avoid in patients with end stage renal disease. Oral
aspirin(ASA) 300mg rectal suppository Yes Renal Dosing:
Reduce dose in impaired renal function. Avoid in patients with end stage renal disease. Rectal
aspirin(ASA) 600mg rectal suppository Yes Renal Dosing:
Reduce dose in impaired renal function. Avoid in patients with end stage renal disease. Rectal
aspirin, buffered (BUFFERIN) 325 mg tablet No Renal Dosing:
Reduce dose in impaired renal function. Avoid in patients with end stage renal disease. Oral
aspirin-codeine (EMPIRIN W/CODEINE #3) 325-30 mg tablet No Renal Dosing:
Aspirin
Reduce dose in impaired renal function.
Avoid in patients with end stage renal disease.
Codeine
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
aspirin-codeine (EMPIRIN W/CODEINE #4) 325-60 mg tablet No Renal Dosing:
Aspirin
Reduce dose in impaired renal function.
Avoid in patients with end stage renal disease.
Codeine
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
aspirin-hydrocodone (DAMASON-P) 500-5 mg tablet No Renal Dosing:
Aspirin
Reduce dose in impaired renal function.
Avoid in patients with end stage renal disease. Oral
asprin - caffeine - butalbital (FIORINAL) 325-50-40 mg capsule No Renal Dosing:
Aspirin
Reduce dose in impaired renal function.
Avoid in patients with end stage renal disease. Oral
atazanavir (REYATAZ) 200 mg capsule Yes Oral
atazanavir (REYATAZ) 300 mg capsule Yes Oral
atenolol - chlorthalidone (TENORETIC) 100-25 mg tablet No Dispense individual ingredients
Renal Dosing:
Avoid in patients with renal failure Oral
atenolol - chlorthalidone (TENORETIC) 50-25 mg tablet No Dispense individual ingredients
Renal Dosing:
Avoid in patients with renal failure Oral
atenolol (TENORMIN) 100 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: give 50% of usual dose
CrCl<10ml/min: give 25% of usual dose
CrCl 15-35ml/min: max dose 50mg/day
CrCl<15ml/min: max dose 25mg/day Oral
atenolol (TENORMIN) 25 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: give 50% of usual dose
CrCl<10ml/min: give 25% of usual dose
CrCl 15-35ml/min: max dose 50mg/day
CrCl<15ml/min: max dose 25mg/day Oral
atenolol (TENORMIN) 50 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: give 50% of usual dose
CrCl<10ml/min: give 25% of usual dose
CrCl 15-35ml/min: max dose 50mg/day
CrCl<15ml/min: max dose 25mg/day Oral
atovaquone - proguanil (MALARONE) 250-100 mg tablet Yes Renal Dosing:
CrCl < 30ml/min: Avoid Oral
azathioprine (IMURAN) injection Yes Renal Dosing:
CrCl 10-50ml/min: give 75% of usual dose
CrCl<10ml/min: give 50% of usual dose IVPB
azathioprine (IMURAN, AZASAN) 100 mg tablet No Dispense 2 x 50mg
Renal Dosing:
CrCl 10-50ml/min: give 75% of usual dose
CrCl<10ml/min: give 50% of usual dose" Oral
azathioprine (IMURAN, AZASAN) 50 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: give 75% of usual dose
CrCl<10ml/min: give 50% of usual dose Oral
azathioprine (IMURAN, AZASAN) 75 mg tablet No Dispense 1.5 of 50mg
Renal Dosing:
CrCl 10-50ml/min: give 75% of usual dose
CrCl<10ml/min: give 50% of usual dose" Oral
aztreonam (AZACTAM) 1 g injection Yes Renal Dosing:
CrCl 10-50ml/min: 1-2gm q8-12h
CrCl<10ml/min: 1gm q12-24h Injection
aztreonam (AZACTAM) 2 g injection Yes Renal Dosing:
CrCl 10-50ml/min: 1-2gm q8-12h
CrCl<10ml/min: 1gm q12-24h Injection
benazapril-hydrochlorothiazide (LOTENSIN HCT) 10-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Benazepril
CrCl 10-50ml/min: give 50-75% of usual dose
CrCl<10ml/min: give 25-50% of usual dose
Maximum daily dose is 40mg/day
Hydrochlorothiazide
Usually ineffective in patien Oral
benazapril-hydrochlorothiazide (LOTENSIN HCT) 20-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Benazepril
CrCl 10-50ml/min: give 50-75% of usual dose
CrCl<10ml/min: give 25-50% of usual dose
Maximum daily dose is 40mg/day
Hydrochlorothiazide
Usually ineffective in patien Oral
benazapril-hydrochlorothiazide (LOTENSIN HCT) 20-25 mg tablet No Dispense individual ingredients
Renal Dosing:
Benazepril
CrCl 10-50ml/min: give 50-75% of usual dose
CrCl<10ml/min: give 25-50% of usual dose
Maximum daily dose is 40mg/day
Hydrochlorothiazide
Usually ineffective in patien Oral
benazapril-hydrochlorothiazide (LOTENSIN HCT) 5-6.25 mg tablet Yes Renal Dosing:
Benazepril
CrCl 10-50ml/min: give 50-75% of usual dose
CrCl<10ml/min: give 25-50% of usual dose
Maximum daily dose is 40mg/day
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
benazepril (LOTENSIN) 10 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: give 50-75% of usual dose
CrCl<10ml/min: give 25-50% of usual dose
Maximum daily dose is 40mg/day Oral
benazepril (LOTENSIN) 20 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: give 50-75% of usual dose
CrCl<10ml/min: give 25-50% of usual dose
Maximum daily dose is 40mg/day Oral
benazepril (LOTENSIN) 40 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: give 50-75% of usual dose
CrCl<10ml/min: give 25-50% of usual dose
Maximum daily dose is 40mg/day Oral
benazepril (LOTENSIN) 5 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: give 50-75% of usual dose
CrCl<10ml/min: give 25-50% of usual dose
Maximum daily dose is 40mg/day Oral
betaxolol (KERLONE) 10 mg tablet Yes Renal Dosing:
CrCl<10ml/min: maximum daily dose 20mg Oral
bismuth subsalicylate (KAOPECTATE ES, PEPTO-BISMOL MS) 525mg/15 ml oral liquid No Renal Dosing:
CrCl 10-50ml/min: short course (less than 4 weeks)
CrCl<10ml/min: Avoid Oral
bismuth subsalicylate (KAOPECTATE, PEPTO-BISMOL) 262 mg/15 ml oral liquid No Renal Dosing:
CrCl 10-50ml/min: short course (less than 4 weeks)
CrCl<10ml/min: Avoid Oral
bismuth subsalicylate (PEPTO-BISMOL) 262 mg chewable tablet Yes Renal Dosing:
CrCl 10-50ml/min: short course (less than 4 weeks)
CrCl<10ml/min: Avoid Oral
bisoprolol - hydrochlorothiazide (ZIAC) 10-6.25 mg tablet Yes Renal Dosing:
Bisoprolol
CrCl<10ml/min: maximum daily dose 10mg
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
bisoprolol - hydrochlorothiazide (ZIAC) 2.5-6.25 mg tablet Yes Renal Dosing:
Bisoprolol
CrCl<10ml/min: maximum daily dose 10mg
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
bisoprolol - hydrochlorothiazide (ZIAC) 5-6.25 mg tablet Yes Renal Dosing:
Bisoprolol
CrCl<10ml/min: maximum daily dose 10mg
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
bisoprolol (ZEBETA ) 10 mg tablet No Dispense 2 x 5mg
Renal Dosing:
CrCl<10ml/min: maximum daily dose 10mg Oral
bisoprolol (ZEBETA ) 5 mg tablet Yes Renal Dosing:
CrCl<10ml/min: maximum daily dose 10mg Oral
bitolterol (TORNALATE) 0.2% nebulizer solution No Withdrawn from the Market (December 2008) Inhalation
bivalirudin (ANGIOMAX) 250 mg/5 ml injection (loading dose) Yes May be administered in: Cath Lab Only Intravenous
bivalirudin (ANGIOMAX) drip Yes May be administered in: Cath Lab Only Drips
bleomycin (BLENOXANE) 15 unit chemo injection Yes Renal Dosing:
CrCl 10-50ml/min: give 75% of usual dose
CrCl<10ml/min: give 50% of usual dose Injection
bleomycin (BLENOXANE) chemo infusion Yes Renal Dosing:
CrCl 10-50ml/min: give 75% of usual dose
CrCl<10ml/min: give 50% of usual dose Chemo
busPIRone (BUSPAR) 10 mg tablet Yes Renal Dosing:
CrCl<10ml/min: reduce dose 25-50% Oral
busPIRone (BUSPAR) 15 mg tablet No Dispense 1 x 10mg + 1 x 5mg
Renal Dosing:
CrCl<10ml/min: reduce dose 25-50% Oral
busPIRone (BUSPAR) 30 mg tablet No Dispense 3 x 10mg
Renal Dosing:
CrCl<10ml/min: reduce dose 25-50% Oral
busPIRone (BUSPAR) 5 mg tablet Yes Renal Dosing:
CrCl<10ml/min: reduce dose 25-50% Oral
busPIRone (BUSPAR) 7.5 mgtablet No Dispense 1.5 x 5mg
Renal Dosing:
CrCl<10ml/min: reduce dose 25-50% Oral
butorphanol (STADOL NS) 10 mg/ml nasal spray No Renal Dosing:
CrCl 10-50ml/min: give 75% of usual dose
CrCl<10ml/min: give 50% of usual dose
Use same dosing intervals. Nasal
butorphanol (STADOL) 1 mg/ml injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl 10-50ml/min: give 75% of usual dose
CrCl<10ml/min: give 50% of usual dose
Use same dosing intervals Injection
butorphanol (STADOL) 2 mg/ml injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl 10-50ml/min: give 75% of usual dose
CrCl<10ml/min: give 50% of usual dose
Use same dosing intervals Injection
candesartan - hydrochlorothiazide (ATACAND HCT) 16-12.5 mg tablet No Dispense individual ingredients
Renal Dosing
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
candesartan - hydrochlorothiazide (ATACAND HCT) 32-12.5 mg tablet No Dispense individual ingredients
Renal Dosing
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
candesartan - hydrochlorothiazide (ATACAND HCT) 32-25 mg tablet No Dispense individual ingredients
Renal Dosing
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
candesartan (ATACAND) 16 mg tablet Yes Oral
candesartan (ATACAND) 32 mg tablet No Dispense 2 x 16mg Oral
candesartan (ATACAND) 4 mg tablet No Dispense 1/2 x 8mg Oral
candesartan (ATACAND) 8 mg tablet Yes Oral
candida albicans (CANDIDA SKIN TEST) injection Yes Intradermal
capecitabine (XELODA) 150 mg tablet Yes Renal Dosing:
CrCl 30-50ml/min: give 75% of usual dose
CrCl<30ml/min: avoid Oral
capecitabine (XELODA) 500 mg tablet Yes Renal Dosing:
CrCl 30-50ml/min: give 75% of usual dose
CrCl<30ml/min: avoid Oral
captopril - hydrochlorothiazide (CAPTOZIDE) 25 - 25 mg tablet No Dispense individual ingredients
Renal Dosing:
Captopril
CrCl 10-50ml/min: 75% of usual dose q8-12h
CrCl<10ml/min: 50% of usual dose q24h
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
captopril - hydrochlorothiazide (CAPTOZIDE) 50- 25 mg tablet No Dispense individual ingredients
Renal Dosing:
Captopril
CrCl 10-50ml/min: 75% of usual dose q8-12h
CrCl<10ml/min: 50% of usual dose q24h
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
CAPTOpril (capOTEN) 100 mg tablet No Dispense 2 x 50mg
Renal Dosing:
CrCl 10-50ml/min: 75% of usual dose q8-12h
CrCl<10ml/min: 50% of usual dose q24h Oral
CAPTOpril (capOTEN) 12.5 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: 75% of usual dose q8-12h
CrCl<10ml/min: 50% of usual dose q24h Oral
CAPTOpril (capOTEN) 25 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: 75% of usual dose q8-12h
CrCl<10ml/min: 50% of usual dose q24h Oral
CAPTOpril (capOTEN) 50 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: 75% of usual dose q8-12h
CrCl<10ml/min: 50% of usual dose q24h Oral
CAPTOpril (capOTEN) 6.25 mg tablet No Dispense 0.5 x 12.5mg
Renal Dosing:
CrCl 10-50ml/min: 75% of usual dose q8-12h
CrCl<10ml/min: 50% of usual dose q24h Oral
CAPTOpril-hydrochlorothiazide (CAPTOZIDE 25/15) 25-15 mg tablet No Renal Dosing:
Captopril
CrCl 10-50ml/min: 75% of usual dose q8-12h
CrCl<10ml/min: 50% of usual dose q24h
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
CAPTOpril-hydrochlorothiazide (CAPTOZIDE 50/15) 50-15 mg tablet No Renal Dosing:
Captopril
CrCl 10-50ml/min: 75% of usual dose q8-12h
CrCl<10ml/min: 50% of usual dose q24h
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
carisoprodil - aspirin (SOMA COMPOUND) 200-325 mg tablet No Renal Dosing:
Aspirin
Reduce dose in impaired renal function.
Avoid in patients with end stage renal disease. Oral
carisoprodil - asprin - codine (SOMA COMPOUND WITH CODEINE) 200-325-16 mg tablet No Renal Dosing:
Aspirin
Reduce dose in impaired renal function.
Avoid in patients with end stage renal disease
Codeine
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
carteolol (CARTROL) 2.5 mg tablet Yes Renal Dosing:
CrCl 20-60ml/min: usual dose q48h
CrCl<20ml/min: usual dose q72h Oral
carteolol (CARTROL) 5 mg tablet No Dispense 2 x 2.5mg
Renal Dosing:
CrCl 20-60ml/min: usual dose q48h
CrCl<20ml/min: usual dose q72h Oral
cefaCLOR (CECLOR) 250 mg capsule No Renal Dosing:
CrCl 10-50ml/min: give 50-100% of usual dose
CrCl<10ml/min: give 50% of usual dose
Use same dosing intervals Oral
cefaCLOR (CECLOR) 250 mg/5 ml oral liquid No Renal Dosing:
CrCl 10-50ml/min: give 50-100% of usual dose
CrCl<10ml/min: give 50% of usual dose
Use same dosing intervals Oral
cefaCLOR (CECLOR) 500 mg capsule No Renal Dosing:
CrCl 10-50ml/min: give 50-100% of usual dose
CrCl<10ml/min: give 50% of usual dose
Use same dosing intervals Oral
cefADROxil (DURICEF) 500 mg capsule No Renal Dosing:
CrCl 10-50ml/min: 500mg q12-24h
CrCl<10ml/min: 500mg q36h Oral
cefazolin (ANCEF) 2gm/1000ml NS irrigation solution Yes Topical Irrigation
cefaZOLIN (ANCEF) 5% (50 mg /ml) ophthalmic solution Yes Ophthalmic
cefaZOLIN (ANCEF, KEFZOL) 1 g/10 ml syringe Yes Renal Dosing:
CrCl 50-80ml/min: 0.5-2gm q8h
CrCl 10-50ml/min: 0.5-1gm q8-12h
CrCl<10ml/min: 1gm q24h Intravenous
cefDINir (OMNICEF) 250 mg/5 ml oral liquid No Renal Dosing:
CrCl<30ml/min: 300mg q24h Oral
cefDINir (OMNICEF) 300 mg capsule No Renal Dosing:
CrCl<30ml/min: 300mg q24h Oral
cefDITOREN (SPECTRACEF) 200 mg tablet No Renal Dosing:
CrCl 30-49ml/min: 200mg bid
CrCl<30ml/min: 200mg daily Oral
cefePIME (MAXIPIME) 500 mg injection Yes Renal Dosing:
Creatinine Clearance:
>60 ml/min 30-60 ml/min 11-29 ml/min < 10 ml/min
500 mg q12h 500 mg q24h 500 mg q24h 250 mg q24h
1 g q12h 1 g q24h 500 mg q24h 250 mg q24h
2 g q12h Injection
cefePIME (MAXIPINE) 1 g injection Yes Renal Dosing:
Creatinine Clearance:
>60 ml/min 30-60 ml/min 11-29 ml/min < 10 ml/min
500 mg q12h 500 mg q24h 500 mg q24h 250 mg q24h
1 g q12h 1 g q24h 500 mg q24h 250 mg q24h
2 g q12h Injection
cefePIME (MAXIPINE) 2 g injection Yes Renal Dosing:
Creatinine Clearance:
>60 ml/min 30-60 ml/min 11-29 ml/min < 10 ml/min
500 mg q12h 500 mg q24h 500 mg q24h 250 mg q24h
1 g q12h 1 g q24h 500 mg q24h 250 mg q24h
2 g q12h Injection
ceFIXime (SUPRAX) 100 mg/5 ml oral liquid Yes Renal Dosing:
CrCl 50-80ml/min: 200mg q12h or 400mg q24h
CrCl 10-50ml/min: 400mg q24h
CrCl <10ml/min: 200mg q24h Oral
ceFIXime (SUPRAX) 400 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: 200mg q12h or 400mg q24h
CrCl 10-50ml/min: 400mg q24h
CrCl <10ml/min: 200mg q24h Oral
cefoTAXime (CLAFORAN) 1 g injection No Renal Dosing:
CrCl 50-80ml/min: 1-2gm q4-6h
CrCl 10-50ml/min: 1-2gm q8-12h
CrCl<10ml/min: 1-2gm q12h Injection
cefoTAXime (CLAFORAN) 2 g injection No Renal Dosing:
CrCl 50-80ml/min: 1-2gm q4-6h
CrCl 10-50ml/min: 1-2gm q8-12h
CrCl<10ml/min: 1-2gm q12h Intravenous
cefoTAXime (CLAFORAN) 500 mg injection No Renal Dosing:
CrCl 50-80ml/min: 1-2gm q4-6h
CrCl 10-50ml/min: 1-2gm q8-12h
CrCl<10ml/min: 1-2gm q12h Injection
cefoteTAN (CEFOTAN) 1 g injection Yes Renal Dosing:
CrCl 10-30ml/min: usual dose q24h
CrCl<10ml/min: usual dose q48h Injection
cefoteTAN (CEFOTAN) 2 g injection Yes Renal Dosing:
CrCl 10-30ml/min: usual dose q24h
CrCl<10ml/min: usual dose q48h Injection
ceFOXitin (MEFOXIN) 1 g injection No Renal Dosing:
CrCl 50-80ml/min: 1-2gm q8h
CrCl 10-50ml/min: 1-2gm q12h
CrCl<10ml/min: 0.5-1gm q12-48h Intravenous
ceFOXitin (MEFOXIN) 2 g injection No Renal Dosing:
CrCl 50-80ml/min: 1-2gm q8h
CrCl 10-50ml/min: 1-2gm q12h
CrCl<10ml/min: 0.5-1gm q12-48h Intravenous
cefPODOxime (VANTIN) 100 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: 200-400mg q12h
CrCl 10-50ml/min: 200-400mg q24h
CrCl<10ml/min: 200mg q24h Oral
cefPODOxime (VANTIN) 100 mg/5 ml oral liquid No Renal Dosing:
CrCl 50-80ml/min: 200-400mg q12h
CrCl 10-50ml/min: 200-400mg q24h
CrCl<10ml/min: 200mg q24h Oral
cefPODOxime (VANTIN) 200 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: 200-400mg q12h
CrCl 10-50ml/min: 200-400mg q24h
CrCl<10ml/min: 200mg q24h Oral
cefPROZil (CEFZIL) 250 mg tablet No Renal Dosing:
CrCl 50-80ml/min: 250-500mg q12h
CrCl 10-50ml/min: 250-500mg q24h
CrCl<10ml/min: 250-500mg q24h Oral
cefPROZil (CEFZIL) 250 mg/5 ml oral liquid No Renal Dosing:
CrCl 50-80ml/min: 250-500mg q12h
CrCl 10-50ml/min: 250-500mg q24h
CrCl<10ml/min: 250-500mg q24h Oral
cefPROZil (CEFZIL) 500 mg tablet No Renal Dosing:
CrCl 50-80ml/min: 250-500mg q12h
CrCl 10-50ml/min: 250-500mg q24h
CrCl<10ml/min: 250-500mg q24h Oral
ceftaziDIME (FORTAZ, TAZICEF) 1 g injection Yes Renal Dosing:
CrCl 50-80ml/min: 1-2gm q8-12h
CrCl 10-50ml/min: 1-2gm q12-24h
CrCl<10ml/min: 0.5-1gm q24h Intravenous
ceftaziDIME (FORTAZ, TAZICEF) 2 g injection Yes Renal Dosing:
CrCl 50-80ml/min: 1-2gm q8-12h
CrCl 10-50ml/min: 1-2gm q12-24h
CrCl<10ml/min: 0.5-1gm q24h Injection
ceftaziDIME (FORTAZ, TAZICEF) 5% (50mg/ml) opththalmic solution Yes Ophthalmic
ceftaziDIME (FORTAZ, TAZICEF) 500 mg injection Yes Renal Dosing:
CrCl 50-80ml/min: 1-2gm q8-12h
CrCl 10-50ml/min: 1-2gm q12-24h
CrCl<10ml/min: 0.5-1gm q24h Injection
ceftazidome (FORTAZ) intravitreal injection Yes Injection
ceftazidome (FORTAZ) subconjunctival injection Yes Injection
ceftiBUTEN (CEDAX) 400 mg capsule No Renal Dosing:
CrCl 50-80ml/min: 400mg q24h
CrCl 10-50ml/min: 200mg q24h
CrCl<10ml/min: 100mg q24h Oral
cefUROXime (CEFTIN) 250 mg tablet No Renal Dosing:
CrCl 50-80ml/min: 250-500mg q12h
CrCl 10-50ml/min: 250-500mg q12h
CrCl<10ml/min: 250mg q24h Oral
cefUROXime (CEFTIN) 250 mg/5 ml oral liquid No Renal Dosing:
CrCl 50-80ml/min: 250-500mg q12h
CrCl 10-50ml/min: 250-500mg q12h
CrCl<10ml/min: 250mg q24h Oral
cefUROXime (CEFTIN) 500 mg tablet No Renal Dosing:
CrCl 50-80ml/min: 250-500mg q12h
CrCl 10-50ml/min: 250-500mg q12h
CrCl<10ml/min: 250mg q24h Oral
ceFURoxime (ZINACEF) 1.5 g injection Yes Renal Dosing:
CrCl 50-80ml/min: 0.75-1.5gm q8h
CrCl 10-50ml/min: 750mg q12h
CrCl<10ml/min: 750mg q24h Injection
ceFURoxime (ZINACEF) 750 mg injection Yes Renal Dosing:
CrCl 50-80ml/min: 0.75-1.5gm q8h
CrCl 10-50ml/min: 750mg q12h
CrCl<10ml/min: 750mg q24h Injection
celecoxib (CELEBREX) 100 mg capsule Yes Oral
celecoxib (CELEBREX) 200 mg capsule Yes Oral
celecoxib (CELEBREX) 400 mg capsule No Dispense 2 x 200mg Oral
CENTRUM PERFORMANCE tablet No Oral
CENTRUM SILVER tablet No Oral
CEPACOL lozenges Yes Mucous Membrane
cephALEXin (KEFLEX) 250 mg capsule Yes Renal Dosing:
CrCl 50-80ml/min: 250-500mg q6h
CrCl 10-50ml/min: 250-500mg q8-12h
CrCl<10ml/min: 250mg q24-48h Oral
cephALEXin (KEFLEX) 250 mg/5 ml oral liquid Yes Renal Dosing:
CrCl 50-80ml/min: 250-500mg q6h
CrCl 10-50ml/min: 250-500mg q8-12h
CrCl<10ml/min: 250mg q24-48h Oral
cephALEXin (KEFLEX) 500 mg capsule Yes Renal Dosing:
CrCl 50-80ml/min: 250-500mg q6h
CrCl 10-50ml/min: 250-500mg q8-12h
CrCl<10ml/min: 250mg q24-48h Oral
cephradine (VELOSEF) 250 mg capsule No Renal Dosing:
CrCl 50-80ml/min: 250-500mg q6h
CrCl 10-50ml/min: 250-500mg q8-12h
CrCl<10ml/min: 250mg q24-48h Oral
cephradine (VELOSEF) 250mg/5ml oral liquid No Renal Dosing:
CrCl 50-80ml/min: 250-500mg q6h
CrCl 10-50ml/min: 250-500mg q8-12h
CrCl<10ml/min: 250mg q24-48h Oral
cephradine (VELOSEF) 500 mg capsule No Renal Dosing:
CrCl 50-80ml/min: 250-500mg q6h
CrCl 10-50ml/min: 250-500mg q8-12h
CrCl<10ml/min: 250mg q24-48h Oral
chloproPAMIDE (DIABINESE) 250 mg tablet Yes Oral
chloral hydrate (AQAUCHLORAL) 500 mg rectal suppository No Renal Dosing:
CrCl<50ml/min: Avoid Rectal
chloral hydrate (AQUACHLORAL) 325 mg rectal suppository Yes Renal Dosing:
CrCl<50ml/min: Avoid Rectal
chloral hydrate (NOCTEC) 500 mg/5 ml oral liquid Yes Renal Dosing:
CrCl<50ml/min: Avoid Oral
chlorambucil (LEUKERAN) 2 mg tablet Yes Oral
chlordiazepoxide (LIBRIUM) 25 mg capsule Yes Renal Dosing:
CrCl<10ml/min: decrease dose by 50% Oral
chlordiazepoxide (LIBRIUM) 5 mg capsule Yes Renal Dosing:
CrCl<10ml/min: decrease dose by 50% Oral
chloroquine (ARALEN) 250 mg tablet Yes Renal Dosing:
CrCl<10ml/min: give 50% of normal dose.
For prolonged treatment, reduce further to 50-100mg/day as
chloroquine base Oral
chloroquine (ARALEN) 500 mg tablet No Dispense 2 x 250mg
Renal Dosing:
CrCl<10ml/min: give 50% of normal dose.
For prolonged treatment, reduce further to 50-100mg/day as
chloroquine base Oral
chlorothiazide (DIURIL) 250 mg tablet Yes Renal Dosing:
Probably ineffective in patients with CrCl 10-50ml/min.
Avoid in patients with CrCl<10ml/min Oral
chlorothiazide (DIURIL) 250 mg/5 ml oral liquid No Renal Dosing:
Probably ineffective in patients with CrCl 10-50ml/min.
Avoid in patients with CrCl<10ml/min Oral
chlorothiazide (DIURIL) 500 mg injection Yes Renal Dosing:
Probably ineffective in patients with CrCl 10-50ml/min.
Avoid in patients with CrCl<10ml/min Injection
chlorothiazide (DIURIL) 500 mg tablet No Dispense 2 x 250mg
Renal Dosing:
Probably ineffective in patients with CrCl 10-50ml/min.
Avoid in patients with CrCl<10ml/min Oral
chlorpropamide 100 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: decrease usual dose 50%
CrCl<50ml/min: Avoid Oral
chlorpropamide 250 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: decrease usual dose 50%
CrCl<50ml/min: Avoid Oral
chlorthalidone (HYGROTON, THALITONE) 100 mg tablet No Dispense 4 x 25mg
Renal Dosing:
Avoid in patients with CrCl<10ml/min or increase dosing interval
to every 48 hours Oral
chlorthalidone (HYGROTON, THALITONE) 15 mg tablet No Renal Dosing:
Avoid in patients with CrCl<10ml/min or increase dosing interval
to every 48 hours Oral
chlorthalidone (HYGROTON, THALITONE) 25 mg tablet Yes Renal Dosing:
Avoid in patients with CrCl<10ml/min or increase dosing interval
to every 48 hours Oral
chlorthalidone (HYGROTON, THALITONE) 50 mg tablet No Dispense 2 x 25mg
Renal Dosing:
Avoid in patients with CrCl<10ml/min or increase dosing interval
to every 48 hours Oral
cidofovir (VISTIDE) injection Yes Renal Dosing:
Contraindicated in patients with Cr>1.5mg/dl or CrCl < or = 55ml/min IVPB
cilostazol (PLETAL) 100 mg tablet Yes Oral
cilostazol (PLETAL) 50 mg tablet No Dispense 1/2 x 100mg Oral
cimetidine (TAGAMET) 300 mg/5 ml oral liquid No Renal Dosing:
CrCl 10-50ml/min: 300mg q12h
CrCl<10ml/min: 200mg q12h Oral
cimetidine (TAGAMET) 200 mg tablet No Renal Dosing:
CrCl 10-50ml/min: 300mg q12h
CrCl<10ml/min: 200mg q12h Oral
cimetidine (TAGAMET) 300 mg tablet No Renal Dosing:
CrCl 10-50ml/min: 300mg q12h
CrCl<10ml/min: 200mg q12h Oral
cimetidine (TAGAMET) 400 mg tablet No Renal Dosing:
CrCl 10-50ml/min: 300mg q12h
CrCl<10ml/min: 200mg q12h Oral
cimetidine (TAGAMET) 800 mg tablet No Renal Dosing:
CrCl 10-50ml/min: 300mg q12h
CrCl<10ml/min: 200mg q12h Oral
cimetidine (TAGAMET) 150 mg/ml injection No May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl 10-50ml/min: 300mg q12h
CrCl<10ml/min: 200mg q12h Injection
ciprofloxacin (CIPRO) 200mg in 100ml D5W injection No Renal Dosing:
CrCl 5-29ml/min: 200-400mg q18-24h Intravenous
ciprofloxacin (CIPRO) 250 mg tablet No Renal Dosing:
CrCl 10-50ml/min: 250-500mg q12-18h
CrCl<10ml/min: 250-500mg q18-24h Oral
ciprofloxacin (CIPRO) 400mg in 200ml D5W injection No Renal Dosing:
CrCl 5-29ml/min: 200-400mg q18-24h Intravenous
ciprofloxacin (CIPRO) 500 mg tablet No Renal Dosing:
CrCl 10-50ml/min: 250-500mg q12-18h
CrCl<10ml/min: 250-500mg q18-24h Oral
ciprofloxacin (CIPRO) 500mg/5ml oral liquid No Renal Dosing:
CrCl 10-50ml/min: 250-500mg q12-18h
CrCl<10ml/min: 250-500mg q18-24h Oral
ciprofloxacin (CIPRO) 750 mg tablet No Renal Dosing:
CrCl 10-50ml/min: 250-500mg q12-18h
CrCl<10ml/min: 250-500mg q18-24h Oral
ciprofloxacin 0.2 % - hydrocortisone 0.1 % (CIPRO HC) otic solution No Otic
ciprofloxacin ER (CIPRO XR, PROQUIN XR) 1000 mg tablet No Renal Dosing:
Do not use extended release porducts in patients with CrCl < 50 ml/min
Dosing for immediate release tablets are as follows:
CrCl 10-50ml/min: 250-500mg q12-18h
CrCl<10ml/min: 250-500mg q18-24h Oral
ciprofloxacin ER (CIPRO XR, PROQUIN XR) 500 mg tablet No Renal Dosing:
Do not use extended release porducts in patients with CrCl < 50 ml/min
Dosing for immediate release tablets are as follows:
CrCl 10-50ml/min: 250-500mg q12-18h
CrCl<10ml/min: 250-500mg q18-24h Oral
cisatracurium (NIMBEX) 10 mg/ml injection Yes Intravenous
cisatracurium (NIMBEX) 2 mg/ml injection Yes Intravenous
cisplatin (PLATINOL AQ) chemo infusion Yes VESICANT
Renal Dosing:
CrCl 10-50ml/min: give 75% of usual dose
CrCl<10ml/min: give 50% of usual dose Chemo
citalopram (celeXA) 10 mg tablet Yes Oral
citalopram (celeXA) 10 mg/5 ml oral liquid No Oral
citalopram (celeXA) 20 mg tablet Yes Oral
citalopram (celeXA) 40 mg tablet No Dispense 2 x 20mg Oral
CITRACAL PRENATAL RX tablet No Oral
citric acid - D gluconic acid (RENACIDIN) irrigation Yes Urologic Irrigation
cladribine (LEUSTATIN) chemo infusion Yes Chemo
clarithromycin (BIAXIN) 250 mg tablet Yes Renal Dosing:
CrCl <30ml/min: Halve the normal dose or double the dosing interval Oral
clarithromycin (BIAXIN) 250 mg/5 ml oral liquid No Renal Dosing:
CrCl <30ml/min: Halve the normal dose or double the dosing interval Oral
clarithromycin (BIAXIN) 500 mg tablet Yes Renal Dosing:
CrCl <30ml/min: Halve the normal dose or double the dosing interval Oral
clarithromycin ER (BIAXIN XL) 1000 mg tablet No Renal Dosing:
CrCl <30ml/min: Halve the normal dose or double the dosing interval Oral
clarithromycin ER (BIAXIN XL) 500 mg tablet No Renal Dosing:
CrCl <30ml/min: Halve the normal dose or double the dosing interval Oral
codeine 15 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
codeine 15 mg/ml injection Yes Renal Dosing:
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Injection
codeine 15mg/5ml oral solution No Renal Dosing:
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
codeine 30 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
codeine 30 mg/ml injection Yes Renal Dosing:
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Injection
codeine 60 mg tablet No Dispense 2 x 30mg
Renal Dosing:
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
COENZYME Q10 100 mg capsule No Dispense 2 x 50mg Oral
COENZYME Q10 30 mg capsule Yes Oral
COENZYME Q10 50 mg capsule Yes Oral
COENZYME Q10 60 mg capsule No Dispense 2 x 30mg Oral
COENZYME Q10 60 mg tablet No Oral
colchicine (COLCRYS) 0.6 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: Max of 2mg IV or 0.6mg po q24-48h
CrCl<10ml/min: contraindicated Oral
colesevelam (WELCHOL) 625 mg tablet Yes Oral
colestipol (COLESTID) 1gm tablet Yes Oral
colestipol (COLESTID) 5 g oral packet Yes Oral
colistimethate (COLY-MYCIN M) nebulizer solution Yes MED NEB
colistimethate (COLYMYCIN-M) IVPB Yes Dosing should be based on IBW in obese patients
May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Cr 1.3-1.5 sugest 2.5-3.8mg/kg/day in 2 divided doses
Cr 1.6-2.5 suggest 2.5mg/kg/day q24h
C Intavenous
cytarabine HIGH dose (CYTOSAR-U) chemo infusion Yes Renal Dosing:
Cr<1.5mg/dl: 2-3gm/m(2)
Cr 1.5-1.9mg/dl: 1gm/m(2)
Cr > or = 2.0mg/dl: 0.1gm/m(2) as continuous infusion Chemo
daptomycin (CUBICIN) injection Yes Dosing based on actual body weight
May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl<30ml/min: 4-6mg/kg q48h IVPB
DAUNOrubicin (CERUBIDINE) chemo infusion Yes VESICANT
Renal Dosing:
For Cr>3mg/dl, reduce usual dose by 50% Chemo
DAUNOrubicin liposomal (DAUNOXOME) chemo infusion Yes Renal Dosing:
For Cr>3mg/dl, reduce usual dose by 50% Chemo
deferoxamine (DESFERAL) 500 mg injection Yes Renal Dosing:
Contraindicated in patients with severe renal disease or anuria Intramuscular
deferoxamine (DESFERAL) injection Yes Renal Dosing:
Contraindicated in patients with severe renal disease or anuria IVPB
demeclocycline (DECLOMYCIN) 150 mg tablet Yes Renal Dosing:
Avoid in patients with renal failure Oral
demeclocycline (DECLOMYCIN) 300 mg tablet No Dispense 2 x 150mg
Renal Dosing:
Avoid in patients with renal failure Oral
desloratadine (CLARINEX) 2.5mg/5 ml oral syrup No Renal Dosing:
In patients with renal impairment, give 5 mg every other day Oral
desloratadine (CLARINEX) 5 mg tablet No Renal Dosing:
In patients with renal impairment, give 5 mg every other day Oral
desloratadine-pseudoephdrine (CLARINEX-D 12 HR) 5-120 mg tablet No Renal Dosing:
In patients with renal impairment, give the 5gm/120mg tab every other day Oral
desloratadine-pseudoephdrine (CLARINEX-D 24 HR) 5-240 mg tablet No Renal Dosing:
In patients with renal impairment, give the 5gm/240mg tab every other day or the 2.5mg/120mg tab every day Oral
desloratidine (CLARINEX REDITAB) 5 mg disintegrating tablet No Renal Dosing:
In patients with renal impairment, give 5 mg every other day Oral
desmopressin (DDAVP) 0.01% nasal solution No Renal Dosing:
Contraindicated in patients with CrCl<50ml/min Nasal
desmopressin (DDAVP) 0.01% nasal spray Yes Renal Dosing:
Contraindicated in patients with CrCl<50ml/min Nasal
desmopressin (DDAVP) 0.1 mg tablet Yes Renal Dosing:
Contraindicated in patients with CrCl<50ml/min Oral
desmopressin (DDAVP) 0.2 mg tablet No Dispense 2 x 0.1mg
Renal Dosing:
Contraindicated in patients with CrCl<50ml/min Oral
desmopressin (DDAVP) 4 mcg/ml injection Yes Renal Dosing:
Contraindicated in patients with CrCl<50ml/min Injection
desmopressin (DDAVP) injection Yes Renal Dosing:
Contraindicated in patients with CrCl<50ml/min IVPB
diclofenac - misoprostol EC (ARTHROTEC 50) 50-0.2 mg tablet No Dispense individual ingredients
Renal Dosing:
CrCl<30ml/min: Contraindicated Oral
diclofenac - misoprostol EC (ARTHROTEC 75) 75-0.2 mg tablet No Dispense individual ingredients
Renal Dosing:
CrCl<30ml/min: Contraindicated Oral
didanosine (VIDEX) 100 mg chewable tablet Yes Renal Dosing:
If wt > 60kg: ORAL TAB VIDEX EC
CrCl 30-59ml/min 100mg twice daily 200mg daily
200mg daily
CrCl 10-29ml/m Oral
didanosine (VIDEX) 10mg/ml oral liquid No Renal Dosing:
If wt > 60kg: ORAL TAB VIDEX EC
CrCl 30-59ml/min 100mg twice daily 200mg daily
200mg daily
CrCl 10-29ml/m Oral
didanosine (VIDEX) 150 mg chewable tablet Yes Renal Dosing:
If wt > 60kg: ORAL TAB VIDEX EC
CrCl 30-59ml/min 100mg twice daily 200mg daily
200mg daily
CrCl 10-29ml/m Oral
didanosine (VIDEX) 200 mg chewable tablet Yes Renal Dosing:
If wt > 60kg: ORAL TAB VIDEX EC
CrCl 30-59ml/min 100mg twice daily 200mg daily
200mg daily
CrCl 10-29ml/m Oral
didanosine EC (VIDEX EC) 125 mg capsule Yes Renal Dosing:
If wt > 60kg: ORAL TAB VIDEX EC
CrCl 30-59ml/min 100mg twice daily 200mg daily
200mg daily
CrCl 10-29ml/m Oral
didanosine EC (VIDEX EC) 200 mg capsule Yes Renal Dosing:
If wt > 60kg: ORAL TAB VIDEX EC
CrCl 30-59ml/min 100mg twice daily 200mg daily
200mg daily
CrCl 10-29ml/m Oral
didanosine EC (VIDEX EC) 250 mg capsule Yes Renal Dosing:
If wt > 60kg: ORAL TAB VIDEX EC
CrCl 30-59ml/min 100mg twice daily 200mg daily
200mg daily
CrCl 10-29ml/m Oral
didanosine EC (VIDEX EC) 400 mg capsule Yes Renal Dosing:
If wt > 60kg: ORAL TAB VIDEX EC
CrCl 30-59ml/min 100mg twice daily 200mg daily
200mg daily
CrCl 10-29ml/m Oral
diethylpropion (TENUATE) 25 mg tablet No Oral
diethylpropion ER (TENUATE DOSPAN) 75 mg tablet No Oral
diflorasone (PSORCON E, APEXICON E) 0.05% topical cream No Topical
diflorasone (PSORCON, MAXIFLOR) 0.05% topical cream No Topical
diflorasone (PSORCON, MAXIFLOR) 0.05% topical ointment No Topical
diflunisal (DOLOBID) 500 mg tablet Yes Renal Dosing:
CrCl<50ml/min: decrease usual dose 50% Oral
diphenhydrAMINE (BENADRYL) 12.5 mg/5 ml oral liquid Yes Renal Dosing:
CrCl 10-50ml/min: give q6-12h
CrCl<10ml/min: give q12-18h Oral
diphenhydrAMINE (BENADRYL) 12.5 mg/5 ml oral elixir No We stock oral liquid
Renal Dosing:
CrCl 10-50ml/min: give q6-12h
CrCl<10ml/min: give q12-18h Oral
diphenhydrAMINE (BENADRYL) 2% topical spray No Topical
diphenhydrAMINE (BENADRYL) 25 mg capsule Yes Renal Dosing:
CrCl 10-50ml/min: give q6-12h
CrCl<10ml/min: give q12-18h Oral
diphenhydrAMINE (BENADRYL) 50 mg capsule Yes Renal Dosing:
CrCl 10-50ml/min: give q6-12h
CrCl<10ml/min: give q12-18h Oral
diphenhydrAMINE (BENADRYL) 50 mg/ml injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl 10-50ml/min: give q6-12h
CrCl<10ml/min: give q12-18h Injection
diphenhydrAMINE(BENADRYL) 1% topical cream No Topical
diphenhydrAMINE(BENADRYL) 2% topical cream Yes Topical
diphenoxylate - atropine (LOMOTIL) 2.5-0.025 mg/5 ml oral liquid No Oral
diphenoxylate - atropine (LOMOTIL, LONOX) 2.5-0.025 mg tablet Yes Oral
dipivefrin (PROPINE) 0.1% ophthalmic solution Yes Ophthalmic
dipyridamole - aspirin (AGGRENOX)n 200-25 mg capsule Yes Renal Dosing:
CrCl < 10ml/min: Avoid Oral
dipyridamole (PERSANTINE) 25 mg tablet Yes Oral
dipyridamole (PERSANTINE) 50 mg tablet No Dispense 2 x 25mg Oral
dipyridamole (PERSANTINE) 75 mg tablet Yes Oral
disopyramide (NORPACE) 100 mg capsule Yes Renal Dosing:
CrCl 10-50ml/min: give q12-24h
CrCl<10ml/min: give q24-48h Oral
disopyramide (NORPACE) 150 mg capsule Yes Renal Dosing:
CrCl 10-50ml/min: give q12-24h
CrCl<10ml/min: give q24-48h Oral
disopyramide ER (NORPACE CR) 100 mg capsule Yes Renal Dosing:
The controlled-release form is not recommended in patients with severe renal impairment
Dosing recommendations for the immeditate-releaee formulation:
CrCl 10-50ml/min: give q12-24h
CrCl<10ml/min: give q24-48h Oral
disopyramide ER (NORPACE CR) 150 mg capsule Yes Renal Dosing:
The controlled-release form is not recommended in patients with severe renal impairment
Dosing recommendations for the immeditate-releaee formulation:
CrCl 10-50ml/min: give q12-24h
CrCl<10ml/min: give q24-48h Oral
dofetilide (TIKOSYN) 125 mcg capsule Yes Renal Dosing:
CrCl 40-60ml/min: 250mcg bid
CrCl 20-40ml/min: 125mcg bid
CrCl<20ml/min: contraindicated Oral
dofetilide (TIKOSYN) 250 mcg capsule Yes Renal Dosing:
CrCl 40-60ml/min: 250mcg bid
CrCl 20-40ml/min: 125mcg bid
CrCl<20ml/min: contraindicated Oral
dofetilide (TIKOSYN) 500 mcg capsule Yes Renal Dosing:
CrCl 40-60ml/min: 250mcg bid
CrCl 20-40ml/min: 125mcg bid
CrCl<20ml/min: contraindicated Oral
dolasetron (ANZEMET) 12.5 mg / 0.625 ml injection No Intravenous
dolastetron (ANZEMET) 100mg tablet No Oral
dolastetron (ANZEMET) 50 mg tablet No Oral
donepezil (ARICEPT ODT) 10 mg oral disinetegrating tablet No Oral
donepezil (ARICEPT ODT) 5 mg oral disinetegrating tablet No Oral
donepezil (ARICEPT) 10 mg tablet Yes Oral
donepezil (ARICEPT) 5 mg tablet Yes Oral
dorzolamide - timolol (COSOPT) 2 - 0.5% ophthalmic solution Yes Renal Dosing:
CrCl<30ml/min: Contraindicated Ophthalmic
dorzolamide (TRUSOPT) 2% ophthalmic solution No Renal Dosing:
Dorzolamide
CrCl<30ml/min: Contraindicated Ophthalmic
duloxetine (CYMBALTA) 20 mg capsule Yes Renal Dosing:
CrCl<30ml/min: Avoid Oral
duloxetine (CYMBALTA) 30 mg capsule Yes Renal Dosing:
CrCl<30ml/min: Avoid Oral
duloxetine (CYMBALTA) 60 mg capsule Yes Renal Dosing:
CrCl<30ml/min: Avoid Oral
DUODERM topical dressing Yes Topical
dutasteride (AVODART) 0.5 mg capsule Yes Oral
d-xylose (XYLOSE) oral powder Yes Oral
econazole (SPECTAZOLE) 1% topical cream No Topical
eculizumab (SOLIRIS) injection Yes IVPB
edetate calcium disodium (CALCIUM DISODIUM VERSENATE) injection Yes Renal Dosing:
Cr of 2-3 mg/dl, give 500mg/m(2) q24h x 5 days
Cr of 3-4 mg/dl, give 500mg/m(2) q48h x 3 doses
Cr >4 mg/dl, give 500mg/m(2) q week IVPB
edetate calcium disodium (CALCIUM DISODIUM) 200mg/ml injection Yes Renal Dosing:
Cr of 2-3 mg/dl, give 500mg/m(2) q24h x 5 days
Cr of 3-4 mg/dl, give 500mg/m(2) q48h x 3 doses
Cr >4 mg/dl, give 500mg/m(2) q week Injection
efavirenz - emtricitabine - tenofovir (ATRIPLA) 600-200-300 mg tablet No Dispense individual ingredients
Renal Dosing:
CrCl<50ml/min: Not Recommended Oral
emtricitabine - tenofovir (TRUVADA) 200-300 mg tablet No Dispense individual ingredients
Renal Dosing:
CrCl 30-49ml/min: 200/300 q48h
CrCl<30ml/min: Avoid Oral
emtricitabine (EMTRIVA) 10 mg/ml oral liquid Yes Not routinely stocked - Order PRN
Renal Dosing:
CrCl 30-49ml/min: 120mg q24h
CrCl 15-29ml/min: 80mg q24h
CrCl<15ml/min: 60mg q24h Oral
emtricitabine (EMTRIVA) 200 mg capsule Yes Renal Dosing:
CrCl 30-49ml/min: 200mg q48h
CrCl 15-29ml/min: 200mg q72h
CrCl<15ml/min: 200mg q96h Oral
enalapril (VASOTEC) 10 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Oral
enalapril (VASOTEC) 2.5 mg tablet No Dispense 1/2 of 5mg
Renal Dosing:
CrCl 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Oral
enalapril (VASOTEC) 20 mg tablet No Dispense 2 x 10mg
Renal Dosing:
CrCl 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Oral
enalapril (VASOTEC) 5 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Oral
enalaprilat (VASOTEC) 1.25 mg/ml injection Yes May be administered in: Non Critical Care Areas (initial dose is 0.625 mg IV every 6 hours, unless the safety of a higher dose has been determined in a critical care area) and all Critical Care Areas
Renal Dosing:
CrCl 10-50ml/min: decrease dose Intravenous
enalapril-HCTZ (VASERETIC 10-25 mg tablet No Dispense individual ingredients
Renal Dosing:
CrCl<30ml/min or Cr > 3mg/dl: Avoid Oral
enalapril-HCTZ (VASERETIC 5-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
CrCl<30ml/min or Cr > 3mg/dl: Avoid Oral
enoxaparin (LOVENOX) 100 mg/ml injection Yes Renal Dosing:
Indication
Prophylaxis in abdominal surgery:
30 mg administered SC q24 hour
Prophylaxis in hip or knee replacement surgery:
30 mg administered SC q24 hour
Prophylaxis in medical patients during acute illness:
Subcutaneous
enoxaparin (LOVENOX) 30 mg/0.3 ml syringe Yes Renal Dosing:
Indication
Prophylaxis in abdominal surgery:
30 mg administered SC q24 hour
Prophylaxis in hip or knee replacement surgery:
30 mg administered SC q24 hour
Prophylaxis in medical patients during acute illness:
Subcutaneous
enoxaparin (LOVENOX) 40 mg/0.4 ml injection Yes Renal Dosing:
Indication
Prophylaxis in abdominal surgery:
30 mg administered SC q24 hour
Prophylaxis in hip or knee replacement surgery:
30 mg administered SC q24 hour
Prophylaxis in medical patients during acute illness:
Subcutaneous
enoxaparin (LOVENOX) 60 mg/0.6 ml injection Yes Renal Dosing:
Indication
Prophylaxis in abdominal surgery:
30 mg administered SC q24 hour
Prophylaxis in hip or knee replacement surgery:
30 mg administered SC q24 hour
Prophylaxis in medical patients during acute illness:
Subcutaneous
enoxaparin (LOVENOX) 80 mg/0.8 ml injection Yes Renal Dosing:
Indication
Prophylaxis in abdominal surgery:
30 mg administered SC q24 hour
Prophylaxis in hip or knee replacement surgery:
30 mg administered SC q24 hour
Prophylaxis in medical patients during acute illness:
Subcutaneous
entacapone (COMTAN) 200 mg tablet Yes Oral
entecavir (BARACLUDE) 0.05 mg/ml oral liquid No Renal Dosing:
Treatment naïve Lamuvidine Refractory
(0.5mg) (1mg)
CrCl 30-50ml/min 0.25mg daily or 0.5mg q48h 0.5mg daily or 1mg q48h
CrCl 10-29ml/min 0.15mg daily or 0.5mg Oral
entecavir (BARACLUDE) 0.5 mg tablet Yes Renal Dosing:
Treatment naïve Lamuvidine Refractory
(0.5mg) (1mg)
CrCl 30-50ml/min 0.25mg daily or 0.5mg q48h 0.5mg daily or 1mg q48h
CrCl 10-29ml/min 0.15mg daily or 0.5mg Oral
entecavir (BARACLUDE) 1 mg tablet No Dispense 2 x 0.5mg
Renal Dosing:
Treatment naïve Lamuvidine Refractory
(0.5mg) (1mg)
CrCl 30-50ml/min 0.25mg daily or 0.5mg q48h 0.5mg daily or 1mg q48h
CrCl 10-29ml/min 0 Oral
ePHEDrine 50 mg/ml injection Yes May be administered in: Critical Care Areas Only Injection
epinastine (ELESTAT) 0.05% ophthalmic solution No Ophthalmic
EPINephrine (ADRENALIN) 0.1% nasal solution Yes Nasal
EPINephrine (ADRENALIN) 1 mg/10 ml prefill IV syringe Yes VESICANT
May be administered in: Critical Care Areas Only Injection
EPINephrine (ADRENALIN) 1 mg/ml injection Yes VESICANT
May be administered in: Non Critical Care Areas (limited to the treatment of anaphylaxis or anaphylactoid reactions (serious hypersensitivity reactions) and Critical Care Areas Only Injection
eptifibatide (INTEGRILIN) drip (conc: 0.75 mg/ml) Yes May be administered in: All Critical Care Areas, Cardiac DOU and Telemetry Areas
Renal Dosing:
Acute Coronary Syndrome :
CrCl<50ml/min or Cr>2mg/dl: bolus dose 180mcg/kg followed by an infusion of 1 mcg/kg/min
Percutaneous Coronary Intervention: Intravenous
ertapenem (INVANZ) 1 g injection Yes Renal Dosing:
CrCl<30ml/min: 500mg q24h Injection
erythromycin (ERY-TAB) 250 mg tablet Yes If converting patient from tablet to liquid (EES) so EES for conversion tablet
Renal Dosing:
CrCl<10ml/min: decrease dose by 25-50%. Maximum daily dose 2gm Oral
erythromycin (ERY-TAB) 333 mg tablet Yes If converting patient from tablet to liquid (EES) so EES for conversion tablet
Renal Dosing:
CrCl<10ml/min: decrease dose by 25-50%. Maximum daily dose 2gm Oral
erythromycin (ERY-TAB) 500 mg tablet Yes If converting patient from tablet to liquid (EES) so EES for conversion tablet
Renal Dosing:
CrCl<10ml/min: decrease dose by 25-50%. Maximum daily dose 2gm Oral
erythromycin - benzoyl peroxide (BENZAMYCIN) 3-5% topical gel Yes Topical
erythromycin - ethanol (ERYDERM, A/T/S) 2% topical solution Yes Topical
erythromycin (AKNE-MYCIN) 2% topical ointment Yes Topical
erythromycin (EMGEL A/T/S) 2% topical gel Yes Topical
erythromycin (ERYDERM, A/T/S) 2% topical solution Yes Topical
erythromycin (ILOTYCIN) 0.5% ophthalmic ointment Yes Ophthalmic
erythromycin 1000mg injection Yes Renal Dosing:
CrCl<10ml/min: decrease dose by 25-50%. Maximum daily dose 2gm IVPB
erythromycin 250mg injection Yes Renal Dosing:
CrCl<10ml/min: decrease dose by 25-50%. Maximum daily dose 2gm IVPB
erythromycin 500mg injection Yes Renal Dosing:
CrCl<10ml/min: decrease dose by 25-50%. Maximum daily dose 2gm IVPB
erythromycin ethylsuccinate (E.E.S.) 400 mg tablet No Dispense 400mg oral liquid
Renal Dosing:
CrCl<10ml/min: decrease dose by 25-50%. Maximum daily dose 2gm Oral
erythromycin ethylsuccinate (E.E.S.) 400 mg/5 ml oral liquid Yes See note regarding tablet to liquid conversion
Renal Dosing:
CrCl<10ml/min: decrease dose by 25-50%. Maximum daily dose 2gm Oral
erythromycin stearate (ERYTHROCIN) 250 mg tablet Yes If converting patient from tablet to liquid (EES) so EES for conversion tablet
Renal Dosing:
CrCl<10ml/min: decrease dose by 25-50%. Maximum daily dose 2gm Oral
ethacrynate (EDECRIN) 50 mg injection Yes Renal Dosing:
CrCl 10-50ml/min: increase dosing interval to q8-12h
CrCl<10ml/min: Avoid Injection
ethacrynic acid (EDECRIN) 25 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: increase dosing interval to q8-12h
CrCl<10ml/min: Avoid Oral
ethambutol (MYAMBUTOL) 100 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: q24-36h
CrCl<10ml/min: q48h Oral
ethambutol (MYAMBUTOL) 400 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: q24-36h
CrCl<10ml/min: q48h Oral
ethionamide (TRECATOR) 250 mg tablet Yes Renal Dosing:
CrCl<10ml/min: decrease dose by 50% Oral
ethosuximide (ZARONTIN) 250 mg capsule Yes Oral
ethosuximide (ZARONTIN) 250 mg/5 ml oral liquid Yes Oral
ethyl alcohol 50% nebulizer solution Yes MED NEB
ethyl chloride topical spray Yes Topical
etidronate (DIDRONEL) 200 mg tablet No Dispense 1/2 x 400mg
Renal Dosing:
Creatinine 2.5-5mg/dl: use cautiously
Creatinine >5mg/dl: Avoid Oral
etidronate (DIDRONEL) 400 mg tablet Yes Renal Dosing:
Creatinine 2.5-5mg/dl: use cautiously
Creatinine >5mg/dl: Avoid Oral
etodolac (LODINE) 200 mg capsule Yes Oral
etodolac (LODINE) 300 mg capsule Yes Oral
etoposide (VEPESID) 50 mg chemo capsule Yes Renal Dosing:
CrCl 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Oral
etoposide (VEPESID) chemo infusion Yes Renal Dosing:
CrCl 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Chemo
exenatide (BYETTA) 10 mcg /0.4 ml injection No Renal Dosing:
CrCl<30ml/min: Avoid Subcutaneous
exenatide (BYETTA) 5 mcg /0.2 ml injection No Renal Dosing:
CrCl<30ml/min: Avoid Subcutaneous
eye patch Yes Miscell. (Med.Supl.;Non-Drugs)
ezetimibe - simvastatin (VYTORIN) 10-10 mg tablet No Dispense individual ingredients
Renal Dosing:
CrCl<10ml/min: avoid unless patient has previously tolerated
simvastatin treatment at a dose of 5mg or higher Oral
ezetimibe - simvastatin (VYTORIN) 10-20 mg tablet No Dispense individual ingredients
Renal Dosing:
CrCl<10ml/min: avoid unless patient has previously tolerated
simvastatin treatment at a dose of 5mg or higher Oral
ezetimibe - simvastatin (VYTORIN) 10-40 mg tablet No Dispense individual ingredients
Renal Dosing:
CrCl<10ml/min: avoid unless patient has previously tolerated
simvastatin treatment at a dose of 5mg or higher Oral
ezetimibe (ZETIA) 10 mg tablet Yes Oral
ezetimibe-simvastatin (VYTORIN) 10-80 mg tablet No Dispense individual ingredients Oral
famciclovir (FAMVIR) 250 mg tablet No Dispense 1/2 of 500mg
Renal Dosing:
CrCl 50-80ml/min: 500mg q12h
CrCl 10-50ml/min: 500mg q24h
CrCl<10ml/min: 500mg q48h Oral
famciclovir (FAMVIR) 500 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: 500mg q12h
CrCl 10-50ml/min: 500mg q24h
CrCl<10ml/min: 500mg q48h Oral
famotidine (PEPCID) 10 mg tablet No Dispense 1/2 of 20mg
Renal Dosing:
CrCl<50ml/min: decrease dose by 50% or increase dosing interval to q36-48h Oral
famotidine (PEPCID) 20 mg tablet Yes Renal Dosing:
CrCl<50ml/min: decrease dose by 50% or increase dosing interval to q36-48h Oral
famotidine (PEPCID) 20 mg/ 2 ml injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl<50ml/min: decrease dose by 50% or increase dosing interval to q36-48h Intravenous
famotidine (PEPCID) 40 mg tablet No Dispense 2 x 20mg
Renal Dosing:
CrCl<50ml/min: decrease dose by 50% or increase dosing interval to q36-48h Oral
famotidine (PEPCID) 40 mg/5 ml oral liquid No Renal Dosing:
CrCl<50ml/min: decrease dose by 50% or increase dosing interval to q36-48h Oral
famotidine (PEPCID) drip (conc: 0.16 mg/ml) Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl<50ml/min: decrease dose by 50% or increase dosing interval to q36-48h Drips
fat emulsion (INTRALIPID, LIPOSYN) 20% IV solution Yes Intravenous
febuxostat (ULORIC) 40 mg tablet No Oral
febuxostat (ULORIC) 80 mg tablet No Oral
felbamate (FELBATOL) 400 mg tablet Yes Renal Dosing:
CrCl<50ml/min: decrease dose by 50% Oral
felbamate (FELBATOL) 600 mg tablet No Dispense 1.5 x 400mg
Renal Dosing:
CrCl<50ml/min: decrease dose by 50% Oral
felbamate (FELBATOL) 600 mg/5 ml oral liquid No Renal Dosing:
CrCl<50ml/min: decrease dose by 50% Oral
fentanyl (FENTORA) 100 mcg buccal tablet No Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Buccal
fentanyl (FENTORA) 200 mcg buccal tablet No Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Buccal
fentanyl (FENTORA) 400 mcg buccal tablet No Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Buccal
fentanyl (FENTORA) 600 mcg buccal tablet No Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Buccal
fentanyl (FENTORA) 800 mcg buccal tablet No Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Buccal
fentanyl (ONSOLIS) 1200 mcg buccal film No Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Buccal
fentanyl (ONSOLIS) 200 mcg buccal film No Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Buccal
fentanyl (ONSOLIS) 400 mcg buccal film No Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Buccal
fentanyl (ONSOLIS) 600 mcg buccal film No Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Buccal
fentanyl (ONSOLIS) 800 mcg buccal film No Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Buccal
fentanYL (ACTIQ) 1,200 mcg lollipop No Dispense 1 x 800mcg + 1 x 400mcg
Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Oral
fentanYL (ACTIQ) 1,600 mcg lollipop No Dispense 2 x 800mcg
Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Oral
fentanYL (ACTIQ) 200 mcg lollipop Yes Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Oral
fentanYL (ACTIQ) 400 mcg lollipop Yes Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Oral
fentanYL (ACTIQ) 600 mcg lollipop Yes Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Oral
fentanYL (ACTIQ) 800 mcg lollipop No Dispense 2 x 400mcg
Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Oral
fentanYL (DURAGESIC) 100 mcg/24 hr transdermal patch Yes Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50%
ALL Patches should be removed prior to MRI Transdermal
fentanYL (DURAGESIC) 12 mcg/24 hr transdermal patch Yes Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50%
ALL Patches should be removed prior to MRI Transdermal
fentanYL (DURAGESIC) 25 mcg/24 hr transdermal patch Yes Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50%
ALL Patches should be removed prior to MRI Transdermal
fentanYL (DURAGESIC) 50 mcg/24 hr transdermal patch Yes Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50%
ALL Patches should be removed prior to MRI Transdermal
fentanYL (DURAGESIC) 75 mcg/24 hr transdermal patch Yes Renal Dosing:
Use with caution because of the renal excretion of fentanyl
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50%
ALL Patches should be removed prior to MRI Transdermal
fentanYL (SUBLIMAZE) 0.05 mg/ml injection Yes May be administered in: Non Critical Care Areas (PCA infusion Only), All Critical Care Areas and DOU/Telemetry Unit
Renal Dosing:
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Injection
fentanYL (SUBLIMAZE) 50 mcg/ml in no diluent (straight drug) 100ml PCA Yes Drips
fentanYL 10 mcg/ml - BUpivacaine 0.05 % epidural (non OB) Yes Drips
fentanYL 2 mcg/ml - BUpivacain 0.1 % epidural (OB) Yes Drips
fentanyl drip Yes May be administered in: Non Critical Care Areas (PCA infusion Only), All Critical Care Areas and DOU/Telemetry Unit
Renal Dosing:
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Drips
fentanyl syringe drip Yes May be administered in: Non Critical Care Areas (PCA infusion Only), All Critical Care Areas and DOU/Telemetry Unit
Renal Dosing:
ClCr 10-50ml/min: decrease dose by 25%
CrCl<10ml/min: decrease dose by 50% Drips
fexofenadine - pseudoephedrine ER (ALLEGRA-D 12 HR) 60-120 mg tablet No Renal Dosing:
CrCr<50ml/min: 60mg q24h Oral
fexofenadine - pseudoephedrine ER (ALLEGRA-D 24 HR) 180-240 mg tablet No Renal Dosing:
CrCr<50ml/min: 60mg q24h Oral
fexofenadine (ALLEGRA ODT) 30 mg disintegrating tablet No Renal Dosing:
CrCr<50ml/min: 60mg q24h Oral
fexofenadine (ALLEGRA) 180 mg tablet No Renal Dosing:
CrCr<50ml/min: 60mg q24h Oral
fexofenadine (ALLEGRA) 30 mg tablet No Renal Dosing:
CrCr<50ml/min: 60mg q24h Oral
fexofenadine (ALLEGRA) 60 mg tablet No Renal Dosing:
CrCr<50ml/min: 60mg q24h Oral
fexofenadine (ALLEGRA) 6mg/ml oral liquid No Renal Dosing:
CrCr<50ml/min: 60mg q24h Oral
flecainide (TAMBOCOR) 100 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: q12-24h
CrCl<10ml/min: q24h Oral
flecainide (TAMBOCOR) 150 mg tablet No Dispense 1 x 50mg + 1 x 100mg
Renal Dosing:
CrCl 10-50ml/min: q12-24h
CrCl<10ml/min: q24h Oral
flecainide (TAMBOCOR) 50 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: q12-24h
CrCl<10ml/min: q24h Oral
floxuridine (FUDR) chemo infusion Yes Chemo
fluconazole (DIFLUCAN) 100 mg tablet Yes Renal Dosing:
CrCl <50ml/min: decrease dose by 50% Oral
fluconazole (DIFLUCAN) 100mg in 50ml NS syringe Yes Renal Dosing:
CrCl <50ml/min: decrease dose by 50% Intravenous
fluconazole (DIFLUCAN) 150 mg tablet No Dispense 1x 50mg + 1 x 100mg
Renal Dosing:
CrCl <50ml/min: decrease dose by 50% Oral
fluconazole (DIFLUCAN) 200 mcg tablet Yes Renal Dosing:
CrCl <50ml/min: decrease dose by 50% Oral
fluconazole (DIFLUCAN) 200 mg in 100ml NS injection Yes Renal Dosing:
CrCl <50ml/min: decrease dose by 50% Intravenous
fluconazole (DIFLUCAN) 40 mg/ml oral liquid No Renal Dosing:
CrCl <50ml/min: decrease dose by 50% Oral
fluconazole (DIFLUCAN) 400 mg in 100ml NS injection Yes Renal Dosing:
CrCl <50ml/min: decrease dose by 50% Intravenous
fluconazole (DIFLUCAN) 50 mg tablet Yes Renal Dosing:
CrCl <50ml/min: decrease dose by 50% Oral
flucytosine (ANCOBON) 250 mg capsule Yes Renal Dosing:
CrCl 10-50ml/min: q12-24h
CrCl<10ml/min: q24-48h Oral
flucytosine (ANCOBON) 500 mg capsule No Dispense 2 x 250mg
Renal Dosing:
CrCl 10-50ml/min: q12-24h
CrCl<10ml/min: q24-48h Oral
fludarabine (FLUDARA) chemo infusion Yes Renal Dosing:
CrCl 30-70ml/min/1.73 m(2): decrease the usual dose 20-50%
CrCl<30ml/min/1.73 m(2): Avoid Chemo
fondaparinux (ARIXTRA) 2.5 mg/0.5 ml syringe Yes Renal Dosing:
CrCl<30ml/min: Contraindicated Subcutaneous
formoterol (FORADIL) 12 mcg inhalation capsule No Inhalation
formoterol (PERFOROMIST) 20mg/2ml nebulizer solution No Inhalation
fosamprenavir (LEXIVA) 700 mg tablet Yes Oral
fosaprepitant (EMEND) 115mg injection Yes Injection
foscarnet (FOSCAVIR) IVPB Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patients with renal impairment IVPB
fosinopril - hydrochlorothiazide (MONOPRIL-HCT) 10 - 12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usualy ineffective in patients with CrCl < 30ml/min Oral
fosinopril - hydrochlorothiazide (MONOPRIL-HCT) 20 - 12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
gabapentin (NEURONTIN) 100 mg capsule Yes Renal Dosing:
CrCl 60ml/min or greater: 300-900 q8h
CrCl 30-59ml/min: 200-700 q12h
CrCl 15-29ml/min: 200-700 daily
CrCl 15ml/min or less: 100-300mg daily Oral
gabapentin (NEURONTIN) 250 mg/5 ml oral liquid Yes Renal Dosing:
CrCl 60ml/min or greater: 300-900 q8h
CrCl 30-59ml/min: 200-700 q12h
CrCl 15-29ml/min: 200-700 daily
CrCl 15ml/min or less: 100-300mg daily Oral
gabapentin (NEURONTIN) 300 mg capsule Yes Renal Dosing:
CrCl 60ml/min or greater: 300-900 q8h
CrCl 30-59ml/min: 200-700 q12h
CrCl 15-29ml/min: 200-700 daily
CrCl 15ml/min or less: 100-300mg daily Oral
gabapentin (NEURONTIN) 400 mg capsule Yes Renal Dosing:
CrCl 60ml/min or greater: 300-900 q8h
CrCl 30-59ml/min: 200-700 q12h
CrCl 15-29ml/min: 200-700 daily
CrCl 15ml/min or less: 100-300mg daily Oral
gabapentin (NEURONTIN) 600 mg tablet No Dispense 2 x 300mg caps
Renal Dosing:
CrCl 60ml/min or greater: 300-900 q8h
CrCl 30-59ml/min: 200-700 q12h
CrCl 15-29ml/min: 200-700 daily
CrCl 15ml/min or less: 100-300mg daily Oral
gabapentin (NEURONTIN) 800 mg tablet No Dispense 2 x 400mg caps
Renal Dosing:
CrCl 60ml/min or greater: 300-900 q8h
CrCl 30-59ml/min: 200-700 q12h
CrCl 15-29ml/min: 200-700 daily
CrCl 15ml/min or less: 100-300mg daily Oral
gadodiamide (OMNISCAN) 287 mg/ml injection No Radiology Only Intravenous
galantamine (RAZADYNE) 12 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: maximum daily dose 16mg
CrCl<9ml/min: Avoid Oral
galantamine (RAZADYNE) 4 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: maximum daily dose 16mg
CrCl<9ml/min: Avoid Oral
galantamine (RAZADYNE) 4mg/ml oral liquid No Renal Dosing:
CrCl 10-50ml/min: maximum daily dose 16mg
CrCl<9ml/min: Avoid Oral
galantamine (RAZADYNE) 8 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: maximum daily dose 16mg
CrCl<9ml/min: Avoid Oral
galantamine ER (RAZADYNE ER) 16 mg capsule No Renal Dosing:
CrCl 10-50ml/min: maximum daily dose 16mg
CrCl<9ml/min: Avoid Oral
galantamine ER (RAZADYNE ER) 24 mg capsule No Renal Dosing:
CrCl 10-50ml/min: maximum daily dose 16mg
CrCl<9ml/min: Avoid Oral
galantamine ER (RAZADYNE ER) 8 mg capsule No Renal Dosing:
CrCl 10-50ml/min: maximum daily dose 16mg
CrCl<9ml/min: Avoid Oral
gallium (GANITE) 25 mg/ml injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas Intravenous
ganciclovir (CYTOVENE) injection Yes Use cytotoxic agent precautions when handling
May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Induction Dosing Maintenance Dosing
CrCl 50-69ml/min: 2.5mg/kg q IVPB
ganciclovir (CYTOVENE, DHPG) 500 mg capsule Yes Renal Dosing:
CrCl 50-69ml/min: 1500mg daily or 500mg tid
CrCl 24-49ml/min: 1000mg daily or 500mg bid
CrCl 10-24ml/min: 500mg daily
CrCl<10ml/min: 500mg 3 times/week after hemodialysis Oral
gentamicin (GARAMYCIN) 100mg in 25ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
gentamicin (GARAMYCIN) 110mg in 27.5ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
gentamicin (GARAMYCIN) 120mg in 30ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
gentamicin (GARAMYCIN) 130mg in 32.5ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
gentamicin (GARAMYCIN) 140mg in 35ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
gentamicin (GARAMYCIN) 150mg in 37.5ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
gentamicin (GARAMYCIN) 160mg in 40ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
gentamicin (GARAMYCIN) 170mg in 42.5ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
gentamicin (GARAMYCIN) 180mg in 45ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
gentamicin (GARAMYCIN) 190mg in 47.5ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
gentamicin (GARAMYCIN) 40mg in 10ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
gentamicin (GARAMYCIN) 50mg in 12.5ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
gentamicin (GARAMYCIN) 60mg in 15ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
gentamicin (GARAMYCIN) 70mg in 17.5ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
gentamicin (GARAMYCIN) 80mg in 20ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
gentamicin (GARAMYCIN) 90mg in 22.5ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
glipizide - metformin (METAGLIP) 2.5 - 250 mg tablet No Dispense individual ingredients
Renal Dosing:
Glipizide
The initial and maintenance dosing should be conservative
to avoid hypoglycemic reactions
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine Oral
glipizide - metformin (METAGLIP) 2.5 - 500 mg tablet No Dispense individual ingredients
Renal Dosing:
Glipizide
The initial and maintenance dosing should be conservative
to avoid hypoglycemic reactions
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine Oral
glipizide - metformin (METAGLIP) 5 - 500 mg tablet No Dispense individual ingredients
Renal Dosing:
Glipizide
The initial and maintenance dosing should be conservative
to avoid hypoglycemic reactions
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine Oral
glipiZIDE (GLUCOTROL) 10 mg tablet Yes Renal Dosing:
The initial and maintenance dosing should be conservative to avoid hypoglycemic reactions Oral
glipiZIDE (GLUCOTROL) 5 mg tablet Yes Renal Dosing:
The initial and maintenance dosing should be conservative to avoid hypoglycemic reactions Oral
glipiZIDE ER (GLUCOTROL XL) 10 mg tablet No Dispense 2 x 5mg
Renal Dosing:
The initial and maintenance dosing should be conservative to avoid hypoglycemic reactions Oral
glipiZIDE ER (GLUCOTROL XL) 2.5 mg tablet Yes Renal Dosing:
The initial and maintenance dosing should be conservative to avoid hypoglycemic reactions Oral
glipiZIDE ER (GLUCOTROL XL) 5 mg tablet Yes Renal Dosing:
The initial and maintenance dosing should be conservative to avoid hypoglycemic reactions Oral
glyBURIDE (DIABETA, MICRONASE) 1.25 mg tablet No Dispense 1/2 of 2.5mg
Renal Dosing:
The initial and maintenance dosing should be conservative to avoid hypoglycemic reactions Oral
glyBURIDE (DIABETA, MICRONASE) 2.5 mg tablet Yes Renal Dosing:
The initial and maintenance dosing should be conservative to avoid hypoglycemic reactions Oral
glyBURIDE (DIABETA, MICRONASE) 5 mg tablet Yes Renal Dosing:
The initial and maintenance dosing should be conservative to avoid hypoglycemic reactions Oral
glyBURIDE micronized (GLYNASE) 1.5 mg tablet No Renal Dosing:
The initial and maintenance dosing should be conservative to avoid hypoglycemic reactions Oral
glyBURIDE micronized (GLYNASE) 3 mg tablet No Renal Dosing:
The initial and maintenance dosing should be conservative to avoid hypoglycemic reactions Oral
glyBURIDE micronized (GLYNASE) 4.5 mg tablet No Renal Dosing:
The initial and maintenance dosing should be conservative to avoid hypoglycemic reactions Oral
glyBURIDE micronized (GLYNASE) 6 mg tablet No Renal Dosing:
The initial and maintenance dosing should be conservative to avoid hypoglycemic reactions Oral
glyBURIDE-metformin (GLUCOVANCE) 1.25-250 mg tablet No Dispense individual ingredients
Renal Dosing:
Glyburide
The initial and maintenance dosing should be conservative
to avoid hypoglycemic reactions
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine Oral
glyBURIDE-metformin (GLUCOVANCE) 2.5-500 mg tablet No Dispense individual ingredients
Renal Dosing:
Glyburide
The initial and maintenance dosing should be conservative
to avoid hypoglycemic reactions
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine Oral
glyBURIDE-metformin (GLUCOVANCE) 5-500 mg tablet No Dispense individual ingredients
Renal Dosing:
Glyburide
The initial and maintenance dosing should be conservative
to avoid hypoglycemic reactions
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine Oral
gold (AUROLATE) 50 mg/ml injection Yes Renal Dosing:
CrCl<50ml/min: Avoid Injection
guaifenesin - codeine (GUIATUSS AC, ROBITUSSIN AC) 100 - 10 mg/5 ml oral liquid Yes Renal Dosing:
Codeine
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
hydralazine - hydrochlorothiazide 50-50 mg tablet No Withdrawn From the Market (Mach 2007)
Renal Dosing:
Hydralazine
CrCl 10-50ml/min: q8h
CrCl<10ml/min: q12-24h
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
hydrALAZINE (APRESOLINE) 10 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: q8h
CrCl<10ml/min: q12-24h Oral
hydrALAZINE (APRESOLINE) 100 mg tablet No Dispense 2 x 50mg
Renal Dosing:
CrCl 10-50ml/min: q8h
CrCl<10ml/min: q12-24h Oral
hydrALAZINE (APRESOLINE) 20 mg/ml injection Yes May be administered in: All Critical Care Areas, Cardiac DOU and L&D/Perinatal Special Care Unit (PSCU) (Intermittent direct IV push only)
Renal Dosing:
CrCl 10-50ml/min: q8h
CrCl<10ml/min: q12-24h Injection
hydrALAZINE (APRESOLINE) 25 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: q8h
CrCl<10ml/min: q12-24h Oral
hydrALAZINE (APRESOLINE) 50 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: q8h
CrCl<10ml/min: q12-24h Oral
hydrochlorothiazide (HCTZ, HYDRODIURIL) 100 mg tablet No Dispense 2 x 50mg
Renal Dosing:
Usually ineffective in patients with CrCl < 30ml/min Oral
hydrochlorothiazide (HCTZ, HYDRODIURIL) 25 mg tablet Yes Renal Dosing:
Usually ineffective in patients with CrCl < 30ml/min Oral
hydrochlorothiazide (HCTZ, HYDRODIURIL) 50 mg tablet Yes Renal Dosing:
Usually ineffective in patients with CrCl < 30ml/min Oral
hydrochlorothiazide (HCTZ, HYDRODIURIL) 50 mg/5 ml oral liquid No Renal Dosing:
Usually ineffective in patients with CrCl < 30ml/min Oral
hydrochlorothiazide (HCTZ, MICROZIDE) 12.5 mg capsule Yes Renal Dosing:
Usually ineffective in patients with CrCl < 30ml/min Oral
hydrocodone - acetaminophen (ANEXIA) 7.5-650 mg tablet No Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (ANEXIA, LORCET-PLUS) 7.5-650 mg tablet No Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (LORCET) 10-650 mg tablet No Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (LORCET-HD) 5-500 mg capsule No Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (LORTAB) 10-500 mg tablet No Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (LORTAB) 2.5-167 mg/5 ml oral liquid Yes Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (LORTAB) 2.5-500 mg tablet No Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (LORTAB) 7.5-500 mg tablet No Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (LORTAB, VICODIN, ANEXSIA) 5-500 mg tablet No Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (MAXIDONE) 10-750 mg tablet No Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (NORCO) 10-325 mg tablet Yes Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (NORCO) 5-325 mg tablet Yes Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (NORCO) 7.5-325 mg tablet Yes Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (VICODIN ES) 7.5-750 mg tablet No Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (VICODIN HP, ANEXSIA) 10-660 mg tablet No Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (XODOL) 10-300 mg tablet No Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (XODOL) 5-300 mg tablet No Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (XODOL) 7.5-300 mg tablet No Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (ZYDONE) 10-400 mg tablet No Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (ZYDONE) 5-400 mg tablet No Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - acetaminophen (ZYDONE) 7.5-400 mg tablet No Renal Dosing:
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - ibuprofen (IBUDONE/REPREXAIN) 10-200 mg tablet Yes Renal Dosing:
Use with caution and monitor kidney function in patients with advanced kidney disease
Administer separately in patients with renal impairment
Hydrocodone
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - ibuprofen (REPREXAIN) 2.5-200 mg tablet Yes Renal Dosing:
Use with caution and monitor kidney function in patients with advanced kidney disease
Administer separately in patients with renal impairment
Hydrocodone
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - ibuprofen (REPREXAIN, IBUDONE) 5-200 mg tablet Yes Renal Dosing:
Use with caution and monitor kidney function in patients with advanced kidney disease
Administer separately in patients with renal impairment
Hydrocodone
CrCl < 10ml/min - dose q8-12h Oral
hydrocodone - ibuprofen (VICOPROFEN, IBUDONE) 7.5-200 mg tablet Yes Renal Dosing:
Use with caution and monitor kidney function in patients with advanced kidney disease
Administer separately in patients with renal impairment
Hydrocodone
CrCl < 10ml/min - dose q8-12h Oral
hydroxyurea (DROXIA, HYDREA) 200 mg capsule Yes Renal Dosing:
CrCl > 50ml/min: 20-30 mg/kg q24h
CrCl 10-50ml/min: 10-15 mg/kg q24h
CrCl < 10ml/min: 4-6 mg/kg q24h Oral
hydroxyurea (DROXIA, HYDREA) 400 mg capsule No Dispense 2 x 200mg
Renal Dosing:
CrCl > 50ml/min: 20-30 mg/kg q24h
CrCl 10-50ml/min: 10-15 mg/kg q24h
CrCl < 10ml/min: 4-6 mg/kg q24h Oral
hydroxyurea (DROXIA, HYDREA) 500 mg capsule Yes Renal Dosing:
CrCl > 50ml/min: 20-30 mg/kg q24h
CrCl 10-50ml/min: 10-15 mg/kg q24h
CrCl < 10ml/min: 4-6 mg/kg q24h Oral
ibandronate (BONIVA) 150 mg oral tablet (monthly) Yes Renal Dosing:
CrCl<30ml/min: Avoid Oral
ibandronate (BONIVA) 2.5 mg oral tablet Yes Renal Dosing:
CrCl<30ml/min: Avoid Oral
ibandronate (BONIVA) 3mg intravenous Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl<30ml/min: Avoid Intravenous
Ibutilide (CORVERT) 0.1 mg/ml injection Yes May be administered in: All Critical Care Areas, Cardiac DOU and Cardiac Telemetry Units Intravenous
imipenem-cilastatin (PRIMAXIN) 250 mg injection Yes Renal Dosing:
CrCl 50-80ml/min: 500mg q6-8h
CrCl 10-50ml/min: 500mg Q8-12h
CrCl<10ml/min: 250-500mg q12-24h Intravenous
imipenem-cilastatin (PRIMAXIN) 500 mg injection Yes Renal Dosing:
CrCl 50-80ml/min: 500mg q6-8h
CrCl 10-50ml/min: 500mg Q8-12h
CrCl<10ml/min: 250-500mg q12-24h Intravenous
imipramine (TOFRANIL) 10 mg tablet Yes Oral
imipramine (TOFRANIL) 25 mg tablet Yes Oral
imipramine (TOFRANIL) 50 mg tablet Yes Oral
imipramine ER (TOFRANIL PM) 100 mg capsule No Oral
imipramine ER (TOFRANIL PM) 125 mg capsule No Oral
imipramine ER (TOFRANIL PM) 150 mg capsule No Oral
imipramine ER (TOFRANIL PM) 75 mg capsule No Oral
imiquimod (ALDARA) 5% topical cream Yes Topical
immune globulin (IGG) (CARIMUNE) intravenous No May be administered in: Non Critical Care Areas and all Critical Care Areas Intravenous
immune globulin (IGG) (FLEBOGAMMA) 5% intrtavenous No May be administered in: Non Critical Care Areas and all Critical Care Areas Intravenous
immune globulin (IGG) (GAMMAGARD) injection No May be administered in: Non Critical Care Areas and all Critical Care Areas Intravenous
immune globulin (IGG) (GAMUNEX) 10% intravenous Yes May be administered in: Non Critical Care Areas and all Critical Care Areas Intravenous
immune globulin (IGG) (VENOGLOBULIN-S) 10% injection No May be administered in: Non Critical Care Areas and all Critical Care Areas LVP
immune globulin (IGG) intravenous Yes Dispense immune globulin (GAMUNEX) 10% intravenous
May be administered in: Non Critical Care Areas and all Critical Care Areas Intravenous
immune globulin IM (GaMaSTAN S/D) injection Yes Intramuscular
inamrinone (INOCOR) drip Yes Drips
incontenent wash (SENSICARE) topical cleanser Yes Topical
indapamide (LOZOL) 1.25 mg tablet No Dispense 1/2 x 2.5 mg
Renal Dosing:
Usually ineffective in patients with CrCl < 30ml/min Oral
indapamide (LOZOL) 2.5 mg tablet Yes Dispense 2 x 1.25mg
Renal Dosing:
Usually ineffective in patients with CrCl < 30ml/min Oral
insulin aspart & insulin aspart protamine (NOVOLOG MIX) 50-50 mix injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Renal metabolism of insulin decreased with increasing azothemia Subcutaneous
insulin aspart & insulin aspart protamine (NOVOLOG MIX) 70-30 mix injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Renal metabolism of insulin decreased with increasing azothemia Subcutaneous
insulin aspart (NOVOlog) injection No May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Renal metabolism of insulin decreased with increasing azothemia Subcutaneous
insulin detemir (LEVEMIR) injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Renal metabolism of insulin decreased with increasing azothemia Subcutaneous
insulin glargine (LANTUS) injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Renal metabolism of insulin decreased with increasing azothemia Subcutaneous
insulin glulisine (APIDRA) injection No May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Renal metabolism of insulin decreased with increasing azothemia Subcutaneous
insulin infusuion per pharmacy guideline Yes Per Pharmacy
insulin lispro & insulin lispro protamine (HUMAlog MIX 75/25) 75/25 mix injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Renal metabolism of insulin decreased with increasing azothemia Subcutaneous
insulin lispro (HUMAlog) injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Renal metabolism of insulin decreased with increasing azothemia Subcutaneous
insulin NPH (NOVOLIN N/HUMULIN N) injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Renal metabolism of insulin decreased with increasing azothemia Subcutaneous
insulin NPH / Reg Human (HUMULIN 50/50) 50/50 injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Renal metabolism of insulin decreased with increasing azothemia Subcutaneous
insulin NPH / Reg Human (NOVOLIN 70/30, HUMULIN 70/30) 70/30 injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Renal metabolism of insulin decreased with increasing azothemia Subcutaneous
insulin R drip Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Renal metabolism of insulin decreased with increasing azothemia Drips
insulin, reg human (HUMULIN R/NOVOLIN R) injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Renal metabolism of insulin decreased with increasing azothemia Injection
irbesartan - hydrochlorothiazide (AVALIDE) 150-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
irbesartan - hydrochlorothiazide (AVALIDE) 300-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
irbesartan - hydrochlorothiazide (AVALIDE) 300-25 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
isoniazid (NYDRAZID) 100 mg tablet Yes Renal Dosing:
CrCl<10ml/min: decrease dose by 50% Oral
isoniazid (NYDRAZID) 300 mg tablet Yes Renal Dosing:
CrCl<10ml/min: decrease dose by 50% Oral
isoniazid (NYDRAZID) 50 mg/ml oral liquid No Renal Dosing:
CrCl<10ml/min: decrease dose by 50% Oral
ketorolac (TORADOL) 15 mg/ml injection Yes There is an automatic 72-hour stop order for ketorolac IV or IM. Continued therapy requires a physician order to continue for up to an additional 48 hours.
May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Do Injection
ketorolac (TORADOL) 30 mg/ml injection Yes There is an automatic 72-hour stop order for ketorolac IV or IM. Continued therapy requires a physician order to continue for up to an additional 48 hours.
May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Do Injection
ketorolac (TORADOL) 60 mg/2 ml injection Yes May be administer IM only for one time dosing
May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Dosage adjustment based upon patient's age, weight, and creatinine clearance (CrCl).
One-time IM dose
< 50 Intramuscular
lamivudine - zidovudine (COMBIVIR) 150-300 mg tablet No Renal Dosing:
Use separate ingredients:
Lamivudine
CrCl 30-49ml/min: 150mg daily
CrCl 15-29ml/min: 150mg x1, then 100mg daily
CrCl 5-14ml/min: 150mg x 1, then 50mg daily
CrCl<5ml/min: 50mg x 1, then 25mg daily
Zidovudine
Oral
lamivudine (EPIVIR, EPIVIR HBV) 10 mg/ml oral liquid No Renal Dosing:
For HIV Infection For Chronic Hepatitis B
CrCl 30-49ml/min: 150mg daily 100mg x 1, then 50mg daily
CrCl 15-29ml/min: 150mg x1, then 100mg daily 100mg x 1, then 25mg daily
CrCl 5-14ml/min: 150mg Oral
lamivudine (EVIVIR, EPIVIR HBV) 100 mg tablet Yes Renal Dosing:
For HIV Infection For Chronic Hepatitis B
CrCl 30-49ml/min: 150mg daily 100mg x 1, then 50mg daily
CrCl 15-29ml/min: 150mg x1, then 100mg daily 100mg x 1, then 25mg daily
CrCl 5-14ml/min: 150mg Oral
lamivudine (EVIVIR, EPIVIR HBV) 150 mg tablet Yes Renal Dosing:
For HIV Infection For Chronic Hepatitis B
CrCl 30-49ml/min: 150mg daily 100mg x 1, then 50mg daily
CrCl 15-29ml/min: 150mg x1, then 100mg daily 100mg x 1, then 25mg daily
CrCl 5-14ml/min: 150mg Oral
lamivudine (EVIVIR, EPIVIR HBV) 300 mg tablet No Dispense 2 x 150mg
Renal Dosing:
For HIV Infection For Chronic Hepatitis B
CrCl 30-49ml/min: 150mg daily 100mg x 1, then 50mg daily
CrCl 15-29ml/min: 150mg x1, then 100mg daily 100mg x 1, then 25mg daily
CrCl Oral
lepirudin (REFLUDAN) drip Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Initial dose: CrCl<60ml/min: decrease to 0.2mg/kg
Infusion dose: CrCl 45-60ml/min: give 50% of usual dose
CrCl 30-44ml/min: give 30% of Drips
lepirudin (REFLUDAN) injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Initial dose: CrCl<60ml/min: decrease to 0.2mg/kg
Infusion dose: CrCl 45-60ml/min: give 50% of usual dose
CrCl 30-44ml/min: give 30% of Intravenous
letrozole (FEMARA) 2.5 mg tablet Yes Oral
leucovorin (WELLCOVORIN) 10 mg tablet No Dispense 2 x 5mg Oral
leucovorin (WELLCOVORIN) 25 mg tablet Yes Oral
leucovorin (WELLCOVORIN) 5 mg tablet Yes Oral
levetiracetam (KEPPRA) 100 mg/ml oral liquid No Renal Dosing:
CrCl 50-80ml/min: 500-1000mg q12h
CrCl 30-50ml/min: 250-750mg q12h
CrCl<30ml/min: 250-500mg q 24h
Dialysis patients: 500-1000mg q24h Oral
levetiracetam (KEPPRA) 1000 mg tablet No Dispense 2 x 500mg
Renal Dosing:
CrCl 50-80ml/min: 500-1000mg q12h
CrCl 30-50ml/min: 250-750mg q12h
CrCl<30ml/min: 250-500mg q 24h
Dialysis patients: 500-1000mg q24h Oral
levetiracetam (KEPPRA) 250 mg tablet No Dispense 1/2 of 500mg
Renal Dosing:
CrCl 50-80ml/min: 500-1000mg q12h
CrCl 30-50ml/min: 250-750mg q12h
CrCl<30ml/min: 250-500mg q 24h
Dialysis patients: 500-1000mg q24h Oral
levetiracetam (KEPPRA) 500 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: 500-1000mg q12h
CrCl 30-50ml/min: 250-750mg q12h
CrCl<30ml/min: 250-500mg q 24h
Dialysis patients: 500-1000mg q24h Oral
levetiracetam (KEPPRA) 750 mg tablet No Dispense 1.5 x 500mg
Renal Dosing:
CrCl 50-80ml/min: 500-1000mg q12h
CrCl 30-50ml/min: 250-750mg q12h
CrCl<30ml/min: 250-500mg q 24h
Dialysis patients: 500-1000mg q24h Oral
levetiracetam (KEPPRA) injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl 50-80ml/min: 500-1000mg q12h
CrCl 30-50ml/min: 250-750mg q12h
CrCl<30ml/min: 250-500mg q 24h
Dialysis patients: 500-1000mg q24h IVPB
levetiracetam ER (KEPPRA XR) 500 mg tablet No Renal Dosing:
CrCl 50-80ml/min: 1000 - 2000mg q24h
CrCl 30-50ml/min: 500-1500mg q24h
CrCl<30ml/min: 500-1000mg q 24h Oral
levetiracetam ER (KEPPRA XR) 750 mg tablet No Renal Dosing:
CrCl 50-80ml/min: 1000 - 2000mg q24h
CrCl 30-50ml/min: 500-1500mg q24h
CrCl<30ml/min: 500-1000mg q 24h Oral
levocetirizine (XYZAL) 0.5mg/ml oral liquid No Renal Dosing:
CrCl 50-80ml/min: 2.5mg daily
CrCl 30-50ml/min: 2.5mg every other day
CrCl 10-30ml/min: 2.5mg twice a week
CrCl<10ml/min: Avoid Oral
levocetirizine (XYZAL) 5 mg tablet No Renal Dosing:
CrCl 50-80ml/min: 2.5mg daily
CrCl 30-50ml/min: 2.5mg every other day
CrCl 10-30ml/min: 2.5mg twice a week
CrCl<10ml/min: Avoid Oral
levofloxacin (LEVAQUIN) 250 mg in 50ml D5W injection Yes Renal Dosing:
If dosage in normal renal fuction is:
750mg q24h
CrCl 20-49ml/min: 750mg q48h
CrC 10-19ml/min: 750mg x 1, then 500mg q48h
HD pt: 750mg x 1, then 500mg q48h
500mg q24h
CrCl 20-49ml/min: 500mg x 1, then 250mg q2 Intravenous
levofloxacin (LEVAQUIN) 250 mg tablet Yes Renal Dosing:
If dosage in normal renal fuction is:
750mg q24h
CrCl 20-49ml/min: 750mg q48h
CrC 10-19ml/min: 750mg x 1, then 500mg q48h
HD pt: 750mg x 1, then 500mg q48h
500mg q24h
CrCl 20-49ml/min: 500mg x 1, then 250mg q2 Oral
levofloxacin (LEVAQUIN) 250 mg/10 ml oral liquid No Renal Dosing:
If dosage in normal renal fuction is:
750mg q24h
CrCl 20-49ml/min: 750mg q48h
CrC 10-19ml/min: 750mg x 1, then 500mg q48h
HD pt: 750mg x 1, then 500mg q48h
500mg q24h
CrCl 20-49ml/min: 500mg x 1, then 250mg q2 Oral
levofloxacin (LEVAQUIN) 500 mg in 100ml D5W injection Yes Renal Dosing:
If dosage in normal renal fuction is:
750mg q24h
CrCl 20-49ml/min: 750mg q48h
CrC 10-19ml/min: 750mg x 1, then 500mg q48h
HD pt: 750mg x 1, then 500mg q48h
500mg q24h
CrCl 20-49ml/min: 500mg x 1, then 250mg q2 Intravenous
levofloxacin (LEVAQUIN) 500 mg tablet Yes Renal Dosing:
If dosage in normal renal fuction is:
750mg q24h
CrCl 20-49ml/min: 750mg q48h
CrC 10-19ml/min: 750mg x 1, then 500mg q48h
HD pt: 750mg x 1, then 500mg q48h
500mg q24h
CrCl 20-49ml/min: 500mg x 1, then 250mg q2 Oral
levofloxacin (LEVAQUIN) 750 mg in 150nl D5W injection Yes Renal Dosing:
If dosage in normal renal fuction is:
750mg q24h
CrCl 20-49ml/min: 750mg q48h
CrC 10-19ml/min: 750mg x 1, then 500mg q48h
HD pt: 750mg x 1, then 500mg q48h
500mg q24h
CrCl 20-49ml/min: 500mg x 1, then 250mg q2 Intravenous
levofloxacin (LEVAQUIN) 750 mg tablet No Renal Dosing:
If dosage in normal renal fuction is:
750mg q24h
CrCl 20-49ml/min: 750mg q48h
CrC 10-19ml/min: 750mg x 1, then 500mg q48h
HD pt: 750mg x 1, then 500mg q48h
500mg q24h
CrCl 20-49ml/min: 500mg x 1, then 250mg q2 Oral
lisinopril - hydrochlorothiazide (ZESTORETIC) 10-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Lisinopril
CrCl 10-50ml/min: initial dose should be 2.5-7.5mg
CrCl<10ml/min: initial dose should be 1.25-2.5mg
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
lisinopril - hydrochlorothiazide (ZESTORETIC) 20-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Lisinopril
CrCl 10-50ml/min: initial dose should be 2.5-7.5mg
CrCl<10ml/min: initial dose should be 1.25-2.5mg
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
lisinopril - hydrochlorothiazide (ZESTORETIC) 20-25 mg tablet No Dispense individual ingredients
Renal Dosing:
Lisinopril
CrCl 10-50ml/min: initial dose should be 2.5-7.5mg
CrCl<10ml/min: initial dose should be 1.25-2.5mg
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
lisinopril (ZESTRIL, PRINIVIL) 10 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: initial dose should be 2.5-7.5mg
CrCl<10ml/min: initial dose should be 1.25-2.5mg Oral
lisinopril (ZESTRIL, PRINIVIL) 2.5 mg tablet No Dispense 1/2 of 5mg
Renal Dosing:
CrCl 10-50ml/min: initial dose should be 2.5-7.5mg
CrCl<10ml/min: initial dose should be 1.25-2.5mg Oral
lisinopril (ZESTRIL, PRINIVIL) 20 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: initial dose should be 2.5-7.5mg
CrCl<10ml/min: initial dose should be 1.25-2.5mg Oral
lisinopril (ZESTRIL, PRINIVIL) 30 mg tablet No Dispense 1 x 20mg + 1 x 30mg
Renal Dosing:
CrCl 10-50ml/min: initial dose should be 2.5-7.5mg
CrCl<10ml/min: initial dose should be 1.25-2.5mg Oral
lisinopril (ZESTRIL, PRINIVIL) 40 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: initial dose should be 2.5-7.5mg
CrCl<10ml/min: initial dose should be 1.25-2.5mg Oral
lisinopril (ZESTRIL, PRINIVIL) 5 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: initial dose should be 2.5-7.5mg
CrCl<10ml/min: initial dose should be 1.25-2.5mg Oral
lithium carbonate (ESKALITH) 150 mg capsule Yes Renal Dosing:
CrCl 10-50ml/min: decrease normal dose by 25-50%
CrCl<10ml/min: decrease normal dose by 50-75% Oral
lithium carbonate (ESKALITH) 300 mg capsule Yes Renal Dosing:
CrCl 10-50ml/min: decrease normal dose by 25-50%
CrCl<10ml/min: decrease normal dose by 50-75% Oral
lithium carbonate (ESKALITH) 600 mg capsule No Dispense 2 x 300mg
Renal Dosing:
CrCl 10-50ml/min: decrease normal dose by 25-50%
CrCl<10ml/min: decrease normal dose by 50-75% Oral
lithium carbonate (LITHOTABS) 300 mg tablet No Renal Dosing:
CrCl 10-50ml/min: decrease normal dose by 25-50%
CrCl<10ml/min: decrease normal dose by 50-75% Oral
lithium carbonate 300mg/5ml oral liquid Yes Renal Dosing:
CrCl 10-50ml/min: decrease normal dose by 25-50%
CrCl<10ml/min: decrease normal dose by 50-75% Oral
lithium carbonate ER (ESKALITH CR, LITHOBID) 300 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: decrease normal dose by 25-50%
CrCl<10ml/min: decrease normal dose by 50-75% Oral
lithium carbonate ER (ESKALITH CR, LITHOBID) 450 mg tablet No Dispense 1.5 x 300mg
Renal Dosing:
CrCl 10-50ml/min: decrease normal dose by 25-50%
CrCl<10ml/min: decrease normal dose by 50-75% Oral
lithium citrate 8 mEq/5ml oral liquid Yes Renal Dosing:
CrCl 10-50ml/min: decrease normal dose by 25-50%
CrCl<10ml/min: decrease normal dose by 50-75% Oral
l-methylfolate - vitamin B6 - vitamine B12 (MENTAX) 2.8-2-25 mg tablet No Oral
l-methylfolate (DEPLIN) 7.5 mg tablet No Not routinely stocked - Order PRN Oral
lodoxamide (ALOMIDE) 0.1% ophthalmic solution No Ophthalmic
lomefloxacin (MAXAQUIN) 400 mg tablet No Withdrawn from the Market (April 2009)
Renal Dosing:
CrCl<40ml/min: 400mg, then 200mg q24h Oral
loratadine - pseudoephedrine SR (CLARITIN D 24 HR) 10-240 mg tablet Yes Renal Dosing:
CrCl<30ml/min:10/240mg every other day Oral
loratadine - pseudoephedrine SR (CLARITIN D 12 HR) 5-120 mg tablet No Renal Dosing:
CrCl<30ml/min:10/240mg every other day Oral
loratadine (CLARITIN REDITAB) 5 mg disintegrating tablet No Renal Dosing:
CrCl<30ml/min: 10mg every other day Oral
loratadine (CLARITIN REDITAB, ALAVERT) 10 mg disintegrating tablet No Renal Dosing:
CrCl<30ml/min: 10mg every other day Oral
loratadine (CLARITIN) 5 mg/5 ml oral liquid No Renal Dosing:
CrCl<30ml/min: 10mg every other day Oral
loratadine (CLARITIN, ALAVERT) 10 mg tablet Yes Renal Dosing:
CrCl<30ml/min: 10mg every other day Oral
losartan - hydrochlorothiazide (HYZAAR) 100-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
losartan - hydrochlorothiazide (HYZAAR) 100-25 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
losartan - hydrochlorothiazide (HYZAAR) 50-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
magnesium chloride SR (SLO-MAG, MAG DELAY) tablet Yes Renal Dosing:
Administer with caution to patients with renal impairment Oral
magnesium citrate (CITRATE OF MAGNESIA) oral liquid Yes Oral
magnesium ER (MAG-TAB) 84 mg tablet No Renal Dosing:
Administer with caution to patients with renal impairment Oral
magnesium gluconate (MAGONATE) 1000 mg/5 ml oral liquid No Renal Dosing:
Administer with caution to patients with renal impairment Oral
magnesium gluconate (MAGONATE) 500 mg tablet No Renal Dosing:
Administer with caution to patients with renal impairment Oral
magnesium gluconate 30 mg tablet No Renal Dosing:
Administer with caution to patients with renal impairment Oral
magnesium hydroxide - calcium carbonate (MYLANTA) 150-350mg tablet No Oral
magnesium hydroxide - calcium carbonate (ROLAID) 110-550mg tablet No Oral
magnesium hydroxide (MILK OF MAGNESIA) 800 mg/5 ml oral liquid Yes Oral
magnesium hydroxide in mineral oil (HALEY'S MO) oral liquid No Oral
magnesium oxide (MAG-OX) 250 mg tablet No Renal Dosing:
Administer with caution to patients with renal impairment Oral
magnesium oxide (MAG-OX) 400 mg tablet Yes Renal Dosing:
Administer with caution to patients with renal impairment Oral
magnesium oxide (URO-MAG) 140 mg tablet No Renal Dosing:
Administer with caution to patients with renal impairment Oral
magnesium salicylate (MAGAN) 545 mg tablet Yes Renal Dosing:
Administer with caution to patients with renal impairment Oral
magnesium sulfate (EPSOM SALTS) topical solution Yes Miscell. (Med.Supl.;Non-Drugs)
magnesium sulfate 1gm in 50ml D5W injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Administer with caution to patients with renal impairment Intravenous
magnesium sulfate 20gm in 250ml D5W injection Yes May be administered in: OB Areas only
Renal Dosing:
Administer with caution to patients with renal impairment Intravenous
magnesium sulfate 2gm in 50ml D5W injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Administer with caution to patients with renal impairment Intravenous
magnesium sulfate 4gm in 100ml D5W injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
Administer with caution to patients with renal impairment Intravenous
mefenamic (PONSTEL) 250 mg capsule Yes Renal Dosing:
Avoid in patients with renal impairment Oral
meloxicam (MOBIC) 15 mg tablet No Dispense 2 x 7.5mg
Renal Dosing:
CrCl<20ml/min: reduce dose to 7.5mg daily Oral
meloxicam (MOBIC) 7.5 mg tablet Yes Renal Dosing:
CrCl<20ml/min: reduce dose to 7.5mg daily Oral
meloxicam (MOBIC) 7.5 mg/5ml oral suspension No Renal Dosing:
CrCl<20ml/min: reduce dose to 7.5mg daily Oral
melphalan (ALKERAN) 2 mg tablet Yes Renal Dosing:
Consider decreasing dose by 50% in patients with creatinine >1.5mg/dl Oral
melphalan (ALKERAN) chemo-infusion Yes Renal Dosing:
Consider decreasing dose by 50% in patients with creatinine >1.5mg/dl Chemo
memantine (NAMENDA) 10 mg tablet No Dispense 2 x 5mg
Renal Dosing:
CrCl 5-29ml/min: reduce dose to 5mg bid Oral
memantine (NAMENDA) 2mg/ml oral liquid No Renal Dosing:
CrCl 5-29ml/min: reduce dose to 5mg bid Oral
memantine (NAMENDA) 5 mg tablet Yes Renal Dosing:
CrCl 5-29ml/min: reduce dose to 5mg bid Oral
meperidine (DEMEROL) 100 mg injection syringe Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl 10-50ml/min: decrease normal dose by 25%
CrCl<10ml/min: decrease normal dose by 50%
Normeperidine, an active metabolite, accumulates in ESRD an Injection
meperidine (DEMEROL) 100 mg tablet No Dispense 2 x 50mg
Renal Dosing:
CrCl 10-50ml/min: decrease normal dose by 25%
CrCl<10ml/min: decrease normal dose by 50%
Normeperidine, an active metabolite, accumulates in ESRD and may cause seizures Oral
meperidine (DEMEROL) 10mg/ml oral liquid No Renal Dosing:
CrCl 10-50ml/min: decrease normal dose by 25%
CrCl<10ml/min: decrease normal dose by 50%
Normeperidine, an active metabolite, accumulates in ESRD and may cause seizures Oral
meperidine (DEMEROL) 25 mg injection syringe Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl 10-50ml/min: decrease normal dose by 25%
CrCl<10ml/min: decrease normal dose by 50%
Normeperidine, an active metabolite, accumulates in ESRD an Injection
meperidine (DEMEROL) 50 mg injection syringe Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl 10-50ml/min: decrease normal dose by 25%
CrCl<10ml/min: decrease normal dose by 50%
Normeperidine, an active metabolite, accumulates in ESRD an Injection
meperidine (DEMEROL) 50 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: decrease normal dose by 25%
CrCl<10ml/min: decrease normal dose by 50%
Normeperidine, an active metabolite, accumulates in ESRD and may cause seizures Oral
meperidine (DEMEROL) 75 mg injection syringe Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl 10-50ml/min: decrease normal dose by 25%
CrCl<10ml/min: decrease normal dose by 50%
Normeperidine, an active metabolite, accumulates in ESRD an Injection
meprobamate (EQUANIL, MILTOWN) 200 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: give q8-12h
CrCl<10ml/min: give q12-18h Oral
meprobamate (EQUANIL, MILTOWN) 400 mg tablet No Dispense 2 x 200mg
Renal Dosing:
CrCl 10-50ml/min: give q8-12h
CrCl<10ml/min: give q12-18h Oral
mercaptopurine (PURINETHOL, 6-MP) 50 mg tablet Yes Oral
meropenem (MERREM) 1 g injection Yes Renal Dosing:
CrCl 50-80ml/min: 1-2gm q8h
CrCl 10-50ml/min: 0.5-1gm q12h
CrCl<10ml/min: 0.5-1gm q24h Intravenous
meropenem (MERREM) 500 mg injection Yes Renal Dosing:
CrCl 50-80ml/min: 1-2gm q8h
CrCl 10-50ml/min: 0.5-1gm q12h
CrCl<10ml/min: 0.5-1gm q24h Intravenous
metformin (GLUCOPHAGE) 1000 mg tablet Yes Renal Dosing:
Avoid in patients with creatinine>1.5mg/dl (males) or creatinine>1.4mg/dl (females) due to risk of lactic acidosis Oral
metformin (GLUCOPHAGE) 100mg/ml oral liquid No Renal Dosing:
Avoid in patients with creatinine>1.5mg/dl (males) or creatinine>1.4mg/dl (females) due to risk of lactic acidosis Oral
metformin (GLUCOPHAGE) 500 mg tablet Yes Renal Dosing:
Avoid in patients with creatinine>1.5mg/dl (males) or creatinine>1.4mg/dl (females) due to risk of lactic acidosis Oral
metformin (GLUCOPHAGE) 850 mg tablet Yes Renal Dosing:
Avoid in patients with creatinine>1.5mg/dl (males) or creatinine>1.4mg/dl (females) due to risk of lactic acidosis Oral
metformin ER (GLUCOPHAGE XR, FORTAMET) 500 mg tablet Yes Renal Dosing:
Avoid in patients with creatinine>1.5mg/dl (males) or creatinine>1.4mg/dl (females) due to risk of lactic acidosis Oral
metformin ER (GLUCOPHAGE XR, FORTAMET) 750 mg tablet No Dispense 1.5 x 500mg
Renal Dosing:
Avoid in patients with creatinine>1.5mg/dl (males) or creatinine>1.4mg/dl (females) due to risk of lactic acidosis Oral
metformin ER (GLUCOPHAGE XR, FORTAMET, GLUMETZA) 1000 mg tablet No Dispense 2 x 500mg
Renal Dosing:
Avoid in patients with creatinine>1.5mg/dl (males) or creatinine>1.4mg/dl (females) due to risk of lactic acidosis Oral
methadone (DOLOPHINE) 10 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: q6h
CrCl 10-50ml/min: q8h
CrCl<10ml/min: q8-12h Oral
methadone (DOLOPHINE) 10 mg/ml injection Yes Renal Dosing:
CrCl 50-80ml/min: q6h
CrCl 10-50ml/min: q8h
CrCl<10ml/min: q8-12h Injection
methadone (DOLOPHINE) 5 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: q6h
CrCl 10-50ml/min: q8h
CrCl<10ml/min: q8-12h Oral
methadone (DOLOPHINE) 5 mg/5 ml oral liquid No Renal Dosing:
CrCl 50-80ml/min: q6h
CrCl 10-50ml/min: q8h
CrCl<10ml/min: q8-12h Oral
methenamine compound (DARPAZ) tablet No Renal Dosing:
CrCl <50ml/min: Avoid Oral
methenamine compound (URIMAR-T) tablet No Renal Dosing:
CrCl <50ml/min: Avoid Oral
methenamine compound (URIMAX) tablet No Renal Dosing:
CrCl <50ml/min: Avoid Oral
methenamine compound (URISED) tablet No Renal Dosing:
CrCl <50ml/min: Avoid Oral
methenamine compound (UROGESIC BLUE) tablet No Renal Dosing:
CrCl <50ml/min: Avoid Oral
methenamine compound (UROQUID # 2) tablet No Renal Dosing:
CrCl <50ml/min: Avoid Oral
methenamine compound (UTICAP) capsule No Renal Dosing:
CrCl <50ml/min: Avoid Oral
methenamine compound (UTRONA-C) tablet No Renal Dosing:
CrCl <50ml/min: Avoid Oral
methenamine hippurate (UREX,HIPREX) 1 g tablet No Renal Dosing:
CrCl <50ml/min: Avoid Oral
methenamine mandelate (MANDELAMINE) 1 g tablet No Withdrawn from the Market (April 2009)
Renal Dosing:
CrCl <50ml/min: Avoid Oral
methocarbamol (ROBAXIN) 100 mg/ml injection No Renal Dosing:
Avoid in patients with renal dysfunction due to the presence of propylene glycol in the vehicle Injection
methocarbamol (ROBAXIN) 500 mg tablet Yes Oral
methocarbamol (ROBAXIN) 750 mg tablet No Dispense 1.5 x 500mg Oral
methotrexate (TREXALL) 2.5 mg chemo tablet Yes Renal Dosing:
CrCl<10ml/min: decrease normal dose by 50% Oral
methotrexate (TREXALL) chemotherapy intrathecal injection Yes Chemo
methotrexate high dose (MTX) chemo infusion (LBM) Yes Renal Dosing:
CrCl<10ml/min: decrease normal dose by 50% Chemo
methotrexate(MTX) chemo infusion (LBM) Yes Renal Dosing:
CrCl<10ml/min: decrease normal dose by 50% Chemo
methyldopa (ALDOMET) 250 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: q8h
CrCl 10-50ml/min: q8-12h
CrCl<10ml/min: q12-24h Oral
methyldopa (ALDOMET) 500 mg tablet No Dispense 2 x 250mg
Renal Dosing:
CrCl 50-80ml/min: q8h
CrCl 10-50ml/min: q8-12h
CrCl<10ml/min: q12-24h Oral
methyldopa-hydrochlorothiazide (ALDORIL-15) 250-15 mg tablet No Withdrawn from the Market (March 2008)
Renal Dosing:
Methyldopa
CrCl 50-80ml/min: q8h
CrCl 10-50ml/min: q8-12h
CrCl<10ml/min: q12-24h
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
methyldopa-hydrochlorothiazide (ALDORIL-25) 250-25 mg tablet No Withdrawn from the Market (March 2008)
Renal Dosing:
Methyldopa
CrCl 50-80ml/min: q8h
CrCl 10-50ml/min: q8-12h
CrCl<10ml/min: q12-24h
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
methyldopa-hydrochlorothiazide (ALDORIL-50) 500-50 mg tablet No Withdrawn from the Market (March 2008)
Renal Dosing:
Methyldopa
CrCl 50-80ml/min: q8h
CrCl 10-50ml/min: q8-12h
CrCl<10ml/min: q12-24h
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
methyldopate (ALDOMET) IVPB Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl 50-80ml/min: q8h
CrCl 10-50ml/min: q8-12h
CrCl<10ml/min: q12-24h IVPB
metoclopramide (METOZOLV) 10 mg disintegrating tablet No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
metoclopramide (METOZOLV) 5 mg disintegrating tablet No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
metoclopramide (REGLAN) 10 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
metoclopramide (REGLAN) 5 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
metoclopramide (REGLAN) 5 mg/5 ml oral liquid No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
metoclopramide (REGLAN) 5 mg/ml injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Injection
metoprolol-hydrochlorothiazide (LOPRESSOR HCT) 100-25 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
metoprolol-hydrochlorothiazide (LOPRESSOR HCT) 100-50 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
metoprolol-hydrochlorothiazide (LOPRESSOR HCT) 50-25 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
metronidazole (FLAGYL) 1gm in 1000mls sterile water topical irrigation solution Yes Topical Irrigation
metronidazole (FLAGYL) 250 mg in 50ml NS injection Yes Renal Dosing:
CrCl<10ml/min: 500mg q12h intravenous
metronidazole (FLAGYL) 250 mg tablet Yes Renal Dosing:
CrCl<10ml/min: 500mg q12h Oral
metronidazole (FLAGYL) 500 mg in 100ml NS injection Yes Renal Dosing:
CrCl<10ml/min: 500mg q12h Intravenous
metronidazole (FLAGYL) 500 mg tablet Yes Renal Dosing:
CrCl<10ml/min: 500mg q12h Oral
metronidazole (FLAGYL) 500mg/10mg oral liquid No Renal Dosing:
CrCl<10ml/min: 500mg q12h Oral
metronidazole ER (FLAGYL ER) 375 mg tablet No Renal Dosing:
Recommend using immediate-release product in patients with ESRD as follows:
CrCl<10ml/min: 500mg q12h Oral
metronidazole ER (FLAGYL ER) 750 mg tablet No Renal Dosing:
Recommend using immediate-release product in patients with ESRD as follows:
CrCl<10ml/min: 500mg q12h Oral
midazolam (VERSED) 1 mg/ml injection Yes May be administered in: All Critical Care Areas and DOU (limited use)
Renal Dose:
CrCl<10ml/min: decrease usual dose by 50% Injection
midazolam (VERSED) 5 mg/ml injection Yes May be administered in: All Critical Care Areas and DOU (limited use)
Renal Dose:
CrCl<10ml/min: decrease usual dose by 50% Injection
midazolam (VERSED) drip Yes May be administered in: All Critical Care Areas and DOU (limited use)
Renal Dose:
CrCl<10ml/min: decrease usual dose by 50% Drips
moexipril - hydrochlorothiazide (UNIRETIC) 15-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Moexipril
CrCl<40ml/min/1.73 m(2):
initial dose 3.75mg daily,
usual dose 3.75-15mg daily
maximum dose 15mg daily
Hydrochlorothiazide
Oral
moexipril - hydrochlorothiazide (UNIRETIC) 15-25 mg tablet No Dispense individual ingredients
Renal Dosing:
Moexipril
CrCl<40ml/min/1.73 m(2):
initial dose 3.75mg daily,
usual dose 3.75-15mg daily
maximum dose 15mg daily
Hydrochlorothiazide
Oral
moexipril - hydrochlorothiazide (UNIRETIC) 7.5-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Moexipril
CrCl<40ml/min/1.73 m(2):
initial dose 3.75mg daily,
usual dose 3.75-15mg daily
maximum dose 15mg daily
Hydrochlorothiazide
Oral
moexipril (UNIVASC) 15 mg tablet Yes Renal Dosing:
CrCl<40ml/min/1.73 m(2):
initial dose 3.75mg daily,
usual dose 3.75-15mg daily
maximum dose 15mg daily Oral
moexipril (UNIVASC) 7.5 mg tablet No Dispense 1/2 of 15mg
Renal Dosing:
CrCl<40ml/min/1.73 m(2):
initial dose 3.75mg daily,
usual dose 3.75-15mg daily
maximum dose 15mg daily Oral
morphine – naltrexone ER (EMBEDA) 100-4 mg oral capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine – naltrexone ER (EMBEDA) 20-0.8 mg oral capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine – naltrexone ER (EMBEDA) 30-1.3 mg oral capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine – naltrexone ER (EMBEDA) 50-2 mg oral capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine – naltrexone ER (EMBEDA) 60-2.4 mg oral capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine – naltrexone ER (EMBEDA) 80-3.2 mg oral capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine (MSIR) 10 mg/5 ml oral liquid Yes Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine (MSIR) 30 mg soluble tablet No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine 1 mg/ml in NS 250ml PCA Yes Drips
morphine 10 mg/ml injection syringe Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Injection
morphine 15 mg tablet no Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine 15 mg/ml injection syringe Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Injection
morphine 2 mg injection syringe Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Injection
morphine 30 mg tablet No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine 4 mg/ml injection syringe Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Injection
morphine 8 mg/ml injection syringe Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Injection
morphine concentrate (ROXANOL) 20 mg/ml oral liquid Yes Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine CR (MS CONTIN) 100 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine drip Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Drips
morphine epidural Yes May be administered in: Non Critical Care Areas and all Critical Care Areas Drips
morphine ER (AVINZA) 120 mg capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine ER (AVINZA) 30 mg capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine ER (AVINZA) 45 mg capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine ER (AVINZA) 60 mg capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine ER (AVINZA) 75 mg capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine ER (AVINZA) 90 mg capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine ER (KADIAN) 100 mg capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine ER (KADIAN) 20 mg capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine ER (KADIAN) 200 mg capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine ER (KADIAN) 30 mg capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine ER (KADIAN) 50 mg capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine ER (KADIAN) 60 mg capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine ER (KADIAN) 80 mg capsule No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine ER (MS CONTIN) 15 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine ER (MS CONTIN) 30 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
morphine ER (MS CONTIN) 90 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
nabumetone (RELAFEN) 500 mg tablet Yes Renal Dosing:
CrCl 30-49ml/min: maximum starting dose should be 750mg daily
CrCl<30ml/min: maximum starting dose should be 500mg daily Oral
nabumetone (RELAFEN) 750 mg tablet No Dispense 1.5 of 500mg
Renal Dosing:
CrCl 30-49ml/min: maximum starting dose should be 750mg daily
CrCl<30ml/min: maximum starting dose should be 500mg daily Oral
nadolol (CORGARD) 120 mg tablet No Dispense 1 x 40mg + 1 x 80mg
Renal Dosing:
CrCl 31-50ml/min: q24-36h
CrCl 10-31ml/min: q24-48h
CrCl<10ml/min: q40-60h Oral
nadolol (CORGARD) 160 mg tablet No Dispense 2 x 80mg
Renal Dosing:
CrCl 31-50ml/min: q24-36h
CrCl 10-31ml/min: q24-48h
CrCl<10ml/min: q40-60h Oral
nadolol (CORGARD) 20 mg tablet No Dispense 1/2 x 40mg
Renal Dosing:
CrCl 31-50ml/min: q24-36h
CrCl 10-31ml/min: q24-48h
CrCl<10ml/min: q40-60h Oral
nadolol (CORGARD) 40mg tablet Yes Renal Dosing:
CrCl 31-50ml/min: q24-36h
CrCl 10-31ml/min: q24-48h
CrCl<10ml/min: q40-60h Oral
nadolol (CORGARD) 80 mg tablet Yes Renal Dosing:
CrCl 31-50ml/min: q24-36h
CrCl 10-31ml/min: q24-48h
CrCl<10ml/min: q40-60h Oral
naratriptan (AMERGE) 1 mg tablet No Renal Dosing:
CrCl 15-50ml/min: initial dose 1mg, maximum dose 2.5mg/24hours
CrCl<15ml/min: Contraindicated Oral
naratriptan (AMERGE) 2.5 mg tablet No Renal Dosing:
CrCl 15-50ml/min: initial dose 1mg, maximum dose 2.5mg/24hours
CrCl<15ml/min: Contraindicated Oral
neomycin (MYCIFRADIN) 25mg/ml oral liquid No Renal Dosing:
CrCl 50-80ml/min: q6h
CrCl 10-50ml/min: q12-18h
CrCl<10ml/min: q18-24h Oral
neomycin (MYCIGUENT) 0.5% topical ointment Yes Topical
neomycin 500mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: q6h
CrCl 10-50ml/min: q12-18h
CrCl<10ml/min: q18-24h Oral
nitrofurantoin macrocrystal (MACRODANTIN) 100 mg capsule No Renal Dosing:
CrCl<50ml/min: Avoid Oral
nitrofurantoin macrocrystal (MACRODANTIN) 25 mg capsule No Renal Dosing:
CrCl<50ml/min: Avoid Oral
nitrofurantoin macrocrystal (MACRODANTIN) 50 mg capsule No Renal Dosing:
CrCl<50ml/min: Avoid Oral
nitrofurantoin monohydrate - macrocrystal (MACROBID) 100 mg capsule Yes Renal Dosing:
CrCl<50ml/min: Avoid Oral
nitroprusside (NIPRIDE) drip Yes May be administered in: Critical Care Areas Only
Renal Dosing:
CrCl <10ml/min: Avoid
Thiocyanate, a toxi metabolite, accumulates causing seizures, coma
Thiocyanate is hemodialyzable - measure thiocyanate levels Drips
nitroprusside (NIPRIDE) syringe drip (conc: 1 mg/ml) Yes May be administered in: Critical Care Areas Only
Renal Dosing:
CrCl <10ml/min: Avoid
Thiocyanate, a toxi metabolite, accumulates causing seizures, coma
Thiocyanate is hemodialyzable - measure thiocyanate levels Drips
nizatidine (AXID) 150 mg capsule No Renal Dosing:
Treatment dosing:
CrCl 20-50ml/min: 150mg daily
CrCl<20ml/min: 150mg every other day
Maintenance dosing:
CrCl 20-50ml/min: 150mg every other day
Oral
nizatidine (AXID) 300 mg capsule No Renal Dosing:
Treatment dosing:
CrCl 20-50ml/min: 150mg daily
CrCl<20ml/min: 150mg every other day
Maintenance dosing:
CrCl 20-50ml/min: 150mg every other day
Oral
norfloxacin (NOROXIN) 400 mg tablet No Renal Dosing:
CrCl 10-50ml/min: 400mg q24h
CrCl<10ml/min: 200mg q24h Oral
ofloxacin (FLOXIN) 200mg tablet No Renal Dosing:
CrCl 10-50ml/min: 200-400mg q 24h
CrCl<10ml/min: 200mg q24h Oral
ofloxacin (FLOXIN) 400 mg in 100ml D5W injection No Renal Dosing:
CrCl 10-50ml/min: 200-400mg q 24h
CrCl<10ml/min: 200mg q24h Intravenous
ofloxacin (FLOXIN) 400 mg tablet No Renal Dosing:
CrCl 10-50ml/min: 200-400mg q 24h
CrCl<10ml/min: 200mg q24h Oral
ofloxacin (OCUFLOX) 0.3% ophthalmic solution No Ophthalmic
ofloxacin(FLOXIN) 300 mg tablet No Renal Dosing:
CrCl 10-50ml/min: 200-400mg q 24h
CrCl<10ml/min: 200mg q24h Oral
olmesartan - hydrochlorothiazide (BENICAR HCT) 20 - 12.5 mg tablet No Dispense individual ingredients
Renal Dosing
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
olmesartan - hydrochlorothiazide (BENICAR HCT) 40 - 12.5 mg tablet No Dispense individual ingredients
Renal Dosing
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
olmesartan - hydrochlorothiazide (BENICAR HCT) 40-25 mg tablet No Dispense individual ingredients
Renal Dosing
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
orphenadrine-aspirin-caffeine (NORGESIC) 25-385-30 mg tablet Yes Renal Dosing:
Aspirin
Reduce dose in impaired renal function.
Avoid in patients with end stage renal disease. Oral
oseltamivir (TAMIFLU) 12 mg/ml oral liquid Yes Renal Dosing:
CrCl 10-30ml/min: 75mg daily x 5 days for treatment; 75mg every other day for prophylaxis Oral
oseltamivir (TAMIFLU) 75 mg capsule Yes Renal Dosing:
CrCl 10-30ml/min: 75mg daily x 5 days for treatment; 75mg every other day for prophylaxis Oral
oxaprozin (DAYPRO) 600 mg tablet Yes Renal Dosing:
Initiate therapy at 600mg daily in azotemic patients Oral
oxaprozin potassion (DAYPRO ALTA) 678 mg tablet No Renal Dosing:
Initiate therapy at 678mg daily in azotemic patients Oral
oxcarbazepine (TRILEPTAL) 150 mg tablet No Dispense 1/2 of 300mg
Renal Dosing:
CrCl<30ml/min: initiate therapy with 300mg daily Oral
oxcarbazepine (TRILEPTAL) 300 mg tablet Yes Renal Dosing:
CrCl<30ml/min: initiate therapy with 300mg daily Oral
oxcarbazepine (TRILEPTAL) 300 mg/5 ml oral suspension No Renal Dosing:
CrCl<30ml/min: initiate therapy with 300mg daily Oral
oxcarbazepine (TRILEPTAL) 600 mg tablet No Dispense 2 x 300mg
Renal Dosing:
CrCl<30ml/min: initiate therapy with 300mg daily Oral
oxycodone - aspirin (PERCODAN) 4.88-325 mg tablet No Renal Dosing:
Aspirin
Reduce dose in impaired renal function.
Avoid in patients with end stage renal disease. Oral
oxymorphone (OPANA) 10 mg tablet No Renal Dosing:
CrCl<50ml/min: reduce doses Oral
oxymorphone (OPANA) 1mg/ml injection No Renal Dosing:
CrCl<50ml/min: reduce doses Injection
oxymorphone (OPANA) 5 mg tablet No Renal Dosing:
CrCl<50ml/min: reduce doses Oral
oxymorphone ER (OPANA ER) 10 mg tablet No Renal Dosing:
CrCl<50ml/min: reduce doses Oral
oxymorphone ER (OPANA ER) 15 mg tablet No Renal Dosing:
CrCl<50ml/min: reduce doses Oral
oxymorphone ER (OPANA ER) 20 mg tablet No Renal Dosing:
CrCl<50ml/min: reduce doses Oral
oxymorphone ER (OPANA ER) 30 mg tablet No Renal Dosing:
CrCl<50ml/min: reduce doses Oral
oxymorphone ER (OPANA ER) 40 mg tablet No Renal Dosing:
CrCl<50ml/min: reduce doses Oral
oxymorphone ER (OPANA ER) 5 mg tablet No Renal Dosing:
CrCl<50ml/min: reduce doses Oral
oxymorphone ER (OPANA ER) 7.5 mg tablet No Renal Dosing:
CrCl<50ml/min: reduce doses Oral
paliperidone (INVEGA) 3 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: 6mg/day maximum dose
CrCl 10-50ml/min: 3mg/day maximum dose Oral
paliperidone (INVEGA) 6 mg tablet No Dispense 2 x 3mg
Renal Dosing:
CrCl 50-80ml/min: 6mg/day maximum dose
CrCl 10-50ml/min: 3mg/day maximum dose Oral
paliperidone (INVEGA) 9 mg tablet No Dispense 3 x 3mg
Renal Dosing:
CrCl 50-80ml/min: 6mg/day maximum dose
CrCl 10-50ml/min: 3mg/day maximum dose Oral
pancuronium (PAVULON) 1 mg/ml injection Yes May be administered in: Critical Care Areas Only
Renal Dosing:
CrCl <10ml/min: Avoid Intravenous
pancuronium (PAVULON) drip Yes May be administered in: Critical Care Areas Only
Renal Dosing:
CrCl <10ml/min: Avoid Drips
paroxetine (PAXIL, PEXEVA) 10 mg tablet Yes Renal Dosing:
In patients with renal failure, the initial dose is 10mg daily to a maximum of 40mg/day Oral
paroxetine (PAXIL, PEXEVA) 10 mg/5 ml oral liquid No Renal Dosing:
In patients with renal failure, the initial dose is 10mg daily to a maximum of 40mg/day Oral
paroxetine (PAXIL, PEXEVA) 20 mg tablet Yes Renal Dosing:
In patients with renal failure, the initial dose is 10mg daily to a maximum of 40mg/day Oral
paroxetine (PAXIL, PEXEVA) 30 mg tablet No Dispense 1 x 10 + 1 x 20mg
Renal Dosing:
In patients with renal failure, the initial dose is 10mg daily to a maximum of 40mg/day Oral
paroxetine (PAXIL, PEXEVA) 40 mg tablet No Dispense 2 x 20mg
Renal Dosing:
In patients with renal failure, the initial dose is 10mg daily to a maximum of 40mg/day Oral
paroxetine CR (PAXIL CR) 12 .5 mg tablet No Renal Dosing:
In patients with renal failure, the initial dose is 12.5mg daily to a maximum of 50mg/day Oral
paroxetine CR (PAXIL CR) 25 mg tablet No Renal Dosing:
In patients with renal failure, the initial dose is 12.5mg daily to a maximum of 50mg/day Oral
paroxetine CR (PAXIL CR) 37.5 mg tablet No Renal Dosing:
In patients with renal failure, the initial dose is 12.5mg daily to a maximum of 50mg/day Oral
peginterferon alfa-2a (PEGASYS) 180 mcg/ml injection Yes Renal Dosing:
CrCl<10ml/min: reduce dose to 135mcg Subcutaneous
pemetrexed (ALIMTA) chemo infusion Yes Renal Dosing:
CrCl<45 ml/min: Avoid Chemo
pemirolast (ALAMAST) 0.1% ophthalmic solution No Ophthalmic
penbutolol (LEVATOL) 20mg tablet Yes Oral
penciclovir (DENAVIR) 1% topical cream Yes Topical
penicillamine (CUPRIMINE) 250 mg capsule Yes Renal Dosing:
CrCl<50ml/min: Avoid Oral
penicillamine (DEPEN) 250 mg tablet No Renal Dosing:
CrCl<50ml/min: Avoid Oral
penicillin G potassium (PFIZERPEN-G, PEN GK) 2 MU in 50ml D5W injection Yes Renal Dosing:
CrCl 50-80ml/min: 2-4 MU q4-6h
CrCl 10-50ml/min: 1-2 MU q4-6h
CrCl<10ml/min: 1 MU q6h Intravenous
penicillin G potassium (PFIZERPEN-G, PEN GK) 3 MU in 50ml D5W injection Yes Renal Dosing:
CrCl 50-80ml/min: 2-4 MU q4-6h
CrCl 10-50ml/min: 1-2 MU q4-6h
CrCl<10ml/min: 1 MU q6h Intravenous
penicillin G procaine - benzathine (BICILLIN CR) 1,200,000 units/2 ml syringe Yes Intramuscular
penicillin G procaine - benzathine (BICILLIN CR) 2,400,000 units/4 ml syringe Yes Intramuscular
penicillin G procaine (WYCILLIN) 1,200,000 units syringe Yes Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50-80% Intramuscular
penicillin G procaine (WYCILLIN) 600,000 units syringe Yes Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50-80% Intramuscular
penicillin G sodium 5 million units injection Yes Renal Dosing:
CrCl 50-80ml/min: 2-4 MU q4-6h
CrCl 10-50ml/min: 1-2 MU q4-6h
CrCl<10ml/min: 1 MU q6h Injection
penicillin V potassium (V-CILLIN, PEN VK) 250 mg tablet Yes Oral
penicillin V potassium (V-CILLIN, PEN VK) 500 mg tablet Yes Oral
pentamidine (NEBUPENT) 300 mg inhalation solution Yes Inhalation
pentamidine (PENTAM) 300 mg injection (for IM use) Yes Renal Dosing:
CrCl 10-50ml/min: 4mg/kg q24-36h
CrCl<10ml/min: 4mg/kg q48h Injection
pentamidine (PENTAM) injection Yes Renal Dosing:
CrCl 10-50ml/min: 4mg/kg q24-36h
CrCl<10ml/min: 4mg/kg q48h IVPB
pentazocine - naloxone (TALWIN NX) 50-0.5 mg tablet Yes Oral
pentazocine - acetaminophen (TALACEN) 25-650 mg tablet No Renal Dosing:
Pentazocine
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
pentazocine - aspirin (TALWIN COMPOUND) 12.5-325 mg tablet No Renal Dosing:
Aspirin
Reduce dose in impaired renal function.
Avoid in patients with end stage renal disease
Pentazocine
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Oral
pentazocine (TALWIN) 30 mg/ml injection No Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 25%
CrCl<10ml/min: decrease usual dose by 50% Injection
pentobarbital (NEMBUTAL) drip Yes May be administered in: Critical Care Areas Only Drips
pentobarbital (NEMBUTAL) infusion per pharmacy guideline Yes Per Pharmacy
pentobarbital (NEMBUTAL) injection Yes May be administered in: Critical Care Areas Only Injection
pentosan polysulfate (ELMIRON) 100mg capsule Yes Oral
pentostatin (NIPENT) injection Yes Intravenous
pentoxyfylline ER (TRENTAL) 400 mg tablet Yes Renal Dosing:
CrCl 30-80ml/min: 400mg bid
CrCl<30ml/min: 400mg daily or Avoid Oral
PEPCID COMPLETE 10 mg chewable tablet No Oral
perindopril (ACEON) 2 mg tablet No Dispense 1/2 of 4mg
Renal Dosing:
CrCl 10-50ml/min: give 75% of usual dose
CrCl<10ml/min: give 50% of usual dose Oral
perindopril (ACEON) 4 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: give 75% of usual dose
CrCl<10ml/min: give 50% of usual dose Oral
perindopril (ACEON) 8 mg tablet No Dispense 2 x 4mg
Renal Dosing:
CrCl 10-50ml/min: give 75% of usual dose
CrCl<10ml/min: give 50% of usual dose Oral
permethrin (ELIMITE) 5% topical cream Yes Topical
permethrin (NIX) 1% topical shampoo Yes Topical
perphenazine - amitriptyline (TRIAVIL, ETRAFON) 2-10 mg tablet No Dispense individual ingredients Oral
perphenazine - amitriptyline (TRIAVIL, ETRAFON) 2-25 mg tablet No Dispense individual ingredients Oral
perphenazine - amitriptyline (TRIAVIL, ETRAFON) 4-10 mg tablet No Dispense individual ingredients Oral
perphenazine - amitriptyline (TRIAVIL, ETRAFON) 4-25 mg tablet No Dispense individual ingredients Oral
phenazopyridine (PYRIDIUM) 100 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: q8-16h
CrCl<50ml/min: Avoid Oral
phenazopyridine (PYRIDIUM) 200 mg tablet No Dispense 2 x 100mg
Renal Dosing:
CrCl 50-80ml/min: q8-16h
CrCl<50ml/min: Avoid Oral
phenazopyridine (URISAT, REAZO) 95 mg tablet No Renal Dosing:
CrCl 50-80ml/min: q8-16h
CrCl<50ml/min: Avoid Oral
phenobarbital 100 mg tablet Yes Renal Dosing:
ClCr<10ml/min: q12-16h Oral
phenobarbital 130 mg/ml injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
ClCr<10ml/min: q12-16h Injection
phenobarbital 15 mg tablet No Dispense 1/2 of 30mg
Renal Dosing:
ClCr<10ml/min: q12-16h Oral
phenobarbital 20mg/5ml oral liquid No Renal Dosing:
ClCr<10ml/min: q12-16h Oral
phenobarbital 30 mg tablet Yes Renal Dosing:
ClCr<10ml/min: q12-16h Oral
phenobarbital 60 mg tablet No Dispense 2 x 30mg
Renal Dosing:
ClCr<10ml/min: q12-16h Oral
phenobarbital 65 mg/ml injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
ClCr<10ml/min: q12-16h Injection
phenylephrine-promethazine-codeine(Phenergan VC w/ Codeine) 5-6.25-10mg/5ml oral liquid No Renal Dosing:
Codeine
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
pioglitazone - metformin (ACTOPLUS MET) 15-500 mg tablet No Dispense individual ingredients
Renal Dosing:
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine>1.4mg/dl (females) due to risk of lactic acidosis Oral
pioglitazone - metformin (ACTOPLUS MET) 15-850 mg tablet No Dispense individual ingredients
Renal Dosing:
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine>1.4mg/dl (females) due to risk of lactic acidosis Oral
pioglitazone - metformin ER (ACTOPLUS MET XT) 15-1000 mg tablet No Dispense individual ingredients
Renal Dosing:
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine>1.4mg/dl (females) due to risk of lactic acidosis Oral
pioglitazone - metformin ER (ACTOPLUS MET XT) 30-1000 mg tablet No Dispense individual ingredients
Renal Dosing:
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine>1.4mg/dl (females) due to risk of lactic acidosis Oral
pioglitazone (ACTOS) 15 mg tablet Yes Oral
pioglitazone (ACTOS) 30 mg tablet Yes Oral
pioglitazone (ACTOS) 45 mg tablet Yes Oral
piperacillin (PIPRACIL) 2 g injection No Renal Dosing:
CrCl 10-50ml/min: 3gm q8h
CrCl<10ml/min: 2gm q8h Intravenous
piperacillin (PIPRACIL) 3 g injection No Renal Dosing:
CrCl 10-50ml/min: 3gm q8h
CrCl<10ml/min: 2gm q8h Intravenous
piperacillin (PIPRACIL) 4 g injection No Renal Dosing:
CrCl 10-50ml/min: 3gm q8h
CrCl<10ml/min: 2gm q8h Intravenous
piperacillin-tazobactam (ZOSYN) 2.25 g intravenous Yes Renal Dosing:
CrCl 10-50ml/min: 3.375gm q8h
CrCl<10ml/min: 2.25gm q8h Intravenous
piperacillin-tazobactam (ZOSYN) 3.375 g intravenous Yes Renal Dosing:
CrCl 10-50ml/min: 3.375gm q8h
CrCl<10ml/min: 2.25gm q8h Intravenous
piperacillin-tazobactam (ZOSYN) 4.5 g intravenous Yes Renal Dosing:
CrCl 10-50ml/min: 3.375gm q8h
CrCl<10ml/min: 2.25gm q8h Intravenous
pirbuterol (MAXAIR) 200 mcg/actuation inhaler No Inhalation
piroxicam (FELDENE) 10 mg capsule Yes Oral
piroxicam (FELDENE) 20 mg capsule No Dispense 2 x 10mg Oral
pitavastatin (LIVALO) 1 mg tablet Yes Renal Dosing:
In patients with significant renal dysfunction, start therapy with 1mg daily Oral
pitavastatin (LIVALO) 2 mg tablet Yes Renal Dosing:
In patients with significant renal dysfunction, start therapy with 1mg daily Oral
pitavastatin (LIVALO) 4 mg tablet Yes Renal Dosing:
In patients with significant renal dysfunction, start therapy with 1mg daily Oral
pramipexole (MIRAPEX) 0.125 mg tablet No Dispense 1/2 of 0.25mg
Renal Dosing:
CrCl 35-59ml/min: 0.125-1.5 mg bid
CrCl 15-34ml/min: 0.125-1.5 daily
CrCl<15ml/min: Avoid Oral
pramipexole (MIRAPEX) 0.25 mg tablet Yes Renal Dosing:
CrCl 35-59ml/min: 0.125-1.5 mg bid
CrCl 15-34ml/min: 0.125-1.5 daily
CrCl<15ml/min: Avoid Oral
pramipexole (MIRAPEX) 0.5 mg tablet No Dispense 2 x 0.25mg
Renal Dosing:
CrCl 35-59ml/min: 0.125-1.5 mg bid
CrCl 15-34ml/min: 0.125-1.5 daily
CrCl<15ml/min: Avoid Oral
pramipexole (MIRAPEX) 1 mg tablet Yes Renal Dosing:
CrCl 35-59ml/min: 0.125-1.5 mg bid
CrCl 15-34ml/min: 0.125-1.5 daily
CrCl<15ml/min: Avoid Oral
pramipexole (MIRAPEX) 1.5 mg tablet No Dispense 1.5 of 1mg
Renal Dosing:
CrCl 35-59ml/min: 0.125-1.5 mg bid
CrCl 15-34ml/min: 0.125-1.5 daily
CrCl<15ml/min: Avoid Oral
pravastatin (PRAVACHOL) 10 mg tablet Yes Renal Dosing:
In patients with significant renal dysfunction, start therapy with 10mg daily Oral
pravastatin (PRAVACHOL) 20 mg tablet Yes Renal Dosing:
In patients with significant renal dysfunction, start therapy with 10mg daily Oral
pravastatin (PRAVACHOL) 40 mg tablet Yes Renal Dosing:
In patients with significant renal dysfunction, start therapy with 10mg daily Oral
pravastatin (PRAVACHOL) 80 mg tablet No Dispense 2 x 40mg
Renal Dosing:
In patients with significant renal dysfunction, start therapy with 10mg daily Oral
pregabalin (LYRICA) 100 mcg capsule Yes Renal Dosing:
CrCl Total daily dose (mg/day) Dosage regimen
>60ml/min 150 300 450 600 divided bid-tid
30-60ml/min 75 150 225 300 divided bid-tid
15-30ml/min 25-50 75 100-15 Oral
pregabalin (LYRICA) 150 mg capsule No Dispense 2 x 75mg
Renal Dosing:
CrCl Total daily dose (mg/day) Dosage regimen
>60ml/min 150 300 450 600 divided bid-tid
30-60ml/min 75 150 225 300 divided bid-tid
15-30ml/min 25-50 Oral
pregabalin (LYRICA) 200 mg capsule No Dispense 2 x 100mg
Renal Dosing:
CrCl Total daily dose (mg/day) Dosage regimen
>60ml/min 150 300 450 600 divided bid-tid
30-60ml/min 75 150 225 300 divided bid-tid
15-30ml/min 25-5 Oral
pregabalin (LYRICA) 225 mg capsule No Dispense 3 x 75mg
Renal Dosing:
CrCl Total daily dose (mg/day) Dosage regimen
>60ml/min 150 300 450 600 divided bid-tid
30-60ml/min 75 150 225 300 divided bid-tid
15-30ml/min 25-50 Oral
pregabalin (LYRICA) 25 mg capsule Yes Renal Dosing:
CrCl Total daily dose (mg/day) Dosage regimen
>60ml/min 150 300 450 600 divided bid-tid
30-60ml/min 75 150 225 300 divided bid-tid
15-30ml/min 25-50 75 100-15 Oral
pregabalin (LYRICA) 300 mg capsule No Dispense 3 x 100mg
Renal Dosing:
CrCl Total daily dose (mg/day) Dosage regimen
>60ml/min 150 300 450 600 divided bid-tid
30-60ml/min 75 150 225 300 divided bid-tid
15-30ml/min 25-5 Oral
pregabalin (LYRICA) 50 mg capsule Yes Renal Dosing:
CrCl Total daily dose (mg/day) Dosage regimen
>60ml/min 150 300 450 600 divided bid-tid
30-60ml/min 75 150 225 300 divided bid-tid
15-30ml/min 25-50 75 100-15 Oral
pregabalin (LYRICA) 75 mg capsule Yes Renal Dosing:
CrCl Total daily dose (mg/day) Dosage regimen
>60ml/min 150 300 450 600 divided bid-tid
30-60ml/min 75 150 225 300 divided bid-tid
15-30ml/min 25-50 75 100-15 Oral
primidone (MYSOLINE) 250 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: q8h
CrCl 10-50ml/min: q8-12h
CrCl<10ml/min: q12-24h Oral
primidone (MYSOLINE) 50 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: q8h
CrCl 10-50ml/min: q8-12h
CrCl<10ml/min: q12-24h Oral
primidone (MYSOLINE) 50 mg/ml oral liquid No Renal Dosing:
CrCl 50-80ml/min: q8h
CrCl 10-50ml/min: q8-12h
CrCl<10ml/min: q12-24h Oral
procainamide (PRONESTYL) 250 mg capsule Yes Renal Dosing:
CrCl 50-80ml/min: q4h
CrCl 10-50ml/min: q6-12h
CrCl<10ml/min: q8-24h Oral
procainamide (PRONESTYL) 500 mg capsule No Dispense 2 x 250mg
Renal Dosing:
CrCl 50-80ml/min: q4h
CrCl 10-50ml/min: q6-12h
CrCl<10ml/min: q8-24h Oral
procainamide (PRONESTYL) drip Yes May be administered in: All Critical Care Areas and DOU/ Telemetry Unit (limited use)
Renal Dosing:
Dose should be adjusted for weight, age and renal function Drips
procainamide (PRONESTYL) IM injection Yes May be administered in: All Critical Care Areas and DOU/ Telemetry Unit (limited use)
Renal Dosing:
Dose should be adjusted for weight, age and renal function Injection
procainamide (PRONESTYL) IV Push Yes May be administered in: All Critical Care Areas and DOU/ Telemetry Unit (limited use)
Renal Dosing:
Dose should be adjusted for weight, age and renal function Injection
procainamide (PRONESTYL) syringe drip (conc: 40 mg/ml) Yes May be administered in: All Critical Care Areas and DOU/ Telemetry Unit (limited use)
Renal Dosing:
Dose should be adjusted for weight, age and renal function Drips
procainamide ER (PROCANBID) 1000 mg tablet No Dispense 2 x 500mg
Renal Dosing:
Dose should be adjusted for weight, age and renal function Oral
procainamide ER (PROCANBID) 500 mg tablet Yes Renal Dosing:
Dose should be adjusted for weight, age and renal function Oral
procainamide SR (PRONESTYL SR) (6 hour) 500 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: q4h
CrCl 10-50ml/min: q6-12h
CrCl<10ml/min: q8-24h Oral
promethazine - codeine (PHENERGAN W/CODEINE) 6.25-10mg/5 ml oral liquid Yes Renal Dosing:
Codeine
CrCl 10-50ml/min: decrease dose 25%
CrCl<10ml/min: decrease dose 50% Oral
propoxyphene - aspirin - caffeine (DARVON COMPOUND) 65-389-32 mg capsule No Withdrawn From the Market (July 2008)
Renal Dosing:
Aspirin
Reduce dose in impaired renal function.
Avoid in patients with end stage renal disease.
Propoxyphene
CrCl < 10ml/min: Avoid Oral
propoxyphene (DARVON) 65 mg capsule No Renal Dosing:
CrCl<10ml/min: Avoid Oral
propoxyphene N - acetaminophen (BALCET, TRYCET) 100-325 mg tablet No Renal Dosing:
Propoxyphene
CrCl<10ml/min: Avoid Oral
propoxyphene N - acetaminophen (DARVOCET N-100) 100-650 mg tablet Yes Renal Dosing:
Propoxyphene
CrCl<10ml/min: Avoid Oral
propoxyphene N - acetaminophen (DARVOCET N-50) 50-325 mg tablet No Renal Dosing:
Propoxyphene
CrCl<10ml/min: Avoid Oral
propoxyphene napsylate (DARVON-N) 100 mg tablet No Renal Dosing:
CrCl<10ml/min: Avoid Oral
propranolol (INDERAL) 1 mg/ml injection Yes May be administered in: All Critical Care Areas and DOU/ Telemetry Unit Intravenous
pyrazinamide 500 mg tablet Yes Renal Dosing:
CrCl<10ml/min: 12-20mg/kg daily Oral
quinapril - hydrochlorothiazide (ACCURETIC, QUINARETIC) 10-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Quinapril
CrCl 10-50ml/min: 75-100% of usual dose daily
CrCl<10ml/min: 75% of usual dose daily
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
quinapril - hydrochlorothiazide (ACCURETIC, QUINARETIC) 20-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Quinapril
CrCl 10-50ml/min: 75-100% of usual dose daily
CrCl<10ml/min: 75% of usual dose daily
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
quinapril - hydrochlorothiazide (ACCURETIC, QUINARETIC) 20-25 mg tablet No Dispense individual ingredients
Renal Dosing:
Quinapril
CrCl 10-50ml/min: 75-100% of usual dose daily
CrCl<10ml/min: 75% of usual dose daily
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
quinapril (ACCUPRIL) 10 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: 75-100% of usual dose daily
CrCl<10ml/min: 75% of usual dose daily Oral
quinapril (ACCUPRIL) 20 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: 75-100% of usual dose daily
CrCl<10ml/min: 75% of usual dose daily Oral
quinapril (ACCUPRIL) 40 mg tablet No Dispense 2 x 20mg
Renal Dosing:
CrCl 10-50ml/min: 75-100% of usual dose daily
CrCl<10ml/min: 75% of usual dose daily Oral
quinapril (ACCUPRIL) 5 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: 75-100% of usual dose daily
CrCl<10ml/min: 75% of usual dose daily Oral
ramipril (ALTACE) 1.25 mg capsule Yes Renal Dosing:
CrCl 10-50ml/min: give 50-75% of usual dose daily
CrCl<10ml/min: give 25-50% of usual dose daily Oral
ramipril (ALTACE) 10 mg capsule No Dispense 2 x 5mg
Renal Dosing:
CrCl 10-50ml/min: give 50-75% of usual dose daily
CrCl<10ml/min: give 25-50% of usual dose daily Oral
ramipril (ALTACE) 2.5 mg capsule Yes Renal Dosing:
CrCl 10-50ml/min: give 50-75% of usual dose daily
CrCl<10ml/min: give 25-50% of usual dose daily Oral
ramipril (ALTACE) 5 mg capsule Yes Renal Dosing:
CrCl 10-50ml/min: give 50-75% of usual dose daily
CrCl<10ml/min: give 25-50% of usual dose daily Oral
ranitidine (ZANTAC) 15 mg/ml oral liquid No Renal Dosing:
CrCl 50-80ml/min: 150mg q12h
CrCl 10-50ml/min: 150mg q24h
CrCl<10ml/min: 150mg q24-48h Oral
ranitidine (ZANTAC) 150 mg tablet No Renal Dosing:
CrCl 50-80ml/min: 150mg q12h
CrCl 10-50ml/min: 150mg q24h
CrCl<10ml/min: 150mg q24-48h Oral
ranitidine (ZANTAC) 25 mg/ml injection No Renal Dosing:
CrCl 50-80ml/min: 50mg q8h
CrCl 10-50ml/min: 50mg q12h
CrCl<10ml/min: 50mg q18-24h Injection
ranitidine (ZANTAC) 75 mg tablet No Renal Dosing:
CrCl 50-80ml/min: 150mg q12h
CrCl 10-50ml/min: 150mg q24h
CrCl<10ml/min: 150mg q24-48h Oral
repaglinide - metformin (PRANDIMET) 1-500 mg tablet No Dispense individual ingredients
Renal Dosing:
Repaglinide
CrCl 20-40ml/min: initial dose should be 0.5mg
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine>1.4mg/dl (females) due to risk of lactic acidosis Oral
repaglinide - metformin (PRANDIMET) 2-500 mg tablet No Dispense individual ingredients
Renal Dosing:
Repaglinide
CrCl 20-40ml/min: initial dose should be 0.5mg
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine>1.4mg/dl (females) due to risk of lactic acidosis Oral
repaglinide (PRANDIN) 0.5 mg tablet Yes Renal Dosing:
CrCl 20-40ml/min: initial dose should be 0.5mg Oral
repaglinide (PRANDIN) 1 mg tablet No Dispense 2 x 0.5mg
Renal Dosing:
CrCl 20-40ml/min: initial dose should be 0.5mg Oral
repaglinide (PRANDIN) 2 mg tablet Yes Renal Dosing:
CrCl 20-40ml/min: initial dose should be 0.5mg Oral
reserpine 0.1 mg tablet Yes Renal Dosing:
CrCl<10ml/min: Avoid Oral
reserpine 0.25 mg tablet Yes Renal Dosing:
CrCl<10ml/min: Avoid Oral
retapamulin (ALTABAX) 1% topical ointment No Not routinely stocked - Order PRN Topical
ribavirin (COPEGUS, RIBASHPERES) 200 mg tablet Yes Renal Dosing:
CrCl<50ml/min: Avoid Oral
ribavirin (REBETROL, RIBASHPERES) 200 mg capsule Yes Renal Dosing:
CrCl<50ml/min: Avoid Oral
ribavirin (RIBATAB, RIBASPHERES) 400 mg tablet No Dispense 2 x 200mg tablets
Renal Dosing:
CrCl<50ml/min: Avoid Oral
ribavirin (RIBATAB, RIBASPHERES) 500 mg tablet Yes Renal Dosing:
CrCl<50ml/min: Avoid Oral
ribavirin (RIBATAB, RIBASPHERES) 600 mg tablet No Dispense 3 x 200mg tab
Renal Dosing:
CrCl<50ml/min: Avoid Oral
rifabutin (MYCOBUTIN) 150 mg capsule Yes Renal Dosing:
CrCl<30ml/min: reduce dose by 50% Oral
rimantadine (FLUMADINE) 100 mg tablet No Renal Dosing:
CrCl 10-50ml/min: 100mg q12-24h
CrCl<10ml/min: 100mg q24h Oral
rimantadine (FLUMADINE) 50 mg/5 ml oral liquid No Renal Dosing:
CrCl 10-50ml/min: 100mg q12-24h
CrCl<10ml/min: 100mg q24h Oral
rimexolone (VEXOL) 1% ophthalmic suspension No Ophthalmic
ringers irrigation Yes Topical Irrigation
risedronate (ACTONEL) 150 mg monthly tablet Yes Renal Dosing:
CrCl<30ml/min: Avoid Oral
risedronate (ACTONEL) 30 mg daily tablet Yes Renal Dosing:
CrCl<30ml/min: Avoid Oral
risedronate (ACTONEL) 35 mg weekly tablet Yes Renal Dosing:
CrCl<30ml/min: Avoid Oral
risedronate (ACTONEL) 5 mg daily tablet Yes Renal Dosing:
CrCl<30ml/min: Avoid Oral
risperidone (RISPERDAL M) 0.5 mg disintegrating tablet No Renal Dosing:
CrCl<10ml/min: 0.5mg bid to a maximum dose of 3mg/day Oral
risperidone (RISPERDAL M) 1 mg disintegrating tablet No Renal Dosing:
CrCl<10ml/min: 0.5mg bid to a maximum dose of 3mg/day Oral
risperidone (RISPERDAL M) 2 mg disintegrating tablet No Renal Dosing:
CrCl<10ml/min: 0.5mg bid to a maximum dose of 3mg/day Oral
risperidone (RISPERDAL M) 4 mg disintegrating tablet No Dispense 2 x 2mg immediate-release tablets
Renal Dosing:
CrCl<10ml/min: 0.5mg bid to a maximum dose of 3mg/day Oral
risperidone (RISPERDAL) 0.25 mg tablet Yes Renal Dosing:
CrCl<10ml/min: 0.5mg bid to a maximum dose of 3mg/day Oral
risperidone (RISPERDAL) 0.5 mg tablet Yes Renal Dosing:
CrCl<10ml/min: 0.5mg bid to a maximum dose of 3mg/day Oral
risperidone (RISPERDAL) 1 mg tablet Yes Renal Dosing:
CrCl<10ml/min: 0.5mg bid to a maximum dose of 3mg/day Oral
risperidone (RISPERDAL) 1 mg/ml oral solution No Renal Dosing:
CrCl<10ml/min: 0.5mg bid to a maximum dose of 3mg/day Oral
risperidone (RISPERDAL) 2 mg tablet Yes Renal Dosing:
CrCl<10ml/min: 0.5mg bid to a maximum dose of 3mg/day Oral
risperidone (RISPERDAL) 3 mg tablet No Dispense 1 x 2mg + 1 x 1 mg
Renal Dosing:
CrCl<10ml/min: 0.5mg bid to a maximum dose of 3mg/day Oral
risperidone (RISPERDAL) 4 mg tablet No Dispense 2 x 2mg
Renal Dosing:
CrCl<10ml/min: 0.5mg bid to a maximum dose of 3mg/day Oral
rosiglitazone - metformin (AVANDAMET) 2-1000 mg tablet No Dispense individual ingredients
Renal Dosing:
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine>1.4mg/dl (females) due to risk of lactic acidosis Oral
rosiglitazone - metformin (AVANDAMET) 2-500 mg tablet No Dispense individual ingredients
Renal Dosing:
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine>1.4mg/dl (females) due to risk of lactic acidosis Oral
rosiglitazone - metformin (AVANDAMET) 4-1000 mg tablet No Dispense individual ingredients
Renal Dosing:
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine>1.4mg/dl (females) due to risk of lactic acidosis Oral
rosiglitazone - metformin (AVANDAMET) 4-500 mg tablet No Dispense individual ingredients
Renal Dosing:
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine>1.4mg/dl (females) due to risk of lactic acidosis Oral
rosuvastatin (CRESTOR) 10 mg tablet Yes Renal Dosing:
CrCl<30ml/min/1.73 m(2): initial dose 5mg daily to max of 10mg daily Oral
rosuvastatin (CRESTOR) 20 mg tablet Yes Renal Dosing:
CrCl<30ml/min/1.73 m(2): initial dose 5mg daily to max of 10mg daily Oral
rosuvastatin (CRESTOR) 40 mg tablet No Dispense 2 x 40mg
Renal Dosing:
CrCl<30ml/min/1.73 m(2): initial dose 5mg daily to max of 10mg daily Oral
rosuvastatin (CRESTOR) 5 mg tablet Yes Renal Dosing:
CrCl<30ml/min/1.73 m(2): initial dose 5mg daily to max of 10mg daily Oral
saxagliptin (ONGLYZA) 2.5 mg tablet Yes Renal Dosing:
CrCl >50ml/min: 5mg daily
CrCl<50ml/min: 2.5mg daily Oral
saxagliptin (ONGLYZA) 5 mg tablet Yes Renal Dosing:
CrCl >50ml/min: 5mg daily
CrCl<50ml/min: 2.5mg daily Oral
sibutramine (MERIDIA) 10 mg capsule No Renal Dosing:
CrCl<10ml/min: Avoid Oral
sibutramine (MERIDIA) 15 mg capsule No Renal Dosing:
CrCl<10ml/min: Avoid Oral
sibutramine (MERIDIA) 5 mg capsule No Renal Dosing:
CrCl<10ml/min: Avoid Oral
sildenafil (REVATIO, VIAGRA) 2.5mg/ml oral liquid No Oral
sildenafil (REVATIO, VIAGRA) 20 mg tablet Yes Oral
sildenafil (VIAGRA) 100 mg tablet No Oral
sildenafil (VIAGRA) 25 mg tablet No Oral
sildenafil (VIAGRA) 50 mg tablet No Oral
silodosic (RAPAFLO) 4 mg capsule No Renal Dosing:
CrCl 30-50ml/min - 4mg daily
CrCl < 30ml/min - contraindicated Oral
silodosic (RAPAFLO) 8 mg capsule No Renal Dosing:
CrCl 30-50ml/min - 4mg daily
CrCl < 30ml/min - contraindicated Oral
simvastatin (ZOCOR) 10 mg tablet Yes Renal Dosing:
CrCl<10ml/min: initial dose should be 5mg daily Oral
simvastatin (ZOCOR) 20 mg tablet Yes Renal Dosing:
CrCl<10ml/min: initial dose should be 5mg daily Oral
simvastatin (ZOCOR) 40 mg tablet Yes Renal Dosing:
CrCl<10ml/min: initial dose should be 5mg daily Oral
simvastatin (ZOCOR) 5 mg tablet Yes Renal Dosing:
CrCl<10ml/min: initial dose should be 5mg daily Oral
simvastatin (ZOCOR) 80 mg tablet Yes Renal Dosing:
CrCl<10ml/min: initial dose should be 5mg daily Oral
sitagliptin - metformin (JANUMET) 50-1000 mg tablet No Dispense individual ingredients
Renal Dosing:
Sitagliptin
CrCl 30-50ml/min: 50mg daily
CrCl<30ml/min: 25mg daily
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine>1.4mg/dl (females) due to risk of Oral
sitagliptin - metformin (JANUMET) 50-500 mg tablet No Dispense individual ingredients
Renal Dosing:
Sitagliptin
CrCl 30-50ml/min: 50mg daily
CrCl<30ml/min: 25mg daily
Metformin
Avoid in patients with creatinine>1.5mg/dl (males) or
creatinine>1.4mg/dl (females) due to risk of Oral
sitagliptin (JANUVIA) 100 mg tablet Yes Renal Dosing:
CrCl 30-50ml/min: 50mg daily
CrCl<30ml/min: 25mg daily Oral
sitagliptin (JANUVIA) 25 mg tablet Yes Renal Dosing:
CrCl 30-50ml/min: 50mg daily
CrCl<30ml/min: 25mg daily Oral
sitagliptin (JANUVIA) 50 mg tablet Yes Renal Dosing:
CrCl 30-50ml/min: 50mg daily
CrCl<30ml/min: 25mg daily Oral
solifenacin (VESICARE) 10 mg tablet No Renal Dosing:
CrCl<30ml/min: max recommended dose 5mg daily Oral
solifenacin (VESICARE) 5 mg tablet No Renal Dosing:
CrCl<30ml/min: max recommended dose 5mg daily Oral
sotalol (BETAPACE, BETAPACE AF) 120 mg tablet No Dispense 1.5 x 80mg
Renal Dosing:
CrCl 30-60ml/min: q24h
CrCl 10-30ml/min: q36-48h
CrCl<10ml/min: individualize Oral
sotalol (BETAPACE, BETAPACE AF) 160 mg tablet No Dispense 2 x 80mg
Renal Dosing:
CrCl 30-60ml/min: q24h
CrCl 10-30ml/min: q36-48h
CrCl<10ml/min: individualize Oral
sotalol (BETAPACE, BETAPACE AF) 240 mg tablet No Dispense 3 x 80mg
Renal Dosing:
CrCl 30-60ml/min: q24h
CrCl 10-30ml/min: q36-48h
CrCl<10ml/min: individualize Oral
sotalol (BETAPACE, BETAPACE AF) 80 mg tablet Yes Renal Dosing:
CrCl 30-60ml/min: q24h
CrCl 10-30ml/min: q36-48h
CrCl<10ml/min: individualize Oral
spironolactone - hydrochlorothiazide (ALDACTAZIDE) 25-25 mg tablet No Dispense individual ingredients
Renal Dosing:
Spironolactone
CrCl 50-80ml/min: q6-12h
CrCl 10-50ml/min: q12-24h
CrCl<10ml/min: avoid
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
spironolactone - hydrochlorothiazide (ALDACTAZIDE) 50-50 mg tablet No Dispense individual ingredients
Renal Dosing:
Spironolactone
CrCl 50-80ml/min: q6-12h
CrCl 10-50ml/min: q12-24h
CrCl<10ml/min: avoid
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
spironolactone (ALDACTONE) 100 mg tablet No Dispense 2 x 50mg
Renal Dosing:
CrCl 50-80ml/min: q6-12h
CrCl 10-50ml/min: q12-24h
CrCl<10ml/min: avoid Oral
spironolactone (ALDACTONE) 25 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: q6-12h
CrCl 10-50ml/min: q12-24h
CrCl<10ml/min: avoid Oral
spironolactone (ALDACTONE) 50 mg tablet Yes Renal Dosing:
CrCl 50-80ml/min: q6-12h
CrCl 10-50ml/min: q12-24h
CrCl<10ml/min: avoid Oral
starch (TUCKS , ANUSOL) 51 % rectal suppository Yes Rectal
stavudine (ZERIT) 1 mg/ml oral liquid Yes Renal Dosing:
Weight >60kg Weight <60kg
CrCl 26-50ml/min 20mg q12h 15mg q12h
CrCl 10-25ml/min 20mg q48h 15mg q24h
CrCl<10ml/min 20mg q48h 15mg q24h Oral
stavudine (ZERIT) 15 mg capsule Yes Renal Dosing:
Weight >60kg Weight <60kg
CrCl 26-50ml/min 20mg q12h 15mg q12h
CrCl 10-25ml/min 20mg q48h 15mg q24h
CrCl<10ml/min 20mg q48h 15mg q24h Oral
stavudine (ZERIT) 20 mg capsule Yes Renal Dosing:
Weight >60kg Weight <60kg
CrCl 26-50ml/min 20mg q12h 15mg q12h
CrCl 10-25ml/min 20mg q48h 15mg q24h
CrCl<10ml/min 20mg q48h 15mg q24h Oral
stavudine (ZERIT) 30 mg capsule No Dispense 2 x 15mg
Renal Dosing:
Weight >60kg Weight <60kg
CrCl 26-50ml/min 20mg q12h 15mg q12h
CrCl 10-25ml/min 20mg q48h 15mg q24h
CrCl<10ml/min 20mg q48h 15mg q24h Oral
stavudine (ZERIT) 40 mg capsule No Dispense 2 x 20mg
Renal Dosing:
Weight >60kg Weight <60kg
CrCl 26-50ml/min 20mg q12h 15mg q12h
CrCl 10-25ml/min 20mg q48h 15mg q24h
CrCl<10ml/min 20mg q48h 15mg q24h Oral
streptomycin 1 g injection No Not routinely stocked - Order PRN
Renal Dosing:
CrCl 10-50ml/min: q24-72h
CrCl<10ml/min: q72-96h Intramuscular
telbivudine (TYZEKA) 600 mg tablet Yes Renal Dosing:
CrCl 30-49ml/min: 600mg q48h
CrCl<30ml/min: 600mg q72h
Hemodialysis patients: 600mg q96h Oral
telithromycin (KETEK) 400 mg tablet No Renal Dosing:
CrCl<30ml/min: 600mg daily Oral
telmisartan - hydrochlorothiazide (MICARDIS HCT) 40-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
telmisartan - hydrochlorothiazide (MICARDIS HCT) 80-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
telmisartan - hydrochlorothiazide (MICARDIS HCT) 80-25 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
tenofovir (VIREAD) 300 mg tablet Yes Renal Dosing:
CrCl>50ml/min: 300mg q24h
CrCl 30-49ml/min: 300mg q48h
CrCl 10-29ml/min: 300mg twice weekly Oral
terbinafine (LAMISIL) 250 mg tablet Yes Renal Dosing:
CrCl<50ml/min: Avoid Oral
terbinafine (LAMISIL, DESENEX MAX) 1% topical cream No Topical
terbutaline (BRETHINE) 2.5 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 50%
CrCl<10ml/min: Avoid Oral
terbutaline (BRETHINE) 5 mg tablet No Dispense 2 x 2.5mg
Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 50%
CrCl<10ml/min: Avoid Oral
terbutaline (BRETHINE) injection Yes Renal Dosing:
CrCl 10-50ml/min: decrease usual dose by 50%
CrCl<10ml/min: Avoid Subcutaneous
tetracycline (SUMYCIN) 250 mg capsule Yes Renal Dosing:
CrCl 50-80ml/min: q8-12h
CrCl 10-50ml/min: q12-24h
CrCl<10ml/min q24h Oral
tetracycline (SUMYCIN) 500 mg capsule No Dispense 2 x 250mg
Renal Dosing:
CrCl 50-80ml/min: q8-12h
CrCl 10-50ml/min: q12-24h
CrCl<10ml/min q24h Oral
tetracycline 125mg/5ml oral liquid Yes Renal Dosing:
CrCl 50-80ml/min: q8-12h
CrCl 10-50ml/min: q12-24h
CrCl<10ml/min q24h Oral
thiopental (PENTOTHAL) 500 mg IV syringe Yes Renal Dosing:
CrCl<10ml/min: decrease usual dose by 25% Intravenous
ticarcillin - clavulanate (TIMENTIN) 3.1 g intravenous No Renal Dosing:
CrCl 50-80ml/min: 3.1gm q4-6h
CrCl 10-50ml/min: 3.1gm q8h
CrCl<10ml/min: 3.1gm q12h Intravenous
ticarcillin (TICAR) 3 g injection No Withdrawn from the Market (March 2009)
Renal Dosing:
CrCl 50-80ml/min: 2-4gm q4-6h (Max 24 gm/day)
CrCl 10-50ml/min: 2-3gm q6-8h
CrCl<10ml/min: 2gm q8h Intravenous
tigecycline (TYGACIL) injection Yes May be administered in: Non Critical Care Areas and all Critical Care Areas IVPB
tiludronate (SKELID) 200mg (equivalent to 240mg tiludronate disodium) tablet Yes Renal Dosing:
CrCl<30ml/min: Avoid Oral
timolol - brimonidine (COMBIGAN) 0.5 - 0.2% ophthalmic solution No Ophthalmic
timolol - hydrochlorothiazide (TIMOLIDE) 10-25mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
tobramycin (NEBCIN) 100mg in 25ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
tobramycin (NEBCIN) 110mg in 27.5ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
tobramycin (NEBCIN) 120mg in 30ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
tobramycin (NEBCIN) 130mg in 32.5ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
tobramycin (NEBCIN) 140mg in 35ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
tobramycin (NEBCIN) 150mg in 37.5ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
tobramycin (NEBCIN) 160mg in 40ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
tobramycin (NEBCIN) 170mg in 42.5ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
tobramycin (NEBCIN) 180mg in 45ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
tobramycin (NEBCIN) 200mg in 50ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Injection
tobramycin (NEBCIN) 40mg in 10ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
tobramycin (NEBCIN) 50mg in 12.5ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
tobramycin (NEBCIN) 60mg in 15ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
tobramycin (NEBCIN) 70mg in 17.5ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
tobramycin (NEBCIN) 80mg in 20ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
tobramycin (NEBCIN) 90mg in 22.5ml D5W injection Yes Renal Dosing:
Contact pharmacist for dosage adjustment in patient with renal impairment Intravenous
tobramycin (NEBCIN) dosing per pharmacy guideline Yes Per Pharmacy
tolterodine (DETROL) 1 mg tablet No Renal Dosing:
CrCl 10-30ml/min: 1mg bid Oral
tolterodine (DETROL) 2 mg tablet No Renal Dosing:
CrCl 10-30ml/min: 1mg bid Oral
tolterodine ER (DETROL LA) 2 mg capsule No Renal Dosing:
CrCl 10-30ml/min: 2mg daily Oral
tolterodine ER (DETROL LA) 4 mg capsule No Renal Dosing:
CrCl 10-30ml/min: 2mg daily Oral
topiramate (TOPAMAX) 100 mg tablet Yes Renal Dosing:
CrCl<70ml/min: give half the usual dose Oral
topiramate (TOPAMAX) 200 mg tablet No Dispense 2 x 100mg
Renal Dosing:
CrCl<70ml/min: give half the usual dose Oral
topiramate (TOPAMAX) 25 mg tablet Yes Renal Dosing:
CrCl<70ml/min: give half the usual dose Oral
topiramate (TOPAMAX) 50 mg tablet No Dispense 2 x 25mg
Renal Dosing:
CrCl<70ml/min: give half the usual dose Oral
tramadol - acetaminophen (ULTRACET) 37.5-325 mg tablet No Renal Dosing:
Tramadol
CrCl 10-30ml/min: q12h with maximum daily dose of 200mg
CrCl<10ml/min: 50mg q12h Oral
tramadol (ULTRAM) 50 mg tablet Yes Renal Dosing:
CrCl 10-30ml/min: q12h with maximum daily dose of 200mg
CrCl<10ml/min: 50mg q12h Oral
tramadol ER (ULTRAM ER/RYZOLT) 100 mg tablets No Renal Dosing
Extended release product – Do not use in severe renal impairment
Regular release product dosaing recommendations:
CrCl 10-30ml/min: q12h with maximum daily dose of 200mg
CrCl<10ml/min: 50mg q12h Oral
tramadol ER (ULTRAM ER/RYZOLT) 200 mg tablets No Renal Dosing
Extended release product – Do not use in severe renal impairment
Regular release product dosaing recommendations:
CrCl 10-30ml/min: q12h with maximum daily dose of 200mg
CrCl<10ml/min: 50mg q12h Oral
tramadol ER (ULTRAM ER/RYZOLT) 300 mg tablets No Renal Dosing
Extended release product – Do not use in severe renal impairment
Regular release product dosaing recommendations:
CrCl 10-30ml/min: q12h with maximum daily dose of 200mg
CrCl<10ml/min: 50mg q12h Oral
trandolapril - verapamil (TARKA) 1-240 mg tablet No Dispense individual ingredients
Renal Dosing:
Avoid fixed combination product in patients with renal impairment. Oral
trandolapril - verapamil (TARKA) 2-180 mg tablet No Dispense individual ingredients
Renal Dosing:
Avoid fixed combination product in patients with renal impairment. Oral
trandolapril - verapamil (TARKA) 2-240 mg tablet No Dispense individual ingredients
Renal Dosing:
Avoid fixed combination product in patients with renal impairment. Oral
trandolapril - verapamil (TARKA) 4-240 mg tablet No Dispense individual ingredients
Renal Dosing:
Avoid fixed combination product in patients with renal impairment. Oral
trandolapril (MAVIK) 1 mg tablet Yes Renal Dosing:
CrCl<30ml/min: initial dose should be 0.5mg Oral
trandolapril (MAVIK) 2 mg tablet Yes Renal Dosing:
CrCl<30ml/min: initial dose should be 0.5mg Oral
trandolapril (MAVIK) 4 mg tablet Yes Renal Dosing:
CrCl<30ml/min: initial dose should be 0.5mg Oral
triamterene - hydrochlorothiazide 50-25 mg capsule Yes Renal Dosing:
Avoid in patients with creatinine >2.5 mg/dl Oral
triamterene - hydrochlorothiazide (DYAZIDE) 37.5-25 mg capsule Yes Renal Dosing:
Avoid in patients with creatinine >2.5 mg/dl Oral
triamterene - hydrochlorothiazide (MAXZIDE) 75-50 mg tablet No Renal Dosing:
Avoid in patients with creatinine >2.5 mg/dl Oral
triamterene - hydrochlorothiazide (MAXZIDE-25) 37.5-25 mg tablet No Renal Dosing:
Avoid in patients with creatinine >2.5 mg/dl Oral
triamterene (DYRENIUM) 100 mg capsule No Dispense 2 x 50mg
Renal Dosing:
CrCl<10ml/min: Avoid Oral
triamterene (DYRENIUM) 50 mg capsule Yes Renal Dosing:
CrCl<10ml/min: Avoid Oral
trimethoprim - sulfamethoxazole DS (BACTRIM DS, SEPTRA DS) 160-800 mg tablet Yes Renal Dosing:
For gram negative infection
CrCl 50-80ml/min: 10mg TMP/kg/day div. q8-12h
CrCl 10-50ml/min: 5-7.5mg TMP/kg/day div. q12-24h
CrCl<10ml/min: 2.5-5mg TMP/kg/day q24h
For Pneumocystis carinii pneumonia
CrCl 5 Oral
trimethoprim - sulfamethoxazole (BACTRIM, SEPTRA) 80-400 mg tablet Yes Renal Dosing:
For gram negative infection
CrCl 50-80ml/min: 10mg TMP/kg/day div. q8-12h
CrCl 10-50ml/min: 5-7.5mg TMP/kg/day div. q12-24h
CrCl<10ml/min: 2.5-5mg TMP/kg/day q24h
For Pneumocystis carinii pneumonia
CrCl 5 Oral
trimethoprim - sulfamethoxazole (SEPTRA) intravenous Yes Renal Dosing:
For gram negative infection
CrCl 50-80ml/min: 10mg TMP/kg/day div. q8-12h
CrCl 10-50ml/min: 5-7.5mg TMP/kg/day div. q12-24h
CrCl<10ml/min: 2.5-5mg TMP/kg/day q24h
For Pneumocystis carinii pneumonia
CrCl 5 Intravenous
trimethoprim - sulfamethoxazole (SULFATRIM) 40-200 mg/5 ml oral suspension No Renal Dosing:
For gram negative infection
CrCl 50-80ml/min: 10mg TMP/kg/day div. q8-12h
CrCl 10-50ml/min: 5-7.5mg TMP/kg/day div. q12-24h
CrCl<10ml/min: 2.5-5mg TMP/kg/day q24h
For Pneumocystis carinii pneumonia
CrCl 5 Oral
trimethoprim (TRIMPEX, PROLOPRIM)100 mg tablet Yes Renal Dosing:
CrCl 15-30ml/min: 50mg q12h
CrCl<15ml/min: Avoid Oral
trospium (SANCTURA) 20 mg tablet No Renal Dosing:
CrCl<30ml/min: 20mg qhs Oral
trospium ER (SANCTURA XR) 60 mg tablet No Renal Dosing:
Avoid extended-release product in patients with renal impairment.
CrCl<30ml/min: 20mg qhs Oral
valacyclovir (VALTREX) 1 g tablet No Dispense 2 x 500mg
Renal Dosing:
CrCl 10-50ml/min: 1gm q12-24h
CrCl<10ml/min: 0.5gm q24h Oral
valacyclovir (VALTREX) 500 mg tablet Yes Renal Dosing:
CrCl 10-50ml/min: 1gm q12-24h
CrCl<10ml/min: 0.5gm q24h Oral
valganciclovir (VALCYTE) 450 mg tablet Yes Renal Dosing:
Induction dose:
CrCl>60ml/min: 900mg bid
CrCl 40-59ml/min: 450mg bid
CrCl 25-39ml/min: 450mg daily
CrCl 10-24ml/min: 450mg every 2 days
Maintenance dose
CrCl>60ml/min: 900mg daily
CrC Oral
valproic acid (DEPAKENE) 250 mg capsule Yes Oral
valproic acid (DEPAKENE) 250 mg/5 ml oral liquid Yes Oral
valproic acid dosing per pharmacy guideline Yes Per Pharmacy
valsartan - hydrochlorothiazide (DIOVAN HCT) 160-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
valsartan - hydrochlorothiazide (DIOVAN HCT) 160-25 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
valsartan - hydrochlorothiazide (DIOVAN HCT) 320-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
valsartan - hydrochlorothiazide (DIOVAN HCT) 320-25 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
valsartan - hydrochlorothiazide (DIOVAN HCT) 80-12.5 mg tablet No Dispense individual ingredients
Renal Dosing:
Hydrochlorothiazide
Usually ineffective in patients with CrCl < 30ml/min Oral
valsartan (DIOVAN) 160 mg tablet Yes Oral
valsartan (DIOVAN) 320 mg tablet Yes Oral
valsartan (DIOVAN) 40 mg tablet Yes Oral
valsartan (DIOVAN) 80 mg tablet Yes Oral
vancomycin (VANCOCIN) 1000 mg intravenous Yes Renal Dosing:
Contact pharmacist for dosage recommendation in patient with renal impairment Advantage
vancomycin (VANCOCIN) 125 mg capsule No Oral
vancomycin (VANCOCIN) 1250 mg injection Yes Renal Dosing:
Contact pharmacist for dosage recommendation in patient with renal impairment IVPB
vancomycin (VANCOCIN) 1500 mg injection Yes Renal Dosing:
Contact pharmacist for dosage recommendation in patient with renal impairment IVPB
vancomycin (VANCOCIN) 2000 mg injection Yes Renal Dosing:
Contact pharmacist for dosage recommendation in patient with renal impairment IVPB
vancomycin (VANCOCIN) 500 mg intravenous Yes Renal Dosing:
Contact pharmacist for dosage recommendation in patient with renal impairment Advantage
vancomycin (VANCOCIN) 750 mg injection Yes Renal Dosing:
Contact pharmacist for dosage recommendation in patient with renal impairment IVPB
vancomycin (VANCOCIN) dosing per pharmacy guideline Yes Per Pharmacy
vancomycin (VANCOCIN) intravenous Yes Renal Dosing:
Contact pharmacist for dosage recommendation in patient with renal impairment Intravenous
varenicline (CHANTIX) 0.5 mg tablets Yes Renal Dosing:
CrCl<30ml/min: initial dose should be 0.5mg daily
Hemodialysis patients: maximum dose is 0.5mg daily Oral
varenicline (CHANTIX) 1 mg tablets No Dispense 2 x 0.5mg
Renal Dosing:
CrCl<30ml/min: initial dose should be 0.5mg daily
Hemodialysis patients: maximum dose is 0.5mg daily Oral
venlafaxine (EFFEXOR) 100 mg tablet No Dispense 2 X 50mg
Renal Dosing:
CrCl 10-70ml/min: reduce dose 25-50%
CrCl<10ml/min: reduce dose 50% Oral
venlafaxine (EFFEXOR) 25 mg tablet No Dispense 1/2 of 50mg
Renal Dosing:
CrCl 10-70ml/min: reduce dose 25-50%
CrCl<10ml/min: reduce dose 50% Oral
venlafaxine (EFFEXOR) 37.5 mg tablet Yes Renal Dosing:
CrCl 10-70ml/min: reduce dose 25-50%
CrCl<10ml/min: reduce dose 50% Oral
venlafaxine (EFFEXOR) 50 mg tablet Yes Renal Dosing:
CrCl 10-70ml/min: reduce dose 25-50%
CrCl<10ml/min: reduce dose 50% Oral
venlafaxine (EFFEXOR) 75 mg tablet Yes Renal Dosing:
CrCl 10-70ml/min: reduce dose 25-50%
CrCl<10ml/min: reduce dose 50% Oral
venlafaxine XR (EFFEXOR XR) 150 mg capsule No Dispense 2 X 75mg
Renal Dosing:
CrCl 10-70ml/min: reduce dose 25-50%
CrCl<10ml/min: reduce dose 50% Oral
venlafaxine XR (EFFEXOR XR) 37.5 mg capsule Yes Renal Dosing:
CrCl 10-70ml/min: reduce dose 25-50%
CrCl<10ml/min: reduce dose 50% Oral
venlafaxine XR (EFFEXOR XR) 75 mg capsule Yes Renal Dosing:
CrCl 10-70ml/min: reduce dose 25-50%
CrCl<10ml/min: reduce dose 50% Oral
zidovudine (RETROVIR, AZT) 10 mg/ml oral liquid Yes Renal Dosing:
CrCl<15ml/min: 100mg q6-8h Oral
zidovudine (RETROVIR, AZT) 100 mg capsule Yes Renal Dosing:
CrCl<15ml/min: 100mg q6-8h Oral
zidovudine (RETROVIR, AZT) 300 mg tablet No Dispense 3 x 100mg
Renal Dosing:
CrCl<15ml/min: 100mg q6-8h Oral
zoledronic (RECLAST) injection No May be administered in: Non Critical Care Areas and all Critical Care Areas
Renal Dosing:
CrCl<35ml/min: Avoid IVPB
zonisamide (ZONEGRAN) 100 mg capsule Yes Renal Dosing:
Avoid in patients with CrCl < 50ml/min - insufficient experience concerning drug dosing and toxicity. Patients with renal disease should be treated with caution and might require slower titration and more frequent monitoring. Oral
zoster vaccine live (ZOSTAVAX) injection Yes Injection